No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4q1sY, 1.0000, 0.00, 1.000, 211, 211, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2, 4q1sK, 0.9992, 0.15, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3, 4y8tY, 0.9990, 0.17, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4, 4y8tK, 0.9990, 0.17, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
5, 4j70Y, 0.9990, 0.16, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
6, 5bxlY, 0.9989, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-G170A MUTANT
7, 5bxlK, 0.9989, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-G170A MUTANT
8, 5bouY, 0.9989, 0.17, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
9, 5bouK, 0.9989, 0.17, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
10, 4ya4Y, 0.9989, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT
11, 4ya4K, 0.9989, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT
12, 4j70K, 0.9989, 0.17, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
13, 5d0wY, 0.9988, 0.19, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT
14, 5d0wK, 0.9988, 0.19, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT
15, 5czaY, 0.9988, 0.18, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT
16, 5czaK, 0.9988, 0.18, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT
17, 5cgfY, 0.9988, 0.18, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-G48C MUTANT
18, 5cgfK, 0.9988, 0.18, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-G48C MUTANT
19, 4z1lY, 0.9988, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
20, 4ya1Y, 0.9988, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116N MUTANT
21, 4ya1K, 0.9988, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116N MUTANT
22, 4y9yY, 0.9988, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116E MUTANT
23, 4y9yK, 0.9988, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116E MUTANT
24, 4y8rY, 0.9988, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116D MUTANT
25, 4y8rK, 0.9988, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116D MUTANT
26, 5fg9Y, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
27, 5fg9K, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
28, 5fg7Y, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-T1A MUTANT
29, 5fg7K, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-T1A MUTANT
30, 4z1lK, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
31, 4y8mY, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
32, 4y8mK, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
33, 4y6vY, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
34, 4y6vK, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
35, 4rurY, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
36, 4rurK, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
37, 4qv7Y, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A50V MUTANT
38, 4qv7K, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A50V MUTANT
39, 4qv4Y, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-M45T MUTANT
40, 4qv4K, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-M45T MUTANT
41, 4quyY, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A49S-MUTANT
42, 4quyK, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A49S-MUTANT
43, 4quxY, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A49T-MUTANT
44, 4quxK, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A49T-MUTANT
45, 3tddY, 0.9987, 0.19, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
46, 3tddK, 0.9987, 0.19, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
47, 5fgaY, 0.9986, 0.20, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
48, 5fgaK, 0.9986, 0.20, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
49, 5cz7Y, 0.9986, 0.20, 0.991, 217, 211, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
50, 5cz7K, 0.9986, 0.20, 0.991, 217, 211, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
51, 4y8uY, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
52, 4y8uK, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
53, 4y8nY, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
54, 4y8nK, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
55, 4y69Y, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
56, 4y69K, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
57, 4x6zZ, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
58, 4qv5Y, 0.9986, 0.20, 0.995, 212, 211, YCP BETA5-M45I MUTANT
59, 4qv5K, 0.9986, 0.20, 0.995, 212, 211, YCP BETA5-M45I MUTANT
60, 4qv1Y, 0.9986, 0.20, 0.995, 212, 211, YCP BETA5-M45A MUTANT
61, 4qv1K, 0.9986, 0.20, 0.995, 212, 211, YCP BETA5-M45A MUTANT
62, 4lqiY, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
63, 4lqiK, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
64, 5cz6Y, 0.9985, 0.20, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
65, 5cz6K, 0.9985, 0.20, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
66, 4ya5Y, 0.9985, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
67, 4ya5K, 0.9985, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
68, 4x6zL, 0.9985, 0.21, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
69, 4qv9Y, 0.9985, 0.20, 0.995, 212, 211, YCP BETA5-C63F MUTANT
70, 4qv9K, 0.9985, 0.21, 0.995, 212, 211, YCP BETA5-C63F MUTANT
71, 4qv3Y, 0.9985, 0.20, 0.995, 212, 211, YCP BETA5-M45V MUTANT
72, 4qv3K, 0.9985, 0.20, 0.995, 212, 211, YCP BETA5-M45V MUTANT
73, 4eu2Z, 0.9985, 0.21, 0.995, 212, 211, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
74, 5fgfY, 0.9984, 0.21, 0.991, 214, 211, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
75, 5fgfK, 0.9984, 0.21, 0.991, 214, 211, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
76, 5cz4Y, 0.9984, 0.21, 1.000, 212, 211, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
77, 5cz4K, 0.9984, 0.21, 1.000, 212, 211, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
78, 4y6aY, 0.9984, 0.21, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
79, 4y6aK, 0.9984, 0.21, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
80, 1rypZ, 0.9984, 0.21, 0.995, 212, 211, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
81, 4ya3Y, 0.9983, 0.22, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
82, 4ya3K, 0.9983, 0.22, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
83, 4ya0Y, 0.9983, 0.22, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
84, 4ya0K, 0.9983, 0.22, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
85, 4qv8Y, 0.9983, 0.22, 0.995, 212, 211, YCP BETA5-C52F MUTANT
86, 4qv8K, 0.9983, 0.22, 0.995, 212, 211, YCP BETA5-C52F MUTANT
87, 2gplY, 0.9983, 0.22, 1.000, 212, 211, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
88, 2gplK, 0.9983, 0.22, 1.000, 212, 211, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
89, 1rypL, 0.9983, 0.22, 0.995, 212, 211, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
90, 5lajY, 0.9982, 0.23, 1.000, 212, 211, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
91, 5lajK, 0.9982, 0.23, 1.000, 212, 211, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
92, 5fgeY, 0.9982, 0.22, 0.995, 218, 211, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
93, 5fgeK, 0.9982, 0.22, 0.995, 218, 211, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
94, 5fgdY, 0.9982, 0.23, 0.995, 216, 211, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
95, 5fgdK, 0.9982, 0.23, 0.995, 215, 211, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
96, 4qzzY, 0.9982, 0.23, 1.000, 212, 211, YCP IN COMPLEX WITH OMURALIDE
97, 4qzzK, 0.9982, 0.23, 1.000, 212, 211, YCP IN COMPLEX WITH OMURALIDE
98, 4eu2L, 0.9982, 0.22, 0.995, 212, 211, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
99, 3e47Y, 0.9980, 0.24, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
100, 3e47K, 0.9980, 0.24, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
101, 5nifL, 0.9979, 0.24, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
102, 4zzgL, 0.9978, 0.25, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
103, 1g0uY, 0.9978, 0.25, 1.000, 212, 211, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
104, 5d0vY, 0.9977, 0.26, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
105, 5d0vK, 0.9977, 0.26, 0.995, 218, 211, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
106, 3wxrZ, 0.9977, 0.26, 1.000, 212, 211, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
107, 1g0uK, 0.9977, 0.26, 1.000, 212, 211, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
108, 4r00Y, 0.9976, 0.26, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
109, 4r00K, 0.9976, 0.26, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
110, 5nifZ, 0.9975, 0.27, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
111, 4qzwY, 0.9975, 0.27, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
112, 4qzwK, 0.9974, 0.27, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
113, 3wxrL, 0.9974, 0.27, 1.000, 212, 211, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
114, 3hyeY, 0.9974, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
115, 3hyeK, 0.9974, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
116, 3dy3Y, 0.9974, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
117, 3dy3K, 0.9974, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
118, 4zzgZ, 0.9973, 0.28, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
119, 4qv6Y, 0.9973, 0.28, 0.995, 212, 211, YCP BETA5-A49V MUTANT
120, 4qv6K, 0.9973, 0.28, 0.995, 212, 211, YCP BETA5-A49V MUTANT
121, 3gptY, 0.9973, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
122, 3gptK, 0.9973, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
123, 3gpwY, 0.9971, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
124, 3gpwK, 0.9971, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
125, 2fakY, 0.9971, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
126, 2fakK, 0.9971, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
127, 3dy4Y, 0.9970, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
128, 3dy4K, 0.9970, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
129, 6gopY, 0.9969, 0.30, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
130, 6gopK, 0.9969, 0.30, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
131, 4qv0K, 0.9964, 0.34, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT
132, 3shjY, 0.9964, 0.32, 1.000, 212, 211, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
133, 3shjK, 0.9964, 0.32, 1.000, 212, 211, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
134, 4v7oZ, 0.9962, 0.33, 0.995, 212, 211, 
135, 4v7oTA, 0.9962, 0.33, 0.995, 212, 211, 
136, 4v7oL, 0.9962, 0.33, 0.995, 212, 211, 
137, 4v7oHB, 0.9962, 0.33, 0.995, 212, 211, 
138, 4qv0Y, 0.9961, 0.36, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT
139, 3un8Y, 0.9961, 0.34, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
140, 3un8K, 0.9961, 0.33, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
141, 1z7qL, 0.9959, 0.35, 0.995, 212, 211, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
142, 5fhsY, 0.9958, 0.35, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
143, 4qw0Y, 0.9958, 0.35, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
144, 4qw0K, 0.9958, 0.35, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
145, 1z7qZ, 0.9958, 0.35, 0.995, 212, 211, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
146, 4fzgY, 0.9957, 0.35, 1.000, 212, 211, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
147, 4fzgK, 0.9957, 0.35, 1.000, 212, 211, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
148, 5fhsK, 0.9956, 0.36, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
149, 4qvyY, 0.9956, 0.36, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
150, 4qvyK, 0.9956, 0.36, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
151, 4fzcY, 0.9956, 0.36, 1.000, 212, 211, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
152, 4fzcK, 0.9956, 0.36, 1.000, 212, 211, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
153, 4r17Y, 0.9941, 0.18, 1.000, 211, 210, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
154, 4r17K, 0.9941, 0.18, 1.000, 211, 210, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
155, 5laiY, 0.9939, 0.19, 1.000, 211, 210, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
156, 5laiK, 0.9939, 0.19, 1.000, 211, 210, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
157, 4r18Y, 0.9937, 0.21, 1.000, 211, 210, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
158, 4r18K, 0.9937, 0.21, 1.000, 211, 210, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
159, 4qvvY, 0.9935, 0.44, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
160, 4qvvK, 0.9935, 0.44, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
161, 4qvwY, 0.9933, 0.44, 0.995, 212, 211, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
162, 4qvwK, 0.9933, 0.45, 0.995, 212, 211, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
163, 1fntL, 0.9931, 0.45, 0.995, 212, 211, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
164, 1fntZ, 0.9930, 0.46, 0.995, 212, 211, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
165, 4y7xY, 0.9929, 0.46, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
166, 4y7xK, 0.9928, 0.46, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
167, 4qw1Y, 0.9922, 0.48, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
168, 4qw1K, 0.9922, 0.48, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
169, 5fghY, 0.9920, 0.49, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
170, 4qvlY, 0.9920, 0.49, 1.000, 212, 211, YCP IN COMPLEX WITH BORTEZOMIB
171, 4qvlK, 0.9920, 0.49, 1.000, 212, 211, YCP IN COMPLEX WITH BORTEZOMIB
172, 5fghK, 0.9919, 0.49, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
173, 5d0xY, 0.9914, 0.51, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
174, 5d0xK, 0.9914, 0.51, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
175, 4r02Y, 0.9911, 0.51, 1.000, 212, 211, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
176, 4jt0Y, 0.9911, 0.51, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
177, 4qw3Y, 0.9910, 0.52, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
178, 4qw3K, 0.9910, 0.52, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
179, 4jt0K, 0.9910, 0.51, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
180, 4qvmY, 0.9909, 0.52, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
181, 4qvmK, 0.9909, 0.52, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
182, 4qbyK, 0.9909, 0.52, 1.000, 212, 211, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
183, 5l5aK, 0.9908, 0.36, 0.776, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
184, 5l5aY, 0.9907, 0.37, 0.776, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
185, 4qbyY, 0.9907, 0.52, 1.000, 212, 211, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
186, 5bxnY, 0.9906, 0.53, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
187, 5bxnK, 0.9906, 0.53, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
188, 5l5bY, 0.9905, 0.38, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
189, 5l5bK, 0.9905, 0.38, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
190, 4qvpY, 0.9904, 0.53, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
191, 4qvpK, 0.9904, 0.53, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
192, 5jhrY, 0.9902, 0.54, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
193, 5jhrK, 0.9901, 0.54, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
194, 4y8kY, 0.9901, 0.54, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
195, 3mg4Y, 0.9901, 0.54, 1.000, 212, 211, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
196, 4y8kK, 0.9900, 0.55, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
197, 5l5rY, 0.9899, 0.40, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
198, 5l5rK, 0.9899, 0.40, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
199, 3bdmY, 0.9897, 0.55, 1.000, 212, 211, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
200, 1jd2R, 0.9897, 0.55, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
201, 4qvnY, 0.9896, 0.56, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
202, 3bdmK, 0.9896, 0.55, 1.000, 212, 211, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
203, 1jd2K, 0.9896, 0.56, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
204, 5l5eY, 0.9895, 0.42, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
205, 4r02K, 0.9895, 0.56, 1.000, 212, 211, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
206, 4qvnK, 0.9895, 0.56, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
207, 4gk7Y, 0.9895, 0.56, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
208, 4gk7K, 0.9895, 0.56, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
209, 3nzjY, 0.9895, 0.56, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
210, 5l5eK, 0.9894, 0.42, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
211, 3nzjK, 0.9894, 0.56, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
212, 5l5wY, 0.9893, 0.42, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
213, 5l5wK, 0.9893, 0.42, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
214, 5m2bY, 0.9890, 0.43, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
215, 5m2bK, 0.9890, 0.43, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
216, 4y7yK, 0.9886, 0.58, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
217, 4y7yY, 0.9885, 0.58, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
218, 4qvqY, 0.9885, 0.59, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
219, 4qvqK, 0.9885, 0.59, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
220, 3mg4K, 0.9885, 0.59, 1.000, 212, 211, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
221, 3mg0K, 0.9883, 0.59, 1.000, 212, 211, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
222, 4inuY, 0.9882, 0.59, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
223, 4inrY, 0.9881, 0.59, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
224, 3mg0Y, 0.9880, 0.60, 1.000, 212, 211, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
225, 4inrK, 0.9879, 0.60, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
226, 3gpjY, 0.9879, 0.60, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
227, 3gpjK, 0.9879, 0.60, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
228, 5dkiY, 0.9878, 0.60, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
229, 5dkiK, 0.9878, 0.60, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
230, 4no1Y, 0.9877, 0.61, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
231, 4no1K, 0.9877, 0.61, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
232, 4inuK, 0.9877, 0.60, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
233, 2f16Y, 0.9877, 0.61, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
234, 2f16K, 0.9876, 0.61, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
235, 4jsqY, 0.9871, 0.62, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
236, 5l64Y, 0.9870, 0.50, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
237, 5dkjY, 0.9870, 0.62, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
238, 5dkjK, 0.9870, 0.62, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
239, 4jsqK, 0.9870, 0.62, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
240, 5mp9l, 0.9869, 0.63, 1.000, 212, 211, 26S PROTEASOME IN PRESENCE OF ATP (S1)
241, 5l64K, 0.9869, 0.50, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
242, 5l5zY, 0.9869, 0.50, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
243, 5l5zK, 0.9869, 0.50, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
244, 4jsuY, 0.9869, 0.63, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
245, 3oevY, 0.9869, 0.63, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
246, 4qwuK, 0.9868, 0.70, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
247, 4jsuK, 0.9868, 0.63, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
248, 3un4K, 0.9868, 0.63, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
249, 4intY, 0.9867, 0.63, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
250, 3un4Y, 0.9867, 0.63, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
251, 4qwuY, 0.9866, 0.71, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
252, 5mp95, 0.9864, 0.64, 1.000, 212, 211, 26S PROTEASOME IN PRESENCE OF ATP (S1)
253, 4intK, 0.9864, 0.64, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
254, 5l5fY, 0.9863, 0.52, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
255, 5l5fK, 0.9863, 0.52, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
256, 3jcpUA, 0.9863, 0.64, 1.000, 212, 211, 
257, 3jcpG, 0.9863, 0.64, 1.000, 212, 211, 
258, 5l5dY, 0.9860, 0.53, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
259, 5l5dK, 0.9859, 0.53, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
260, 5l63Y, 0.9856, 0.54, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
261, 5l63K, 0.9856, 0.54, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
262, 5l60Y, 0.9854, 0.54, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
263, 5l60K, 0.9854, 0.54, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
264, 5l62Y, 0.9852, 0.55, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
265, 5l62K, 0.9852, 0.55, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
266, 5l5iY, 0.9851, 0.55, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
267, 5l5iK, 0.9851, 0.55, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
268, 5l61Y, 0.9850, 0.56, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
269, 5d0tY, 0.9850, 0.67, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
270, 5l61K, 0.9849, 0.56, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
271, 5d0tK, 0.9849, 0.67, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
272, 5mpal, 0.9848, 0.68, 1.000, 212, 211, 26S PROTEASOME IN PRESENCE OF ATP (S2)
273, 3oevK, 0.9848, 0.68, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
274, 5l6bK, 0.9846, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
275, 5l6cY, 0.9845, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
276, 5l6cK, 0.9845, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
277, 5l6bY, 0.9845, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
278, 2zcyY, 0.9845, 0.68, 1.000, 212, 211, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
279, 5cghY, 0.9844, 0.69, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
280, 5cghK, 0.9844, 0.69, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
281, 2zcyK, 0.9844, 0.68, 1.000, 212, 211, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
282, 5l67Y, 0.9843, 0.58, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
283, 5l65Y, 0.9843, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
284, 5l65K, 0.9843, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
285, 5l5xY, 0.9843, 0.57, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
286, 5l5xK, 0.9843, 0.57, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
287, 5l5oY, 0.9843, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
288, 5l5jY, 0.9843, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
289, 5l5jK, 0.9843, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
290, 5l67K, 0.9842, 0.58, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
291, 5l5oK, 0.9842, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
292, 5l5uY, 0.9841, 0.58, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
293, 5l5uK, 0.9841, 0.58, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
294, 5l5tY, 0.9841, 0.58, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
295, 5l5tK, 0.9841, 0.58, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
296, 5l68Y, 0.9840, 0.58, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
297, 5l68K, 0.9840, 0.58, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
298, 5l5pK, 0.9840, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
299, 4y8sY, 0.9840, 0.70, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
300, 5l5vY, 0.9839, 0.59, 0.767, 211, 210,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
301, 5l5vK, 0.9839, 0.59, 0.767, 211, 210,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
302, 5l5pY, 0.9839, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
303, 4y8sK, 0.9839, 0.70, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
304, 5l5yY, 0.9838, 0.59, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
305, 5l5yK, 0.9838, 0.59, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
306, 5l6aY, 0.9837, 0.59, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
307, 5l6aK, 0.9837, 0.59, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
308, 5l66Y, 0.9837, 0.59, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
309, 5l66K, 0.9837, 0.59, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
310, 5mpa5, 0.9836, 0.70, 1.000, 212, 211, 26S PROTEASOME IN PRESENCE OF ATP (S2)
311, 4qwrY, 0.9835, 0.71, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
312, 5lttY, 0.9834, 0.60, 0.776, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
313, 4qwrK, 0.9834, 0.71, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
314, 4ltcY, 0.9834, 0.71, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
315, 5lttK, 0.9833, 0.60, 0.776, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
316, 3nzxY, 0.9833, 0.71, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
317, 3nzxK, 0.9832, 0.71, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
318, 5l5sY, 0.9831, 0.61, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
319, 5l5sK, 0.9831, 0.61, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
320, 5l5hY, 0.9830, 0.61, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
321, 5l5hK, 0.9830, 0.61, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
322, 5fggY, 0.9830, 0.72, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
323, 5fggK, 0.9830, 0.72, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
324, 5l5qK, 0.9829, 0.61, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
325, 5l5qY, 0.9828, 0.61, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
326, 4qwjY, 0.9827, 0.72, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
327, 4qwjK, 0.9827, 0.72, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
328, 4ltcK, 0.9827, 0.72, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
329, 4no8Y, 0.9821, 0.74, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
330, 4no8K, 0.9821, 0.74, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
331, 4qwkY, 0.9820, 0.74, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
332, 5l69Y, 0.9819, 0.63, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
333, 5l69K, 0.9819, 0.64, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
334, 4qwkK, 0.9819, 0.74, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
335, 4qz6Y, 0.9818, 0.74, 0.991, 212, 211, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
336, 4qz6K, 0.9818, 0.74, 0.991, 212, 211, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
337, 5cz9Y, 0.9816, 0.75, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
338, 5cz9K, 0.9816, 0.75, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
339, 4no6Y, 0.9814, 0.75, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
340, 4no6K, 0.9813, 0.75, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
341, 4ya2Y, 0.9812, 0.76, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
342, 5cggY, 0.9811, 0.76, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
343, 4ya2K, 0.9811, 0.76, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
344, 5cggK, 0.9810, 0.76, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
345, 4ya7Y, 0.9803, 0.77, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
346, 4ya7K, 0.9803, 0.77, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
347, 4y70Y, 0.9803, 0.77, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
348, 4y70K, 0.9803, 0.77, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
349, 4qwiY, 0.9803, 0.77, 0.995, 212, 211, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
350, 4qwiK, 0.9803, 0.77, 0.995, 212, 211, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
351, 4y9zY, 0.9802, 0.77, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
352, 4y9zK, 0.9802, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
353, 4y7wY, 0.9802, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
354, 4y78Y, 0.9802, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
355, 4hnpK, 0.9802, 0.78, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
356, 4y7wK, 0.9801, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
357, 4qw7Y, 0.9801, 0.78, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
358, 4qw7K, 0.9801, 0.78, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
359, 4y78K, 0.9800, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
360, 4qwlY, 0.9800, 0.78, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
361, 4qwlK, 0.9800, 0.78, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
362, 4hnpY, 0.9800, 0.78, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
363, 4ya9Y, 0.9799, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
364, 4ya9K, 0.9799, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
365, 4y8pY, 0.9799, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
366, 4y8pK, 0.9799, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
367, 4y8lY, 0.9799, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
368, 4y8lK, 0.9799, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
369, 4qwgK, 0.9799, 0.78, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
370, 4y80Y, 0.9798, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
371, 4y80K, 0.9798, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
372, 4qwgY, 0.9798, 0.78, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
373, 3nzwY, 0.9798, 0.78, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
374, 3jcoUA, 0.9798, 0.78, 1.000, 212, 211, 
375, 3jcoG, 0.9798, 0.78, 1.000, 212, 211, 
376, 4y8hY, 0.9797, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
377, 4y8hK, 0.9797, 0.78, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
378, 4y6zY, 0.9797, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
379, 4nnnY, 0.9797, 0.78, 1.000, 212, 211, YCP IN COMPLEX WITH MG132
380, 4nnnK, 0.9797, 0.78, 1.000, 212, 211, YCP IN COMPLEX WITH MG132
381, 3nzwK, 0.9797, 0.78, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
382, 1g65K, 0.9797, 0.78, 1.000, 212, 211, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
383, 4y8qY, 0.9796, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
384, 4y8qK, 0.9796, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
385, 4y8gY, 0.9796, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
386, 4y6zK, 0.9796, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
387, 4y8gK, 0.9795, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
388, 4qw6Y, 0.9795, 0.79, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
389, 4qw6K, 0.9795, 0.79, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
390, 4hrcY, 0.9795, 0.79, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
391, 5d0sY, 0.9794, 0.79, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
392, 5d0sK, 0.9794, 0.79, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
393, 4y8jY, 0.9794, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
394, 4y8jK, 0.9794, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
395, 4y84Y, 0.9794, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
396, 4y84K, 0.9794, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
397, 4y74Y, 0.9794, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
398, 4no9Y, 0.9794, 0.79, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
399, 4no9K, 0.9794, 0.79, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
400, 1g65Y, 0.9794, 0.79, 1.000, 212, 211, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
401, 5cz5Y, 0.9793, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
402, 5cz5K, 0.9793, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
403, 4y8iY, 0.9793, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
404, 4y8iK, 0.9793, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
405, 4y75Y, 0.9793, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
406, 4y75K, 0.9793, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
407, 4y74K, 0.9793, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
408, 4qz5Y, 0.9793, 0.79, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
409, 4qz5K, 0.9793, 0.79, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
410, 4qwfY, 0.9793, 0.79, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
411, 4qwfK, 0.9793, 0.79, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
412, 5jhsY, 0.9792, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
413, 5jhsK, 0.9792, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
414, 5d0zY, 0.9792, 0.79, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
415, 5d0zK, 0.9792, 0.79, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
416, 4y77Y, 0.9792, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
417, 4y77K, 0.9792, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
418, 4qw5Y, 0.9792, 0.79, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
419, 4qw5K, 0.9792, 0.79, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
420, 3oeuY, 0.9792, 0.80, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
421, 4y82Y, 0.9791, 0.80, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
422, 4y82K, 0.9791, 0.80, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
423, 4y81Y, 0.9791, 0.80, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
424, 4qwsY, 0.9791, 0.80, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
425, 4qwsK, 0.9791, 0.80, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
426, 4y81K, 0.9790, 0.80, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
427, 4hrcK, 0.9790, 0.80, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
428, 5fgiY, 0.9788, 0.80, 1.000, 212, 211, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
429, 5fgiK, 0.9788, 0.80, 1.000, 212, 211, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
430, 4qw4Y, 0.9788, 0.80, 1.000, 212, 211, YCP IN COMPLEX WITH CARFILZOMIB
431, 4qw4K, 0.9788, 0.80, 1.000, 212, 211, YCP IN COMPLEX WITH CARFILZOMIB
432, 3okjY, 0.9788, 0.80, 1.000, 212, 211, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
433, 3okjK, 0.9788, 0.80, 1.000, 212, 211, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
434, 5cz8Y, 0.9786, 0.81, 0.995, 221, 211, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
435, 5ahjK, 0.9786, 0.81, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
436, 5cz8K, 0.9785, 0.81, 0.995, 220, 211, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
437, 5ahjY, 0.9785, 0.81, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
438, 4y8oY, 0.9785, 0.81, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
439, 4y8oK, 0.9785, 0.81, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
440, 4qz3Y, 0.9783, 0.81, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
441, 4qz3K, 0.9783, 0.81, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
442, 3oeuK, 0.9783, 0.82, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
443, 4hrdK, 0.9782, 0.82, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
444, 3mg7Y, 0.9782, 0.82, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
445, 4qz7Y, 0.9781, 0.82, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
446, 4qz7K, 0.9781, 0.82, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
447, 5l54Y, 0.9780, 0.82, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
448, 5l54K, 0.9780, 0.82, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
449, 4hrdY, 0.9780, 0.82, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
450, 3mg7K, 0.9780, 0.82, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
451, 3d29Y, 0.9780, 0.81, 1.000, 212, 211, PROTEASOME INHIBITION BY FELLUTAMIDE B
452, 3d29K, 0.9780, 0.82, 1.000, 212, 211, PROTEASOME INHIBITION BY FELLUTAMIDE B
453, 3sdiY, 0.9779, 0.83, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
454, 3sdiK, 0.9778, 0.83, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
455, 5l55Y, 0.9777, 0.82, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
456, 5l55K, 0.9777, 0.82, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
457, 4qltY, 0.9777, 0.82, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
458, 4qltK, 0.9777, 0.82, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
459, 3mg6K, 0.9777, 0.83, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
460, 3mg6Y, 0.9776, 0.83, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
461, 5cgiY, 0.9775, 0.83, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
462, 5cgiK, 0.9775, 0.83, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
463, 3sdkY, 0.9775, 0.83, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
464, 5l52Y, 0.9774, 0.83, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
465, 5l52K, 0.9774, 0.83, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
466, 5mpcL, 0.9772, 0.84, 1.000, 212, 211, 
467, 4nnwY, 0.9772, 0.83, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
468, 4qz4Y, 0.9771, 0.84, 0.995, 212, 211, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
469, 4qwxK, 0.9771, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
470, 4nnwK, 0.9771, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
471, 3sdkK, 0.9771, 0.84, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
472, 3mg8Y, 0.9771, 0.84, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
473, 4qz4K, 0.9770, 0.84, 0.995, 212, 211, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
474, 4qxjY, 0.9770, 0.84, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
475, 4qxjK, 0.9770, 0.84, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
476, 4qluY, 0.9770, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
477, 4qluK, 0.9770, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
478, 4qzxK, 0.9769, 0.84, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
479, 4qlvY, 0.9769, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
480, 4qlvK, 0.9769, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
481, 4qlsY, 0.9769, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
482, 4qlsK, 0.9769, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
483, 4g4sL, 0.9769, 0.84, 1.000, 212, 211, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
484, 4qzxY, 0.9768, 0.84, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
485, 4qz1K, 0.9768, 0.84, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
486, 4qz0Y, 0.9768, 0.84, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
487, 4qz0K, 0.9768, 0.84, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
488, 4qwxY, 0.9768, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
489, 4qz1Y, 0.9767, 0.84, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
490, 3mg8K, 0.9767, 0.85, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
491, 4qz2Y, 0.9762, 0.85, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
492, 4qz2K, 0.9762, 0.85, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
493, 4qlqK, 0.9748, 0.88, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
494, 4qlqY, 0.9747, 0.88, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
495, 5mpbZ, 0.9707, 0.96, 1.000, 212, 211, 
496, 5mpcZ, 0.9700, 1.00, 1.000, 212, 211, 
497, 5wvkE, 0.9690, 0.99, 1.000, 212, 211, 
498, 5mpbL, 0.9651, 1.06, 1.000, 212, 211, 
499, 5wvkL, 0.9599, 1.12, 1.000, 212, 211, 
500, 5wviIA, 0.9446, 1.34, 1.000, 212, 211, 
501, 5wviSA, 0.9444, 1.35, 1.000, 212, 211, 
502, 4r3oZ, 0.9357, 0.62, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
503, 4r3oL, 0.9357, 0.62, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
504, 3uneK, 0.9343, 0.66, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
505, 1iruZ, 0.9340, 0.67, 0.665, 201, 200, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
506, 1iruL, 0.9340, 0.67, 0.665, 201, 200, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
507, 5gjqs, 0.9339, 0.67, 0.665, 201, 200, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
508, 5gjrRA, 0.9337, 0.67, 0.665, 201, 200, 
509, 5gjrDA, 0.9336, 0.67, 0.665, 201, 200, 
510, 5gjqe, 0.9331, 0.69, 0.665, 201, 200, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
511, 3une1, 0.9331, 0.69, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
512, 3uneY, 0.9330, 0.69, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
513, 3unem, 0.9323, 0.71, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
514, 5le5K, 0.9321, 0.72, 0.665, 201, 200, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
515, 5l4gZ, 0.9299, 0.76, 0.665, 201, 200, 
516, 5lexK, 0.9296, 0.66, 0.668, 200, 199, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
517, 5l4gL, 0.9294, 0.77, 0.665, 201, 200, 
518, 5lf3Y, 0.9288, 0.79, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
519, 4r67L, 0.9283, 0.79, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
520, 4r673, 0.9283, 0.79, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
521, 4r67Z, 0.9281, 0.79, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
522, 5vfqL, 0.9279, 0.80, 0.665, 201, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
523, 4r67n, 0.9279, 1.97, 0.207, 213, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
524, 5vfpL, 0.9278, 0.80, 0.665, 201, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
525, 5vfuCA, 0.9274, 0.80, 0.665, 201, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
526, 5vftR, 0.9274, 2.19, 0.230, 215, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
527, 5lf1Y, 0.9274, 0.81, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
528, 5lf0Y, 0.9272, 0.81, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
529, 5vfsL, 0.9269, 0.82, 0.665, 201, 200, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
530, 5vfoR, 0.9268, 0.82, 0.665, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
531, 5vfor, 0.9267, 0.82, 0.665, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
532, 5vfqKA, 0.9266, 2.08, 0.201, 213, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
533, 5lf7Y, 0.9265, 0.82, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
534, 5vfpJA, 0.9264, 0.83, 0.665, 201, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
535, 5lf4Y, 0.9260, 0.83, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
536, 5vfrR, 0.9259, 0.83, 0.665, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
537, 5vfsKA, 0.9258, 0.83, 0.665, 201, 200, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
538, 5t0cJB, 0.9256, 0.84, 0.665, 201, 200, 
539, 5t0cDA, 0.9256, 0.84, 0.660, 201, 200, 
540, 5lexY, 0.9256, 0.85, 0.665, 201, 200, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
541, 5lf3K, 0.9254, 0.85, 0.660, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
542, 5vfrr, 0.9253, 0.85, 0.660, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
543, 5le5Y, 0.9253, 0.64, 0.672, 199, 198, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
544, 5lf0K, 0.9239, 0.75, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
545, 5lf1K, 0.9238, 0.85, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
546, 5t0gR, 0.9237, 0.65, 0.672, 199, 198, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
547, 5lf6Y, 0.9237, 0.79, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
548, 5vfuQA, 0.9233, 0.79, 0.668, 200, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
549, 5vftr, 0.9233, 0.88, 0.660, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
550, 3unhY, 0.9232, 0.89, 0.665, 201, 200, MOUSE 20S IMMUNOPROTEASOME
551, 3unhK, 0.9232, 0.89, 0.665, 201, 200, MOUSE 20S IMMUNOPROTEASOME
552, 3unb1, 0.9230, 0.89, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
553, 5lf7K, 0.9228, 0.90, 0.620, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
554, 3unbY, 0.9225, 0.90, 0.620, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
555, 5lezK, 0.9224, 0.90, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
556, 5lf4K, 0.9221, 0.81, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
557, 5leyK, 0.9216, 0.90, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
558, 3unbK, 0.9206, 0.82, 0.668, 200, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
559, 3unbm, 0.9205, 0.82, 0.668, 200, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
560, 5lf6K, 0.9200, 0.84, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
561, 4cr45, 0.9187, 0.94, 0.665, 201, 200, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
562, 3unfK, 0.9183, 0.94, 0.665, 201, 200, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
563, 3unfY, 0.9182, 0.87, 0.668, 200, 199, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
564, 5lezY, 0.9176, 1.66, 0.981, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
565, 5leyY, 0.9169, 0.98, 0.620, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
566, 6avoD, 0.9161, 0.98, 0.620, 201, 200, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
567, 6avoC, 0.9161, 0.82, 0.672, 199, 198, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
568, 5m32Y, 0.9153, 0.84, 0.672, 199, 198, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
569, 5m32K, 0.9122, 1.02, 0.600, 201, 200, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
570, 4cr25, 0.9118, 1.02, 0.600, 201, 200, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
571, 5a5b5, 0.9116, 1.04, 0.660, 201, 200, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
572, 4cr35, 0.9116, 1.01, 0.663, 200, 199, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
573, 5t0hR, 0.9074, 1.96, 0.976, 212, 209, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
574, 5t0iR, 0.8965, 1.84, 0.976, 212, 209, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
575, 5t0jR, 0.8938, 1.84, 0.976, 212, 209, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
576, 3mi0V, 0.8786, 1.16, 0.660, 201, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
577, 3mi0R, 0.8786, 1.39, 0.660, 201, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
578, 5gjqo, 0.8776, 1.38, 0.660, 201, 200, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
579, 5gjrNA, 0.8771, 2.57, 0.232, 239, 211, 
580, 5gjrZ, 0.8770, 2.57, 0.232, 239, 211, 
581, 4r3oV, 0.8770, 1.78, 0.269, 202, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
582, 4r3oH, 0.8770, 1.79, 0.269, 202, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
583, 5gjqa, 0.8756, 1.79, 0.269, 202, 201, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
584, 3uneN, 0.8756, 1.79, 0.269, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
585, 3unep, 0.8753, 1.80, 0.269, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
586, 3uneb, 0.8752, 1.81, 0.269, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
587, 5le5N, 0.8750, 1.82, 0.264, 202, 201, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
588, 3une4, 0.8746, 1.82, 0.264, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
589, 5le5b, 0.8744, 1.81, 0.264, 202, 201, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
590, 5a0qZ, 0.8742, 1.80, 0.269, 202, 201, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
591, 5a0qL, 0.8742, 1.81, 0.264, 202, 201, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
592, 5lf1N, 0.8737, 1.82, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
593, 4r67x, 0.8737, 1.03, 0.681, 192, 191, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
594, 4r67H, 0.8737, 1.03, 0.681, 192, 191, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
595, 5lf1b, 0.8736, 1.83, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
596, 4r67V, 0.8736, 1.83, 0.269, 202, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
597, 4r67j, 0.8736, 1.83, 0.269, 202, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
598, 5lf0N, 0.8734, 1.84, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
599, 5l4gM, 0.8734, 1.83, 0.269, 202, 201, 
600, 5lf0b, 0.8729, 1.83, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
601, 5leyN, 0.8729, 1.83, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
602, 5leyb, 0.8728, 1.62, 0.271, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
603, 5lf3N, 0.8726, 1.84, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
604, 5lf3b, 0.8723, 1.85, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
605, 1iruH, 0.8723, 1.84, 0.269, 203, 201, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
606, 1pmaY, 0.8722, 1.86, 0.269, 202, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
607, 1iruV, 0.8722, 1.86, 0.269, 203, 201, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
608, 5lf7N, 0.8720, 1.86, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
609, 5lexb, 0.8720, 2.18, 0.255, 203, 200, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
610, 1pma1, 0.8720, 1.86, 0.269, 202, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
611, 5lf7b, 0.8719, 1.87, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
612, 5lexN, 0.8719, 1.87, 0.269, 203, 201, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
613, 1pmaZ, 0.8719, 2.19, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
614, 5vy3Z, 0.8717, 1.86, 0.269, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
615, 5vy3X, 0.8717, 1.87, 0.269, 202, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
616, 5vy3V, 0.8717, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
617, 5vy3T, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
618, 5vy3R, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
619, 5vy3P, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
620, 5vy3N, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
621, 5vy3L, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
622, 5vy3J, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
623, 5vy3H, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
624, 5vy3F, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
625, 5vy3D, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
626, 5vy3B, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
627, 5vy31, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
628, 1ya7M, 0.8716, 2.22, 0.255, 203, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
629, 5vy4Z, 0.8715, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
630, 5vy4X, 0.8715, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
631, 5vy4V, 0.8715, 2.24, 0.250, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
632, 5vy4T, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
633, 5vy4R, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
634, 5vy4P, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
635, 5vy4N, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
636, 5vy4L, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
637, 5vy4J, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
638, 5vy4H, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
639, 5vy4F, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
640, 5vy4D, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
641, 5vy4BA, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
642, 5vy4B, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
643, 5vy41, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
644, 3c92Z, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
645, 3c92X, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
646, 3c92W, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
647, 3c92L, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
648, 3c92J, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
649, 3c92I, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
650, 3c91Z, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
651, 3c91X, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
652, 3c91W, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
653, 3c91L, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
654, 3c91J, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
655, 3c91I, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
656, 1pmaS, 0.8715, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
657, 1pmaQ, 0.8715, 2.19, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
658, 1pmaP, 0.8715, 2.19, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
659, 5lf6N, 0.8714, 2.20, 0.255, 203, 200, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
660, 5lf6b, 0.8714, 2.19, 0.255, 203, 200, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
661, 3c92V, 0.8714, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
662, 3c92H, 0.8714, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
663, 3c91V, 0.8714, 1.87, 0.269, 202, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
664, 3c91H, 0.8714, 1.86, 0.269, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
665, 1pmaW, 0.8714, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
666, 1pmaB, 0.8714, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
667, 1pma2, 0.8714, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
668, 3c92N, 0.8713, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
669, 3c922, 0.8713, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
670, 3c91N, 0.8713, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
671, 3c912, 0.8713, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
672, 1pmaV, 0.8713, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
673, 1pmaU, 0.8713, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
674, 1yauM, 0.8711, 2.20, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
675, 1yarM, 0.8711, 2.20, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
676, 5m32b, 0.8710, 2.20, 0.255, 203, 200, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
677, 3jseM, 0.8710, 2.20, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
678, 3c92Y, 0.8710, 2.25, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
679, 3c92M, 0.8710, 2.24, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
680, 3c92K, 0.8710, 1.87, 0.269, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
681, 3c921, 0.8710, 2.23, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
682, 3c91Y, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
683, 3c91M, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
684, 3c91K, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
685, 3c911, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
686, 1pmaT, 0.8710, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
687, 1pmaR, 0.8710, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
688, 3jseK, 0.8709, 2.20, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
689, 1pmaX, 0.8709, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
690, 5m32N, 0.8708, 2.20, 0.255, 203, 200, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
691, 3jseL, 0.8708, 2.20, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
692, 3jseJ, 0.8708, 2.25, 0.250, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
693, 3jseN, 0.8707, 2.20, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
694, 3jseI, 0.8707, 1.89, 0.269, 202, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
695, 3jseH, 0.8707, 2.25, 0.250, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
696, 6avoF, 0.8705, 2.25, 0.250, 203, 200, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
697, 5lzpP, 0.8705, 2.25, 0.250, 203, 200, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
698, 6avoA, 0.8704, 2.25, 0.250, 203, 200, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
699, 5lf4N, 0.8704, 2.25, 0.250, 203, 200, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
700, 1ya7L, 0.8704, 1.58, 0.293, 199, 198, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
701, 1ya7K, 0.8704, 2.63, 0.230, 234, 209, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
702, 5lzpN, 0.8703, 1.58, 0.293, 199, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
703, 3unb4, 0.8703, 1.87, 0.269, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
704, 5lf4b, 0.8702, 2.24, 0.255, 203, 200, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
705, 3unbb, 0.8702, 2.23, 0.255, 203, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
706, 1yauL, 0.8702, 2.61, 0.230, 234, 209, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
707, 1yarJ, 0.8702, 1.89, 0.264, 202, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
708, 1ya7J, 0.8702, 1.88, 0.269, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
709, 1ya7H, 0.8702, 1.87, 0.264, 202, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
710, 1j2qN, 0.8702, 2.25, 0.255, 203, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
711, 1j2qL, 0.8702, 2.25, 0.255, 203, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
712, 1j2qJ, 0.8702, 2.23, 0.255, 203, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
713, 5lezN, 0.8701, 2.24, 0.255, 203, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
714, 3unbp, 0.8701, 2.14, 0.310, 202, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
715, 3jtlM, 0.8701, 2.14, 0.310, 202, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
716, 3jtlL, 0.8701, 2.14, 0.310, 202, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
717, 3jtlJ, 0.8701, 1.88, 0.269, 202, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
718, 1yauJ, 0.8701, 1.90, 0.264, 202, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
719, 1ya7I, 0.8701, 2.24, 0.255, 203, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
720, 1j2qK, 0.8701, 2.24, 0.255, 203, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
721, 1j2qI, 0.8701, 2.24, 0.255, 203, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
722, 1j2qH, 0.8701, 2.24, 0.255, 203, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
723, 3jtlN, 0.8700, 2.26, 0.250, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
724, 3jtlK, 0.8700, 2.14, 0.310, 202, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
725, 3jtlI, 0.8700, 2.14, 0.310, 202, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
726, 3jrmM, 0.8700, 2.14, 0.310, 202, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
727, 1yauK, 0.8700, 2.24, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
728, 1yarK, 0.8700, 2.24, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
729, 1j2qM, 0.8700, 2.24, 0.255, 203, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
730, 3unbN, 0.8699, 2.26, 0.255, 203, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
731, 3jtlH, 0.8699, 2.24, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
732, 3jrmL, 0.8699, 2.24, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
733, 3jrmK, 0.8699, 2.14, 0.310, 202, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
734, 3jrmJ, 0.8699, 1.90, 0.264, 202, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
735, 3jrmI, 0.8699, 2.24, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
736, 3jrmH, 0.8699, 2.26, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
737, 1yarL, 0.8699, 2.26, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
738, 5lezb, 0.8697, 2.26, 0.255, 203, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
739, 3jrmN, 0.8697, 2.26, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
740, 1yauI, 0.8697, 2.26, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
741, 1yarI, 0.8697, 2.24, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
742, 1ya7N, 0.8696, 1.89, 0.269, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
743, 1yauN, 0.8694, 2.26, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
744, 1yarN, 0.8694, 2.26, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
745, 1yauH, 0.8693, 2.25, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
746, 1yarH, 0.8689, 2.26, 0.250, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
747, 3krdV, 0.8682, 2.27, 0.250, 203, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
748, 3h4pl, 0.8682, 2.25, 0.255, 203, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
749, 3h4pf, 0.8678, 2.26, 0.255, 203, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
750, 3krdR, 0.8677, 2.25, 0.255, 203, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
751, 3h4pg, 0.8675, 2.73, 0.229, 229, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
752, 3h4pj, 0.8674, 2.12, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
753, 5l4gAA, 0.8673, 2.14, 0.291, 202, 199, 
754, 3h4ph, 0.8672, 2.74, 0.229, 229, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
755, 3h4pd, 0.8672, 2.26, 0.285, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
756, 3h4pa, 0.8672, 2.14, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
757, 3j9iZ, 0.8671, 1.65, 0.273, 199, 198, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
758, 3j9iY, 0.8671, 2.14, 0.291, 202, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
759, 3j9iX, 0.8671, 2.13, 0.291, 202, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
760, 3j9iW, 0.8671, 2.15, 0.291, 202, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
761, 3j9iV, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
762, 3j9iN, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
763, 3j9iM, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
764, 3j9iL, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
765, 3j9iK, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
766, 3j9iJ, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
767, 3j9iI, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
768, 3j9iH, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
769, 3j9i2, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
770, 3j9i1, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
771, 3h4pi, 0.8668, 2.31, 0.254, 203, 201, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
772, 3h4pk, 0.8667, 2.31, 0.254, 203, 201, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
773, 3hfaX, 0.8666, 2.31, 0.254, 203, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
774, 1q5qN, 0.8666, 2.31, 0.254, 203, 201, THE RHODOCOCCUS 20S PROTEASOME
775, 1q5qJ, 0.8666, 2.14, 0.291, 202, 199, THE RHODOCOCCUS 20S PROTEASOME
776, 1q5qL, 0.8665, 2.14, 0.291, 202, 199, THE RHODOCOCCUS 20S PROTEASOME
777, 1q5qK, 0.8665, 2.44, 0.233, 224, 206, THE RHODOCOCCUS 20S PROTEASOME
778, 1q5qH, 0.8665, 2.18, 0.265, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
779, 6avoE, 0.8664, 2.18, 0.265, 224, 204, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
780, 6avoB, 0.8664, 2.18, 0.265, 224, 204, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
781, 1q5qM, 0.8664, 2.18, 0.265, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
782, 1q5qI, 0.8664, 2.18, 0.265, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
783, 3h4pm, 0.8663, 1.27, 0.281, 219, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
784, 3h4pc, 0.8663, 1.27, 0.281, 219, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
785, 3hfaZ, 0.8662, 2.19, 0.265, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
786, 3h4pn, 0.8662, 2.19, 0.265, 224, 204, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
787, 3hfaV, 0.8660, 2.13, 0.291, 202, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
788, 3h4pb, 0.8660, 2.14, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
789, 3h4pe, 0.8658, 2.48, 0.233, 224, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
790, 6bdfZ, 0.8655, 2.13, 0.291, 202, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
791, 6bdfX, 0.8655, 2.49, 0.233, 226, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
792, 6bdfV, 0.8655, 2.14, 0.291, 202, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
793, 6bdfT, 0.8655, 2.15, 0.291, 202, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
794, 6bdfR, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
795, 6bdfP, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
796, 6bdfN, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
797, 6bdfL, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
798, 6bdfJ, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
799, 6bdfH, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
800, 6bdfF, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
801, 6bdfD, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
802, 6bdfB, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
803, 6bdf1, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
804, 3hfaT, 0.8654, 2.21, 0.256, 201, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
805, 3hfaN, 0.8653, 2.21, 0.256, 201, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
806, 3hfaE, 0.8653, 2.21, 0.256, 201, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
807, 3mi0L, 0.8651, 2.21, 0.256, 201, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
808, 3hfaH, 0.8650, 2.39, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
809, 3mi02, 0.8649, 2.39, 0.239, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
810, 3mi0E, 0.8647, 2.39, 0.239, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
811, 3mi0Z, 0.8645, 2.40, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
812, 3mi0T, 0.8645, 2.40, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
813, 3unhV, 0.8644, 2.39, 0.234, 223, 205, MOUSE 20S IMMUNOPROTEASOME
814, 3unhH, 0.8644, 2.39, 0.234, 223, 205, MOUSE 20S IMMUNOPROTEASOME
815, 5l4gBA, 0.8643, 2.39, 0.234, 223, 205, 
816, 4q1sV, 0.8643, 2.40, 0.234, 223, 205, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
817, 5trgL, 0.8642, 1.32, 0.276, 219, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
818, 5le5H, 0.8642, 1.32, 0.276, 219, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
819, 4r3oI, 0.8641, 1.34, 0.250, 220, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
820, 4q1sH, 0.8641, 1.34, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
821, 3unhN, 0.8641, 2.38, 0.234, 223, 205, MOUSE 20S IMMUNOPROTEASOME
822, 3unhb, 0.8641, 1.36, 0.250, 220, 192, MOUSE 20S IMMUNOPROTEASOME
823, 3tddV, 0.8641, 1.35, 0.250, 220, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
824, 3tddH, 0.8641, 1.34, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
825, 3mi0X, 0.8640, 1.67, 0.278, 199, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
826, 5gjrAA, 0.8639, 1.67, 0.278, 199, 198, 
827, 4r3oW, 0.8639, 1.34, 0.276, 222, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
828, 5lf1H, 0.8638, 1.34, 0.276, 222, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
829, 5lzpU, 0.8637, 2.41, 0.234, 223, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
830, 5gjrOA, 0.8637, 1.35, 0.250, 220, 192, 
831, 5trrL, 0.8636, 1.35, 0.250, 220, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
832, 5le5V, 0.8636, 1.36, 0.250, 220, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
833, 3hfaR, 0.8636, 2.41, 0.229, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
834, 5lzpO, 0.8635, 1.35, 0.250, 220, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
835, 5lf1V, 0.8635, 2.40, 0.234, 223, 205, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
836, 5l6cV, 0.8635, 1.36, 0.250, 220, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
837, 5l6cH, 0.8635, 2.35, 0.235, 222, 204, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
838, 3e47H, 0.8635, 2.41, 0.229, 223, 205, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
839, 4j70H, 0.8634, 1.36, 0.250, 220, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
840, 3e47V, 0.8634, 1.35, 0.276, 226, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
841, 5trsL, 0.8633, 1.35, 0.276, 226, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
842, 4j70V, 0.8633, 1.35, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
843, 3unfN, 0.8633, 1.35, 0.276, 222, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
844, 3unfb, 0.8633, 1.35, 0.276, 222, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
845, 3mg6V, 0.8633, 2.40, 0.234, 223, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
846, 3hfaL, 0.8633, 1.35, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
847, 1iruW, 0.8633, 1.67, 0.283, 199, 198, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
848, 3hfaP, 0.8632, 1.67, 0.283, 199, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
849, 3hfaG, 0.8632, 1.34, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
850, 3hfaC, 0.8632, 2.36, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
851, 3hfa2, 0.8632, 1.36, 0.250, 220, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
852, 1iruI, 0.8632, 2.37, 0.235, 222, 204, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
853, 5trgY, 0.8631, 2.37, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
854, 5l67V, 0.8631, 2.37, 0.235, 222, 204, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
855, 5l67H, 0.8631, 2.36, 0.235, 222, 204, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
856, 5l5vV, 0.8631, 1.36, 0.250, 220, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
857, 5l5vH, 0.8631, 2.39, 0.234, 223, 205,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
858, 5l5pV, 0.8631, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
859, 5l5pH, 0.8631, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
860, 4zzgI, 0.8631, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
861, 4v7oW, 0.8631, 1.35, 0.276, 226, 192, 
862, 4v7oI, 0.8631, 1.35, 0.276, 226, 192, 
863, 4r67y, 0.8631, 1.35, 0.276, 226, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
864, 4r67k, 0.8631, 1.35, 0.276, 222, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
865, 3mi0N, 0.8631, 1.35, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
866, 5lzpI, 0.8630, 1.35, 0.276, 222, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
867, 5l64V, 0.8630, 1.36, 0.250, 220, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
868, 5l64H, 0.8630, 1.36, 0.250, 220, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
869, 5l5tV, 0.8630, 2.38, 0.235, 222, 204, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
870, 5l5tH, 0.8630, 2.42, 0.229, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
871, 4z1lH, 0.8630, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
872, 4v7oEB, 0.8630, 1.36, 0.276, 226, 192, 
873, 4r67W, 0.8630, 1.36, 0.276, 226, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
874, 4r67I, 0.8630, 1.36, 0.276, 226, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
875, 3unex, 0.8630, 1.35, 0.276, 226, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
876, 3hfaJ, 0.8630, 1.35, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
877, 5nifI, 0.8629, 1.36, 0.250, 220, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
878, 5lf3H, 0.8629, 1.36, 0.250, 220, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
879, 5lexH, 0.8629, 1.37, 0.250, 220, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
880, 5l5qV, 0.8629, 2.37, 0.235, 222, 204, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
881, 5l5qH, 0.8629, 1.35, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
882, 4z1lV, 0.8629, 1.38, 0.250, 220, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
883, 4v7oQA, 0.8629, 1.37, 0.250, 220, 192, 
884, 3mg8V, 0.8629, 1.35, 0.276, 226, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
885, 3mg7V, 0.8629, 1.35, 0.276, 226, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
886, 5lzpC, 0.8628, 1.35, 0.276, 226, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
887, 5l5uH, 0.8628, 1.35, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
888, 5l5oV, 0.8628, 1.35, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
889, 4y8mV, 0.8628, 1.35, 0.276, 222, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
890, 4y8mH, 0.8628, 2.41, 0.229, 223, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
891, 3unfH, 0.8628, 1.36, 0.276, 226, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
892, 3uneV, 0.8628, 1.36, 0.276, 226, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
893, 5tryL, 0.8627, 1.36, 0.276, 226, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
894, 5lttV, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
895, 5lttH, 0.8627, 1.34, 0.276, 219, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
896, 5laiH, 0.8627, 1.38, 0.250, 220, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
897, 5l6aV, 0.8627, 2.41, 0.234, 223, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
898, 5l6aH, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
899, 5l5uV, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
900, 5l5oH, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
901, 5cz4H, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
902, 5bouH, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
903, 4r17V, 0.8627, 1.36, 0.276, 226, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
904, 4r17H, 0.8627, 1.36, 0.276, 226, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
905, 3unfV, 0.8627, 1.36, 0.276, 226, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
906, 3sdiH, 0.8627, 1.36, 0.276, 226, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
907, 5vfuNA, 0.8626, 1.36, 0.276, 226, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
908, 5vfto, 0.8626, 1.36, 0.276, 226, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
909, 5thoL, 0.8626, 1.34, 0.276, 219, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
910, 5lf3V, 0.8626, 1.35, 0.276, 222, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
911, 5lf0H, 0.8626, 1.36, 0.250, 220, 192, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
912, 5laiV, 0.8626, 1.36, 0.250, 220, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
913, 5l4gN, 0.8626, 2.40, 0.234, 223, 205, 
914, 5bouV, 0.8626, 1.38, 0.250, 220, 192, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
915, 3oevV, 0.8626, 1.38, 0.250, 220, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
916, 3dy4V, 0.8626, 1.36, 0.276, 226, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
917, 3dy4H, 0.8626, 1.37, 0.250, 220, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
918, 5trsY, 0.8625, 1.36, 0.276, 226, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
919, 5trrb, 0.8625, 1.35, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
920, 5nifW, 0.8625, 1.36, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
921, 5lzpT, 0.8625, 1.36, 0.276, 222, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
922, 5lajV, 0.8625, 2.39, 0.234, 223, 205, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
923, 5lajH, 0.8625, 2.42, 0.234, 223, 205, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
924, 5l69V, 0.8625, 1.35, 0.276, 222, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
925, 5l69H, 0.8625, 2.42, 0.229, 223, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
926, 5l62V, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
927, 5l62H, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
928, 5l5hV, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
929, 5l5hH, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
930, 5fg9H, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
931, 3sdiV, 0.8625, 1.36, 0.276, 226, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
932, 5lf7H, 0.8624, 1.36, 0.276, 226, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
933, 5lexV, 0.8624, 1.36, 0.276, 226, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
934, 5l61V, 0.8624, 1.36, 0.276, 230, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
935, 5l61H, 0.8624, 1.36, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
936, 5l5sV, 0.8624, 1.38, 0.250, 220, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
937, 5l5sH, 0.8624, 1.38, 0.250, 220, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
938, 5fg9V, 0.8624, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
939, 5cghV, 0.8624, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
940, 5cghH, 0.8624, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
941, 4rurV, 0.8624, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
942, 4rurH, 0.8624, 1.36, 0.276, 230, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
943, 3unej, 0.8624, 1.36, 0.276, 222, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
944, 3mi0J, 0.8624, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
945, 5m2bH, 0.8623, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
946, 5lf0V, 0.8623, 1.36, 0.276, 226, 192, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
947, 5l60V, 0.8623, 1.38, 0.250, 220, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
948, 5l60H, 0.8623, 2.38, 0.235, 222, 204, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
949, 4zzgW, 0.8623, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
950, 4ya1H, 0.8623, 1.38, 0.250, 220, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
951, 5trga, 0.8622, 1.36, 0.276, 226, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
952, 5m2bV, 0.8622, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
953, 5lzpR, 0.8622, 1.36, 0.276, 222, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
954, 5l63V, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
955, 5l5rV, 0.8622, 2.41, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
956, 5l5rH, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
957, 5l5jV, 0.8622, 2.43, 0.229, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
958, 5l5jH, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
959, 5l5iV, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
960, 5l5iH, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
961, 4ya1V, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
962, 4y6vV, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
963, 4y6vH, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
964, 4r00V, 0.8622, 1.37, 0.276, 226, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
965, 4r00H, 0.8622, 1.37, 0.276, 226, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
966, 4qz7V, 0.8622, 1.37, 0.276, 226, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
967, 4qz7H, 0.8622, 1.37, 0.276, 226, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
968, 4inrV, 0.8622, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
969, 3uneH, 0.8622, 1.36, 0.276, 226, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
970, 3oevH, 0.8622, 1.36, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
971, 3oeuV, 0.8622, 1.36, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
972, 3mi0G, 0.8622, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
973, 3mg7H, 0.8622, 1.38, 0.250, 220, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
974, 5trra, 0.8621, 1.35, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
975, 5leyH, 0.8621, 1.36, 0.276, 222, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
976, 5l68V, 0.8621, 2.38, 0.235, 222, 204, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
977, 5l68H, 0.8621, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
978, 5l63H, 0.8621, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
979, 5l5bV, 0.8621, 1.39, 0.250, 220, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
980, 5l5bH, 0.8621, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
981, 5cz4V, 0.8621, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
982, 5cgfV, 0.8621, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
983, 5cgfH, 0.8621, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
984, 4qzzV, 0.8621, 1.37, 0.276, 226, 192, YCP IN COMPLEX WITH OMURALIDE
985, 4qzzH, 0.8621, 1.36, 0.276, 226, 192, YCP IN COMPLEX WITH OMURALIDE
986, 4quxV, 0.8621, 1.36, 0.276, 226, 192, YCP BETA5-A49T-MUTANT
987, 4inuV, 0.8621, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
988, 4inuH, 0.8621, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
989, 4eu2W, 0.8621, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
990, 3mi0C, 0.8621, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
991, 3mg8H, 0.8621, 1.37, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
992, 3mg6H, 0.8621, 1.37, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
993, 5trrW, 0.8620, 1.36, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
994, 5trgI, 0.8620, 2.38, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
995, 5lf7V, 0.8620, 1.36, 0.276, 222, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
996, 5lf4H, 0.8620, 1.36, 0.276, 222, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
997, 5leyV, 0.8620, 2.42, 0.234, 223, 205, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
998, 5d0xV, 0.8620, 2.37, 0.235, 222, 204, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
999, 4y8nV, 0.8620, 1.38, 0.250, 220, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1000, 4y8nH, 0.8620, 1.38, 0.250, 220, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1001, 4r02H, 0.8620, 1.38, 0.250, 220, 192, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1002, 4qw3V, 0.8620, 1.37, 0.276, 226, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1003, 4qw3H, 0.8620, 1.37, 0.276, 226, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1004, 4quxH, 0.8620, 1.37, 0.276, 226, 192, YCP BETA5-A49T-MUTANT
1005, 4inrH, 0.8620, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1006, 3un8V, 0.8620, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1007, 3nzwV, 0.8620, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1008, 3nzwH, 0.8620, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1009, 3ipmM, 0.8620, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1010, 3ipmL, 0.8620, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1011, 3ipmK, 0.8620, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1012, 3ipmJ, 0.8620, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1013, 5trgK, 0.8619, 2.34, 0.255, 203, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1014, 5l5aV, 0.8619, 2.34, 0.255, 203, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1015, 5l55V, 0.8619, 2.34, 0.255, 203, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1016, 5d0xH, 0.8619, 2.34, 0.255, 203, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1017, 4x6zW, 0.8619, 2.42, 0.234, 223, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1018, 4r02V, 0.8619, 1.37, 0.276, 226, 192, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1019, 4qlvV, 0.8619, 1.37, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1020, 4qlvH, 0.8619, 1.37, 0.276, 226, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1021, 4hnpV, 0.8619, 1.37, 0.276, 220, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1022, 3sdkV, 0.8619, 1.37, 0.276, 226, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1023, 3ipmN, 0.8619, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1024, 3ipmI, 0.8619, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1025, 3ipmH, 0.8619, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1026, 1z7qW, 0.8619, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1027, 1z7qI, 0.8619, 2.34, 0.255, 203, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1028, 5trgW, 0.8618, 2.34, 0.255, 203, 200, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1029, 5lf4V, 0.8618, 2.34, 0.255, 203, 200, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1030, 5l5wV, 0.8618, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1031, 5l5wH, 0.8618, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1032, 5l5aH, 0.8618, 2.41, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1033, 5l55H, 0.8618, 1.39, 0.250, 220, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1034, 5d0wV, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1035, 5d0wH, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1036, 5cz6V, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1037, 5cz6H, 0.8618, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1038, 4ya5V, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1039, 4ya5H, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1040, 4ya3V, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1041, 4ya3H, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1042, 4eu2I, 0.8618, 1.37, 0.281, 226, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1043, 3unbx, 0.8618, 1.37, 0.281, 226, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1044, 3sdkH, 0.8618, 1.37, 0.276, 226, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1045, 3oeuH, 0.8618, 1.37, 0.276, 226, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1046, 5ts0W, 0.8617, 1.37, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1047, 5l6bV, 0.8617, 1.38, 0.250, 220, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1048, 5l6bH, 0.8617, 1.36, 0.276, 222, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1049, 5fgaV, 0.8617, 1.36, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1050, 5fgaH, 0.8617, 2.41, 0.234, 223, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1051, 5czaV, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1052, 5czaH, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1053, 4y7xV, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1054, 4y7xH, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1055, 4y69V, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1056, 4qw0V, 0.8617, 1.37, 0.276, 226, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1057, 4qw0H, 0.8617, 1.37, 0.276, 222, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1058, 4qvvV, 0.8617, 1.37, 0.276, 222, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1059, 4qvvH, 0.8617, 1.37, 0.276, 226, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1060, 4qv7V, 0.8617, 1.37, 0.276, 226, 192, YCP BETA5-A50V MUTANT
1061, 4qv7H, 0.8617, 1.37, 0.276, 226, 192, YCP BETA5-A50V MUTANT
1062, 4hnpH, 0.8617, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1063, 3hyeV, 0.8617, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1064, 3hyeH, 0.8617, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1065, 5vfuZ, 0.8616, 1.37, 0.276, 226, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1066, 5vftO, 0.8616, 1.37, 0.276, 222, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1067, 5ts0L, 0.8616, 1.37, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1068, 5l5zH, 0.8616, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1069, 5l5fV, 0.8616, 1.37, 0.250, 220, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1070, 5l5fH, 0.8616, 1.37, 0.250, 220, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1071, 5l5dV, 0.8616, 2.41, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1072, 5l5dH, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1073, 5d0tV, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1074, 5d0tH, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1075, 5cz7V, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1076, 5cz7H, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1077, 4ya4H, 0.8616, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1078, 4y9yV, 0.8616, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1079, 4x6zI, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1080, 4qvyV, 0.8616, 1.38, 0.276, 226, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1081, 4qvyH, 0.8616, 1.37, 0.281, 226, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1082, 4qvmV, 0.8616, 1.38, 0.276, 226, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1083, 4qvmH, 0.8616, 1.37, 0.276, 221, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1084, 4qv3V, 0.8616, 1.38, 0.276, 226, 192, YCP BETA5-M45V MUTANT
1085, 4qv3H, 0.8616, 1.38, 0.276, 226, 192, YCP BETA5-M45V MUTANT
1086, 4jsqV, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1087, 4jsqH, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1088, 4intV, 0.8616, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1089, 3un8H, 0.8616, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1090, 3mi0H, 0.8616, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1091, 3gptV, 0.8616, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1092, 5tryb, 0.8615, 1.37, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1093, 5trgV, 0.8615, 1.37, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1094, 5trgb, 0.8615, 2.39, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1095, 5lzpG, 0.8615, 1.38, 0.276, 222, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1096, 5l66V, 0.8615, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1097, 5l66H, 0.8615, 2.42, 0.234, 223, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1098, 5l5zV, 0.8615, 2.42, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1099, 5gjqb, 0.8615, 2.39, 0.230, 222, 204, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1100, 5dkiV, 0.8615, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1101, 4ya4V, 0.8615, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1102, 4y9yH, 0.8615, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1103, 3mi0P, 0.8615, 1.38, 0.250, 220, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1104, 3gptH, 0.8615, 1.38, 0.276, 226, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1105, 5lezH, 0.8614, 1.38, 0.281, 226, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1106, 5fghV, 0.8614, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1107, 5fghH, 0.8614, 2.40, 0.235, 222, 204, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1108, 5dkjV, 0.8614, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1109, 5dkjH, 0.8614, 1.39, 0.250, 220, 192, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1110, 5dkiH, 0.8614, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1111, 4y8rV, 0.8614, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1112, 4y8rH, 0.8614, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1113, 4y6aV, 0.8614, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1114, 4y6aH, 0.8614, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1115, 4y69H, 0.8614, 1.38, 0.281, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1116, 4qv1H, 0.8614, 1.38, 0.281, 226, 192, YCP BETA5-M45A MUTANT
1117, 4intH, 0.8614, 1.38, 0.281, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1118, 3wxrI, 0.8614, 1.38, 0.281, 226, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1119, 3nzjV, 0.8614, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1120, 3nzjH, 0.8614, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1121, 3mg0H, 0.8614, 1.37, 0.276, 222, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1122, 1fntW, 0.8614, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1123, 5trrI, 0.8613, 1.37, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1124, 5thoa, 0.8613, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1125, 5l52V, 0.8613, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1126, 5l52H, 0.8613, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1127, 5jhsV, 0.8613, 2.37, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1128, 5jhsH, 0.8613, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1129, 4qzxV, 0.8613, 1.38, 0.276, 222, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1130, 4qzxH, 0.8613, 1.38, 0.276, 222, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1131, 4qvqV, 0.8613, 1.38, 0.276, 222, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1132, 4qvqH, 0.8613, 1.38, 0.276, 222, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1133, 4qv8H, 0.8613, 1.38, 0.276, 222, 192, YCP BETA5-C52F MUTANT
1134, 4qv4V, 0.8613, 1.38, 0.276, 222, 192, YCP BETA5-M45T MUTANT
1135, 4qv4H, 0.8613, 1.38, 0.276, 226, 192, YCP BETA5-M45T MUTANT
1136, 4qv1V, 0.8613, 1.38, 0.276, 226, 192, YCP BETA5-M45A MUTANT
1137, 4quyV, 0.8613, 1.37, 0.276, 226, 192, YCP BETA5-A49S-MUTANT
1138, 4quyH, 0.8613, 1.38, 0.276, 226, 192, YCP BETA5-A49S-MUTANT
1139, 1fntI, 0.8613, 1.38, 0.276, 226, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1140, 5trrV, 0.8612, 1.38, 0.276, 226, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1141, 5thob, 0.8612, 1.38, 0.276, 226, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1142, 5lf6H, 0.8612, 1.38, 0.276, 226, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1143, 4ya0V, 0.8612, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1144, 4ya0H, 0.8612, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1145, 4y8uV, 0.8612, 2.42, 0.234, 223, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1146, 4y8uH, 0.8612, 1.40, 0.250, 220, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1147, 4y8kV, 0.8612, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1148, 4y8kH, 0.8612, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1149, 4y84V, 0.8612, 1.38, 0.281, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1150, 4r18V, 0.8612, 1.38, 0.281, 226, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1151, 4r18H, 0.8612, 1.38, 0.276, 222, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1152, 4qvwV, 0.8612, 1.38, 0.276, 222, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1153, 4qvwH, 0.8612, 1.38, 0.276, 222, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1154, 4qv8V, 0.8612, 1.37, 0.276, 226, 192, YCP BETA5-C52F MUTANT
1155, 3nzxV, 0.8612, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1156, 3mg0V, 0.8612, 1.38, 0.276, 226, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1157, 2fakV, 0.8612, 1.38, 0.276, 226, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1158, 2fakH, 0.8612, 1.37, 0.276, 226, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1159, 1g0uH, 0.8612, 1.38, 0.276, 222, 192, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1160, 5trya, 0.8611, 1.38, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1161, 5lzpA, 0.8611, 1.38, 0.276, 222, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1162, 5l5xV, 0.8611, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1163, 5l5eV, 0.8611, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1164, 5l5eH, 0.8611, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1165, 5l54V, 0.8611, 2.40, 0.230, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1166, 5l54H, 0.8611, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1167, 4y84H, 0.8611, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1168, 4qwjV, 0.8611, 1.38, 0.276, 226, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1169, 4qwjH, 0.8611, 1.37, 0.276, 222, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1170, 4qvpV, 0.8611, 1.37, 0.276, 222, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1171, 4qvpH, 0.8611, 1.38, 0.276, 222, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1172, 4qv5V, 0.8611, 1.38, 0.276, 222, 192, YCP BETA5-M45I MUTANT
1173, 4qv5H, 0.8611, 1.38, 0.276, 222, 192, YCP BETA5-M45I MUTANT
1174, 4qluV, 0.8611, 1.39, 0.276, 226, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1175, 4qluH, 0.8611, 1.39, 0.276, 226, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1176, 4qlsH, 0.8611, 1.38, 0.276, 226, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1177, 3nzxH, 0.8611, 1.38, 0.276, 226, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1178, 3d29V, 0.8611, 1.37, 0.276, 222, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
1179, 3d29H, 0.8611, 1.37, 0.276, 222, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
1180, 5trrY, 0.8610, 1.37, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1181, 5thoW, 0.8610, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1182, 5lezV, 0.8610, 1.38, 0.276, 222, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1183, 5l5xH, 0.8610, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1184, 5gjqp, 0.8610, 2.41, 0.234, 223, 205, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1185, 5cgiH, 0.8610, 2.41, 0.234, 223, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1186, 5cggV, 0.8610, 1.40, 0.250, 220, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1187, 5cggH, 0.8610, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1188, 4y8hV, 0.8610, 1.38, 0.250, 220, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1189, 4qvlV, 0.8610, 1.38, 0.276, 222, 192, YCP IN COMPLEX WITH BORTEZOMIB
1190, 4qvlH, 0.8610, 1.38, 0.276, 222, 192, YCP IN COMPLEX WITH BORTEZOMIB
1191, 4qv0V, 0.8610, 1.38, 0.276, 222, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1192, 4qv0H, 0.8610, 1.38, 0.276, 222, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1193, 4qlsV, 0.8610, 1.39, 0.276, 226, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1194, 4ltcV, 0.8610, 1.39, 0.276, 226, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1195, 3wxrW, 0.8610, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1196, 1g0uV, 0.8610, 1.38, 0.276, 226, 192, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1197, 6gopV, 0.8609, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1198, 6gopH, 0.8609, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1199, 5lzpF, 0.8609, 1.38, 0.276, 222, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1200, 5jhrH, 0.8609, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1201, 5cgiV, 0.8609, 1.39, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1202, 4y8hH, 0.8609, 1.39, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1203, 4qz0V, 0.8609, 2.40, 0.230, 222, 204, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1204, 4qz0H, 0.8609, 1.39, 0.276, 222, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1205, 4qxjV, 0.8609, 1.38, 0.276, 222, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1206, 4qxjH, 0.8609, 1.38, 0.276, 222, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1207, 4qv9V, 0.8609, 1.38, 0.276, 222, 192, YCP BETA5-C63F MUTANT
1208, 4qv9H, 0.8609, 1.38, 0.276, 222, 192, YCP BETA5-C63F MUTANT
1209, 3mg4V, 0.8609, 1.38, 0.276, 222, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1210, 5tryI, 0.8608, 1.38, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1211, 5lf6V, 0.8608, 1.38, 0.276, 226, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1212, 5l65V, 0.8608, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1213, 5l65H, 0.8608, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1214, 5jhrV, 0.8608, 2.39, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1215, 4qz2V, 0.8608, 1.40, 0.250, 220, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1216, 4qz2H, 0.8608, 1.39, 0.276, 226, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1217, 4lqiV, 0.8608, 1.39, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1218, 4lqiH, 0.8608, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1219, 3unbH, 0.8608, 1.38, 0.276, 222, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1220, 3mg4H, 0.8608, 1.38, 0.276, 222, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1221, 6bgoZ, 0.8607, 1.38, 0.276, 222, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1222, 6bgoY, 0.8607, 1.38, 0.276, 222, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1223, 6bgoX, 0.8607, 1.40, 0.250, 220, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1224, 6bgoW, 0.8607, 1.37, 0.276, 222, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1225, 6bgoV, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1226, 6bgoU, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1227, 6bgoT, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1228, 6bgoS, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1229, 6bgoR, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1230, 6bgoQ, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1231, 6bgoP, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1232, 6bgoc, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1233, 6bgob, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1234, 6bgoa, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1235, 6bglZ, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1236, 6bglY, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1237, 6bglX, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1238, 6bglW, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1239, 6bglV, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1240, 6bglU, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1241, 6bglT, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1242, 6bglS, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1243, 6bglR, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1244, 6bglQ, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1245, 6bglP, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1246, 6bglc, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1247, 6bglb, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1248, 6bgla, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1249, 5trsb, 0.8607, 2.41, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1250, 5trsa, 0.8607, 2.41, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1251, 5thoV, 0.8607, 2.41, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1252, 5mp9i, 0.8607, 2.41, 0.235, 222, 204, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1253, 5lzpL, 0.8607, 2.42, 0.234, 223, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1254, 5l5yV, 0.8607, 2.44, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1255, 5l5yH, 0.8607, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1256, 5fgiV, 0.8607, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1257, 5fg7H, 0.8607, 2.41, 0.230, 222, 204, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1258, 4y8mN, 0.8607, 1.39, 0.276, 226, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1259, 4y8mb, 0.8607, 1.39, 0.276, 226, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1260, 4y8gV, 0.8607, 1.38, 0.271, 234, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1261, 4y8gH, 0.8607, 1.38, 0.271, 228, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1262, 4qw1V, 0.8607, 1.56, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1263, 4qw1H, 0.8607, 1.56, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1264, 4q1sb, 0.8607, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1265, 4no9V, 0.8607, 1.38, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1266, 3gpwV, 0.8607, 1.39, 0.276, 226, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1267, 3gpwH, 0.8607, 1.39, 0.276, 226, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1268, 3dy3V, 0.8607, 1.56, 0.256, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1269, 3dy3H, 0.8607, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1270, 3bdmV, 0.8607, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1271, 3bdmH, 0.8607, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1272, 2f16V, 0.8607, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1273, 2f16H, 0.8607, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1274, 5trsW, 0.8606, 1.39, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1275, 5fg7V, 0.8606, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1276, 5czaN, 0.8606, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1277, 5czab, 0.8606, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1278, 4z1lb, 0.8606, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1279, 4y8qV, 0.8606, 1.38, 0.271, 228, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1280, 4y8qH, 0.8606, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1281, 4y8lH, 0.8606, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1282, 4y80V, 0.8606, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1283, 4qzwV, 0.8606, 1.38, 0.276, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1284, 4qzwH, 0.8606, 1.38, 0.276, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1285, 4qwkV, 0.8606, 1.39, 0.276, 222, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1286, 4qwkH, 0.8606, 1.39, 0.276, 222, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1287, 4qvnH, 0.8606, 1.39, 0.276, 222, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1288, 4no9H, 0.8606, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1289, 4ltcH, 0.8606, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1290, 5tryW, 0.8605, 1.38, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1291, 5trgX, 0.8605, 1.40, 0.276, 226, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1292, 4z1lN, 0.8605, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1293, 4y82V, 0.8605, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1294, 4y82H, 0.8605, 2.42, 0.234, 223, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1295, 4y80H, 0.8605, 2.38, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1296, 4qz1V, 0.8605, 1.56, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1297, 4qz1H, 0.8605, 1.39, 0.276, 222, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1298, 4qvnV, 0.8605, 1.39, 0.276, 222, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1299, 4qv6V, 0.8605, 1.39, 0.276, 222, 192, YCP BETA5-A49V MUTANT
1300, 4qv6H, 0.8605, 1.39, 0.276, 222, 192, YCP BETA5-A49V MUTANT
1301, 4qltV, 0.8605, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1302, 4qlqV, 0.8605, 1.40, 0.276, 226, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1303, 4qlqH, 0.8605, 1.39, 0.276, 226, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1304, 4qbyV, 0.8605, 1.39, 0.276, 226, 192, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1305, 4qbyH, 0.8605, 1.38, 0.276, 222, 192, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1306, 2gplV, 0.8605, 1.39, 0.276, 222, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1307, 2gplH, 0.8605, 1.39, 0.276, 222, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1308, 5vfsI, 0.8604, 1.39, 0.276, 226, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1309, 5t0cGB, 0.8604, 1.39, 0.276, 226, 192, 
1310, 5t0cAA, 0.8604, 1.39, 0.276, 222, 192, 
1311, 4ya1N, 0.8604, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1312, 4ya1b, 0.8604, 1.40, 0.250, 220, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1313, 4y81V, 0.8604, 2.11, 0.206, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1314, 4y81H, 0.8604, 1.39, 0.250, 220, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1315, 4qwgV, 0.8604, 1.39, 0.250, 220, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1316, 4qwgH, 0.8604, 1.56, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1317, 4qltH, 0.8604, 1.56, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1318, 4g4sI, 0.8604, 1.39, 0.276, 222, 192, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1319, 4fzcV, 0.8604, 1.39, 0.276, 222, 192, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1320, 3oeuN, 0.8604, 1.39, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1321, 5ts0a, 0.8603, 1.39, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1322, 5trsI, 0.8603, 1.38, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1323, 5trgM, 0.8603, 1.38, 0.276, 220, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1324, 5lzpE, 0.8603, 1.40, 0.276, 222, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1325, 5lajN, 0.8603, 1.56, 0.256, 196, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1326, 5lajb, 0.8603, 2.45, 0.239, 223, 205, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1327, 5fhsV, 0.8603, 2.39, 0.235, 222, 204, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1328, 5fhsH, 0.8603, 2.38, 0.235, 222, 204, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1329, 5fgaN, 0.8603, 2.41, 0.230, 222, 204, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1330, 5fgab, 0.8603, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1331, 5cgfN, 0.8603, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1332, 5cgfb, 0.8603, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1333, 5bxlb, 0.8603, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1334, 5bouN, 0.8603, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1335, 5boub, 0.8603, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1336, 4y8lV, 0.8603, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1337, 4qz3V, 0.8603, 1.56, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1338, 4qz3H, 0.8603, 1.56, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1339, 4jt0V, 0.8603, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1340, 4jt0H, 0.8603, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1341, 4fzcH, 0.8603, 1.39, 0.276, 222, 192, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1342, 3sdkN, 0.8603, 1.39, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1343, 5vfsHA, 0.8602, 1.39, 0.276, 222, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1344, 5thoM, 0.8602, 1.39, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1345, 5mp92, 0.8602, 1.39, 0.276, 222, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1346, 5lzpK, 0.8602, 1.40, 0.276, 222, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1347, 5l5bN, 0.8602, 1.56, 0.256, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1348, 5l5bb, 0.8602, 1.40, 0.250, 220, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1349, 5fgiH, 0.8602, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1350, 5fgdV, 0.8602, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1351, 5fgdH, 0.8602, 2.41, 0.230, 222, 204, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1352, 5cz9V, 0.8602, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1353, 5cz9H, 0.8602, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1354, 5bxlN, 0.8602, 1.39, 0.271, 234, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1355, 4ya4N, 0.8602, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1356, 4ya4b, 0.8602, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1357, 4y9yN, 0.8602, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1358, 4y8iV, 0.8602, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1359, 4y7yV, 0.8602, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1360, 4y7yH, 0.8602, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1361, 4y6zV, 0.8602, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1362, 4y6zH, 0.8602, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1363, 4qwxV, 0.8602, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1364, 4qwxH, 0.8602, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1365, 4qv7N, 0.8602, 1.39, 0.276, 222, 192, YCP BETA5-A50V MUTANT
1366, 4qv7b, 0.8602, 1.39, 0.276, 222, 192, YCP BETA5-A50V MUTANT
1367, 5trsN, 0.8601, 1.39, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1368, 5trgN, 0.8601, 1.39, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1369, 5l5aN, 0.8601, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1370, 5l5ab, 0.8601, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1371, 5fg9N, 0.8601, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1372, 5fg9b, 0.8601, 2.42, 0.234, 223, 205, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1373, 5d0wN, 0.8601, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1374, 5d0wb, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1375, 5cz5N, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1376, 5cz4N, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1377, 5cz4b, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1378, 4y9yb, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1379, 4y8iH, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1380, 4qwuV, 0.8601, 1.56, 0.256, 206, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1381, 4qwuH, 0.8601, 1.57, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1382, 4qv3N, 0.8601, 1.57, 0.262, 196, 195, YCP BETA5-M45V MUTANT
1383, 4qv3b, 0.8601, 1.57, 0.262, 196, 195, YCP BETA5-M45V MUTANT
1384, 4quxN, 0.8601, 1.39, 0.276, 222, 192, YCP BETA5-A49T-MUTANT
1385, 4quxb, 0.8601, 1.40, 0.276, 226, 192, YCP BETA5-A49T-MUTANT
1386, 4no1V, 0.8601, 1.40, 0.276, 226, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1387, 4no1H, 0.8601, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1388, 3oevN, 0.8601, 1.57, 0.262, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1389, 3mg62, 0.8601, 1.57, 0.262, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1390, 3gpjV, 0.8601, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1391, 3gpjH, 0.8601, 1.40, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1392, 5ts0b, 0.8600, 1.40, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1393, 5tryY, 0.8600, 1.56, 0.256, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1394, 5fgeV, 0.8600, 1.57, 0.256, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1395, 5fgeH, 0.8600, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1396, 5fg7N, 0.8600, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1397, 5fg7b, 0.8600, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1398, 5cz6N, 0.8600, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1399, 5cz6b, 0.8600, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1400, 5cz5V, 0.8600, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1401, 5cz5H, 0.8600, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1402, 4y77V, 0.8600, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1403, 4y77H, 0.8600, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1404, 4rurN, 0.8600, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1405, 4rurb, 0.8600, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1406, 4r18N, 0.8600, 1.39, 0.276, 222, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1407, 4r18b, 0.8600, 1.40, 0.276, 222, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1408, 4r17N, 0.8600, 1.40, 0.276, 222, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1409, 4r17b, 0.8600, 1.57, 0.262, 196, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1410, 4qzzb, 0.8600, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH OMURALIDE
1411, 4qwiV, 0.8600, 1.57, 0.262, 196, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1412, 4qwiH, 0.8600, 1.57, 0.262, 196, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1413, 4hnpb, 0.8600, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1414, 3sdk2, 0.8600, 1.57, 0.262, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1415, 2gplN, 0.8600, 1.57, 0.262, 196, 195, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1416, 2gpl2, 0.8600, 1.39, 0.276, 222, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1417, 5laiN, 0.8599, 1.39, 0.276, 222, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1418, 5laib, 0.8599, 1.56, 0.262, 196, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1419, 5l5rN, 0.8599, 1.57, 0.256, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1420, 5l5rb, 0.8599, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1421, 5jhrN, 0.8599, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1422, 5jhrb, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1423, 4y8rN, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1424, 4y8rb, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1425, 4qzzN, 0.8599, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH OMURALIDE
1426, 4qz6V, 0.8599, 1.57, 0.262, 196, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1427, 4qz6H, 0.8599, 1.57, 0.262, 196, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1428, 4qwsV, 0.8599, 1.57, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1429, 4qwsH, 0.8599, 1.57, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1430, 4qv8N, 0.8599, 1.57, 0.262, 196, 195, YCP BETA5-C52F MUTANT
1431, 4qv8b, 0.8599, 1.40, 0.276, 222, 192, YCP BETA5-C52F MUTANT
1432, 4qv4N, 0.8599, 1.40, 0.276, 222, 192, YCP BETA5-M45T MUTANT
1433, 4qv4b, 0.8599, 1.40, 0.276, 222, 192, YCP BETA5-M45T MUTANT
1434, 4quyN, 0.8599, 1.40, 0.276, 222, 192, YCP BETA5-A49S-MUTANT
1435, 4jsuV, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1436, 4jsuH, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1437, 3shjV, 0.8599, 1.57, 0.262, 196, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1438, 3shjH, 0.8599, 1.57, 0.262, 196, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1439, 3oev2, 0.8599, 1.57, 0.262, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1440, 5thoY, 0.8598, 1.40, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1441, 5lttb, 0.8598, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1442, 5d0sV, 0.8598, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1443, 5d0sH, 0.8598, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1444, 5cghN, 0.8598, 1.57, 0.256, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1445, 5cghb, 0.8598, 2.42, 0.234, 223, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1446, 4y70V, 0.8598, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1447, 4y70H, 0.8598, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1448, 4y6vN, 0.8598, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1449, 4y6aN, 0.8598, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1450, 4y6ab, 0.8598, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1451, 4r00N, 0.8598, 1.40, 0.276, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1452, 4r00b, 0.8598, 1.40, 0.276, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1453, 4qv5N, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-M45I MUTANT
1454, 4qv5b, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-M45I MUTANT
1455, 4qv1N, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-M45A MUTANT
1456, 4qv1b, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-M45A MUTANT
1457, 4quyb, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-A49S-MUTANT
1458, 4no8V, 0.8598, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1459, 4no8H, 0.8598, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1460, 4lqib, 0.8598, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1461, 3mg72, 0.8598, 1.57, 0.262, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1462, 5lttN, 0.8597, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1463, 4y8ub, 0.8597, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1464, 4y6vb, 0.8597, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1465, 4qv9N, 0.8597, 1.57, 0.262, 196, 195, YCP BETA5-C63F MUTANT
1466, 4qv9b, 0.8597, 1.57, 0.256, 196, 195, YCP BETA5-C63F MUTANT
1467, 4no6V, 0.8597, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1468, 4no6H, 0.8597, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1469, 4lqiN, 0.8597, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1470, 4eu2V, 0.8597, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1471, 1rypI, 0.8597, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1472, 5trsK, 0.8596, 1.40, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1473, 5trrM, 0.8596, 1.40, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1474, 5trgH, 0.8596, 1.57, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1475, 5m2bb, 0.8596, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1476, 5l5oN, 0.8596, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1477, 5l5ob, 0.8596, 2.46, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1478, 4ya5N, 0.8596, 2.39, 0.235, 222, 204, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1479, 4y8uN, 0.8596, 2.39, 0.235, 222, 204, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1480, 4qz4V, 0.8596, 1.58, 0.262, 196, 195, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1481, 4qz4H, 0.8596, 1.58, 0.262, 196, 195, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1482, 4qw0N, 0.8596, 1.58, 0.262, 196, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1483, 4qw0b, 0.8596, 1.57, 0.262, 196, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1484, 4qvyN, 0.8596, 1.57, 0.262, 196, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1485, 4qvyb, 0.8596, 1.40, 0.276, 222, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1486, 4qv0N, 0.8596, 1.40, 0.276, 222, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1487, 4qv0b, 0.8596, 1.57, 0.262, 196, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1488, 4q1sN, 0.8596, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1489, 4no9N, 0.8596, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1490, 4no9b, 0.8596, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1491, 4hrdN, 0.8596, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1492, 5trrZ, 0.8595, 1.57, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1493, 5thoI, 0.8595, 1.58, 0.256, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1494, 5m2bN, 0.8595, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1495, 5l6cN, 0.8595, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1496, 5l6cb, 0.8595, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1497, 5l6aN, 0.8595, 2.38, 0.235, 222, 204, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1498, 5l6ab, 0.8595, 2.40, 0.235, 222, 204, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1499, 5l67N, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1500, 5l67b, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1501, 5l5vN, 0.8595, 1.58, 0.262, 196, 195,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1502, 5l5vb, 0.8595, 1.58, 0.256, 196, 195,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1503, 5l5pN, 0.8595, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1504, 5l5pb, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1505, 5l5eN, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1506, 5l5eb, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1507, 5l55N, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1508, 5l55b, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1509, 5d0zV, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1510, 5d0zH, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1511, 4ya5b, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1512, 4y8oH, 0.8595, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1513, 4y8jV, 0.8595, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1514, 4y8jH, 0.8595, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1515, 4y7wH, 0.8595, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1516, 4y78V, 0.8595, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1517, 4y78H, 0.8595, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1518, 4y69b, 0.8595, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1519, 4qz5V, 0.8595, 1.40, 0.276, 222, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1520, 4qz5H, 0.8595, 1.40, 0.276, 222, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1521, 4qwrV, 0.8595, 1.40, 0.276, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1522, 4qwrH, 0.8595, 1.40, 0.276, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1523, 4qvvN, 0.8595, 1.57, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1524, 4qvvb, 0.8595, 1.40, 0.276, 222, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1525, 3unbj, 0.8595, 1.40, 0.276, 222, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1526, 3un4V, 0.8595, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1527, 3un4H, 0.8595, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1528, 3tddN, 0.8595, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1529, 3tdd2, 0.8595, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1530, 3sdiN, 0.8595, 1.42, 0.250, 220, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1531, 3mg8N, 0.8595, 1.40, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1532, 3mg82, 0.8595, 1.40, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1533, 5trrK, 0.8594, 1.57, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1534, 5mpai, 0.8594, 1.57, 0.262, 196, 195, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1535, 5l64N, 0.8594, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1536, 5l64b, 0.8594, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1537, 5l5hN, 0.8594, 1.57, 0.256, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1538, 5l5hb, 0.8594, 2.46, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1539, 5fggV, 0.8594, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1540, 5fggH, 0.8594, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1541, 5fgfV, 0.8594, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1542, 5fgfH, 0.8594, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1543, 5cggN, 0.8594, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1544, 5cggb, 0.8594, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1545, 4y8oV, 0.8594, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1546, 4y7wV, 0.8594, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1547, 4y69N, 0.8594, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1548, 4ltcb, 0.8594, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1549, 4j70b, 0.8594, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1550, 4hnpN, 0.8594, 1.40, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1551, 3unbV, 0.8594, 1.40, 0.276, 222, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1552, 3sdi2, 0.8594, 1.58, 0.262, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1553, 3mg7N, 0.8594, 1.57, 0.262, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1554, 3mg6N, 0.8594, 1.58, 0.262, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1555, 5trsV, 0.8593, 1.57, 0.256, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1556, 5thoK, 0.8593, 1.41, 0.250, 220, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1557, 5l5tN, 0.8593, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1558, 5l5tb, 0.8593, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1559, 5l5qN, 0.8593, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1560, 5l5iN, 0.8593, 2.44, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1561, 5l5ib, 0.8593, 2.45, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1562, 5jhsb, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1563, 5fgeN, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1564, 5fgeb, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1565, 5cz7N, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1566, 5cz7b, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1567, 4ya3b, 0.8593, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1568, 4y8pV, 0.8593, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1569, 4y8pH, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1570, 4y7xN, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1571, 4y7xb, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1572, 4y74V, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1573, 4y74H, 0.8593, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1574, 4x6zH, 0.8593, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1575, 4qlvN, 0.8593, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1576, 4qlvb, 0.8593, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1577, 4qlsN, 0.8593, 1.41, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1578, 4qlsb, 0.8593, 1.41, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1579, 4no1N, 0.8593, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1580, 4no1b, 0.8593, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1581, 4hrcH, 0.8593, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1582, 4fzgV, 0.8593, 1.58, 0.262, 196, 195, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1583, 4fzgH, 0.8593, 1.58, 0.262, 196, 195, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1584, 2zcyV, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1585, 1rypW, 0.8593, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1586, 5ts0I, 0.8592, 1.41, 0.276, 222, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1587, 5l5uN, 0.8592, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1588, 5l5ub, 0.8592, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1589, 5l5qb, 0.8592, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1590, 5l5fN, 0.8592, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1591, 5jhsN, 0.8592, 2.40, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1592, 5cz9N, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1593, 4y8nN, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1594, 4qwlV, 0.8592, 1.58, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1595, 4qwlH, 0.8592, 1.58, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1596, 4qw4V, 0.8592, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH CARFILZOMIB
1597, 4qw4H, 0.8592, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH CARFILZOMIB
1598, 4qw3N, 0.8592, 1.58, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1599, 4qw3b, 0.8592, 1.41, 0.276, 222, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1600, 4qvwN, 0.8592, 1.40, 0.276, 222, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1601, 4qvwb, 0.8592, 1.41, 0.276, 222, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1602, 4qvmN, 0.8592, 1.41, 0.276, 222, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1603, 4j70N, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1604, 3nzwN, 0.8592, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1605, 3nzw2, 0.8592, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1606, 3e47N, 0.8592, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1607, 2zcyH, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1608, 1g65V, 0.8592, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1609, 5trsZ, 0.8591, 1.57, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1610, 5trsH, 0.8591, 1.57, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1611, 5trrN, 0.8591, 1.58, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1612, 5l65N, 0.8591, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1613, 5l65b, 0.8591, 1.42, 0.276, 222, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1614, 5l63N, 0.8591, 2.38, 0.235, 222, 204, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1615, 5l63b, 0.8591, 2.40, 0.235, 222, 204, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1616, 5l62N, 0.8591, 2.43, 0.234, 223, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1617, 5l62b, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1618, 5l5wN, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1619, 5l5wb, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1620, 5l5sN, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1621, 5l5sb, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1622, 5l5fb, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1623, 5l5dN, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1624, 5l5db, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1625, 5l54N, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1626, 5l54b, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1627, 5fhsN, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1628, 5fhsb, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1629, 5fghN, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1630, 5fghb, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1631, 5fgfN, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1632, 5fgfb, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1633, 5d0xN, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1634, 5d0xb, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1635, 5d0tN, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1636, 5d0tb, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1637, 5cz9b, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1638, 4ya3N, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1639, 4x6zV, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1640, 4qw7V, 0.8591, 1.58, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1641, 4qw7H, 0.8591, 1.58, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1642, 4qw6V, 0.8591, 1.58, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1643, 4qw6H, 0.8591, 1.58, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1644, 4qvpN, 0.8591, 1.59, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1645, 4qvpb, 0.8591, 1.41, 0.276, 222, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1646, 4qvmb, 0.8591, 1.41, 0.276, 222, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1647, 4ltcN, 0.8591, 1.41, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1648, 4hrdH, 0.8591, 1.41, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1649, 3okjV, 0.8591, 1.58, 0.262, 196, 195, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1650, 3okjH, 0.8591, 1.58, 0.262, 196, 195, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1651, 3oeu2, 0.8591, 1.58, 0.262, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1652, 3e472, 0.8591, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1653, 5l68N, 0.8590, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1654, 5l68b, 0.8590, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1655, 5l60N, 0.8590, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1656, 5l60b, 0.8590, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1657, 5fgdN, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1658, 5fgdb, 0.8590, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1659, 5bxnV, 0.8590, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1660, 4y8nb, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1661, 4y75V, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1662, 4y70N, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1663, 4y70b, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1664, 4r02N, 0.8590, 1.58, 0.269, 222, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1665, 4qwsN, 0.8590, 1.58, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1666, 4qw5V, 0.8590, 1.41, 0.276, 222, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1667, 4qw5H, 0.8590, 1.58, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1668, 4qltN, 0.8590, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1669, 4qltb, 0.8590, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1670, 4hrdb, 0.8590, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1671, 3nzxN, 0.8590, 1.41, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1672, 3nzx2, 0.8590, 1.41, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1673, 1g65H, 0.8590, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1674, 5ts0V, 0.8589, 1.58, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1675, 5l69N, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1676, 5l69b, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1677, 5l5jN, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1678, 5l5jb, 0.8589, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1679, 5d0zb, 0.8589, 2.44, 0.234, 223, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1680, 5cz8V, 0.8589, 1.59, 0.256, 196, 195, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1681, 5cz8H, 0.8589, 1.59, 0.256, 196, 195, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1682, 5ahjH, 0.8589, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1683, 4y8kb, 0.8589, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1684, 4y80N, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1685, 4y80b, 0.8589, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1686, 4y7yN, 0.8589, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1687, 4y7yb, 0.8589, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1688, 4y75H, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1689, 4r02b, 0.8589, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1690, 4qwsb, 0.8589, 1.58, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1691, 4qvlN, 0.8589, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH BORTEZOMIB
1692, 4qvlb, 0.8589, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH BORTEZOMIB
1693, 4qluN, 0.8589, 1.41, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1694, 4qlub, 0.8589, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1695, 4eu2H, 0.8589, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1696, 6gopN, 0.8588, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1697, 6gopb, 0.8588, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1698, 5ts0H, 0.8588, 1.58, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1699, 5trrH, 0.8588, 1.58, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1700, 5l6bN, 0.8588, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1701, 5l6bb, 0.8588, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1702, 5l66N, 0.8588, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1703, 5l66b, 0.8588, 2.40, 0.235, 222, 204, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1704, 5fggN, 0.8588, 2.40, 0.235, 222, 204, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1705, 5d0zN, 0.8588, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1706, 5cz5b, 0.8588, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1707, 5ahjV, 0.8588, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1708, 4ya2V, 0.8588, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1709, 4ya2H, 0.8588, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1710, 4qwjN, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1711, 4qwjb, 0.8588, 1.58, 0.256, 206, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1712, 4qw1N, 0.8588, 1.41, 0.276, 222, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1713, 4qw1b, 0.8588, 1.41, 0.276, 222, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1714, 4qvnN, 0.8588, 1.41, 0.276, 222, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1715, 4qvnb, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1716, 4qv6N, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-A49V MUTANT
1717, 4qv6b, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-A49V MUTANT
1718, 4fzgN, 0.8588, 1.58, 0.262, 196, 195, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1719, 3nzjN, 0.8588, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1720, 3nzj2, 0.8588, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1721, 3krdL, 0.8588, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1722, 5trgZ, 0.8587, 1.58, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1723, 5l61N, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1724, 5l61b, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1725, 5l5zN, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1726, 5l5zb, 0.8587, 2.40, 0.235, 222, 204, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1727, 5l5yN, 0.8587, 2.41, 0.235, 222, 204, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1728, 5l5yb, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1729, 5fggb, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1730, 5dkjN, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1731, 5dkjb, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1732, 5d0sN, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1733, 5d0sb, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1734, 5bxnN, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1735, 5bxnH, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1736, 5bxnb, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1737, 4ya0N, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1738, 4y9zV, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1739, 4y9zH, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1740, 4y8tV, 0.8587, 1.61, 0.269, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1741, 4y8tH, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1742, 4y8kN, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1743, 4qwkN, 0.8587, 1.41, 0.276, 222, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1744, 4qwiN, 0.8587, 1.41, 0.276, 222, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1745, 4qwfV, 0.8587, 1.42, 0.281, 226, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1746, 4qwfH, 0.8587, 1.42, 0.281, 226, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1747, 4qw7N, 0.8587, 1.58, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1748, 4qw7b, 0.8587, 1.58, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1749, 4qvqN, 0.8587, 1.58, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1750, 4no8N, 0.8587, 1.41, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1751, 4no8b, 0.8587, 1.41, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1752, 4nnnN, 0.8587, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH MG132
1753, 4nnnH, 0.8587, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH MG132
1754, 4jt0N, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1755, 4jt0b, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1756, 4fzgb, 0.8587, 1.59, 0.262, 196, 195, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1757, 3un8b, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1758, 3krdT, 0.8587, 1.41, 0.276, 222, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1759, 3hyeN, 0.8587, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1760, 3hye2, 0.8587, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1761, 3gptN, 0.8587, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1762, 3gpt2, 0.8587, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1763, 5ts0K, 0.8586, 2.40, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1764, 5thoZ, 0.8586, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1765, 5ahjN, 0.8586, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1766, 5ahjb, 0.8586, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1767, 4ya0b, 0.8586, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1768, 4y8sH, 0.8586, 2.46, 0.234, 223, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1769, 4y74N, 0.8586, 2.39, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1770, 4qwkb, 0.8586, 1.58, 0.262, 196, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1771, 4qwib, 0.8586, 1.58, 0.262, 196, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1772, 4qvqb, 0.8586, 1.59, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1773, 4nnnV, 0.8586, 1.42, 0.281, 222, 192, YCP IN COMPLEX WITH MG132
1774, 4nnnb, 0.8586, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH MG132
1775, 4hrdV, 0.8586, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1776, 3mg4N, 0.8586, 1.58, 0.262, 196, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1777, 3krdE, 0.8586, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1778, 1z7qV, 0.8586, 1.42, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1779, 1z7qH, 0.8586, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1780, 4ya7V, 0.8585, 1.42, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1781, 4ya7H, 0.8585, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1782, 4y8sV, 0.8585, 2.39, 0.235, 222, 204, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1783, 4y7wN, 0.8585, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1784, 4y7wb, 0.8585, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1785, 4y78b, 0.8585, 1.42, 0.281, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1786, 4y74b, 0.8585, 1.42, 0.281, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1787, 4qwrN, 0.8585, 1.42, 0.281, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1788, 4qwrb, 0.8585, 1.59, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1789, 4qwgN, 0.8585, 1.59, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1790, 4qwgb, 0.8585, 1.59, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1791, 4qw6N, 0.8585, 1.59, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1792, 4qw6b, 0.8585, 1.59, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1793, 4qlqN, 0.8585, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1794, 4qlqb, 0.8585, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1795, 4hrcV, 0.8585, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1796, 3un8N, 0.8585, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1797, 5tryK, 0.8584, 1.58, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1798, 5trrJ, 0.8584, 1.59, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1799, 5thoH, 0.8584, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1800, 5l5xN, 0.8584, 1.42, 0.276, 222, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1801, 5l5xb, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1802, 5d0vV, 0.8584, 2.47, 0.234, 223, 205, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1803, 5d0vN, 0.8584, 2.41, 0.235, 222, 204, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1804, 5d0vH, 0.8584, 2.41, 0.235, 222, 204, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1805, 5d0vb, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1806, 4y8tN, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1807, 4y8tb, 0.8584, 1.42, 0.276, 222, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1808, 4y78N, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1809, 4y6zb, 0.8584, 1.42, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1810, 4qwlb, 0.8584, 1.59, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1811, 4qw5N, 0.8584, 1.59, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1812, 4qw5b, 0.8584, 1.59, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1813, 4no6N, 0.8584, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1814, 4no6b, 0.8584, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1815, 3krdJ, 0.8584, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1816, 5trrX, 0.8583, 1.59, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1817, 4ya7N, 0.8583, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1818, 4ya7b, 0.8583, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1819, 4y8jN, 0.8583, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1820, 4y77N, 0.8583, 2.41, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1821, 4qwlN, 0.8583, 2.41, 0.235, 222, 204, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1822, 4qwfN, 0.8583, 1.59, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1823, 4qwfb, 0.8583, 1.59, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1824, 4qw4N, 0.8583, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH CARFILZOMIB
1825, 4qw4b, 0.8583, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH CARFILZOMIB
1826, 4jsuN, 0.8583, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1827, 4jsub, 0.8583, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1828, 4hrcN, 0.8583, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1829, 4fzcb, 0.8583, 1.59, 0.262, 196, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1830, 3shjN, 0.8583, 1.59, 0.262, 196, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1831, 3shj2, 0.8583, 1.59, 0.262, 196, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1832, 3krdN, 0.8583, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1833, 5tryV, 0.8582, 1.59, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1834, 5dkib, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1835, 5cz8N, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1836, 5cz8b, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1837, 5cgiN, 0.8582, 2.41, 0.235, 222, 204, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1838, 5cgib, 0.8582, 2.46, 0.234, 223, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1839, 4ya9N, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1840, 4ya9b, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1841, 4y8sN, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1842, 4y8sb, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1843, 4y6zN, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1844, 4qzxN, 0.8582, 1.59, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1845, 4qzxb, 0.8582, 1.59, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1846, 4qz0b, 0.8582, 1.59, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1847, 4qwuN, 0.8582, 1.59, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1848, 4qwub, 0.8582, 1.59, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1849, 4fzcN, 0.8582, 1.59, 0.262, 196, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1850, 3mkaV, 0.8582, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1851, 3mg42, 0.8582, 1.59, 0.262, 196, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1852, 3krd2, 0.8582, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1853, 5l52N, 0.8581, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1854, 5l52b, 0.8581, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1855, 5fgiN, 0.8581, 2.45, 0.229, 249, 205, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1856, 5fgib, 0.8581, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1857, 5dkiN, 0.8581, 2.40, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1858, 4y8lb, 0.8581, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1859, 4y75b, 0.8581, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1860, 4qzwN, 0.8581, 1.59, 0.256, 213, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1861, 4qzwb, 0.8581, 1.59, 0.256, 213, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1862, 4qz6N, 0.8581, 1.59, 0.262, 196, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1863, 4qz6b, 0.8581, 1.59, 0.262, 196, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1864, 4qz0N, 0.8581, 1.59, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1865, 5trgJ, 0.8580, 1.59, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1866, 5thoJ, 0.8580, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1867, 4y9zb, 0.8580, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1868, 4y8jb, 0.8580, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1869, 4y82b, 0.8580, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1870, 4y77b, 0.8580, 2.41, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1871, 4qwxN, 0.8580, 2.42, 0.235, 222, 204, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1872, 4qwxb, 0.8580, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1873, 4inrN, 0.8580, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1874, 3gpwN, 0.8580, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1875, 3gpw2, 0.8580, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1876, 1g0uN, 0.8580, 1.59, 0.262, 196, 195, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1877, 4ya9V, 0.8579, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1878, 4ya9H, 0.8579, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1879, 4y9zN, 0.8579, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1880, 4y8lN, 0.8579, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1881, 4y84N, 0.8579, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1882, 4y84b, 0.8579, 1.43, 0.281, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1883, 4y82N, 0.8579, 1.43, 0.281, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1884, 4qz2N, 0.8579, 1.59, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1885, 4qz2b, 0.8579, 1.59, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1886, 4inrb, 0.8579, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1887, 2f16N, 0.8579, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1888, 2f162, 0.8579, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1889, 1g0u2, 0.8579, 1.59, 0.262, 196, 195, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1890, 5ts0Y, 0.8578, 1.59, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1891, 5tryZ, 0.8578, 1.60, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1892, 5tryN, 0.8578, 1.59, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1893, 5trsM, 0.8578, 1.59, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1894, 4y8ib, 0.8578, 1.60, 0.256, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1895, 4qz7N, 0.8578, 2.44, 0.234, 223, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1896, 4qz7b, 0.8578, 2.41, 0.235, 222, 204, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1897, 4qz3N, 0.8578, 2.44, 0.234, 223, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1898, 4qz3b, 0.8578, 2.42, 0.235, 222, 204, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1899, 4qxjN, 0.8578, 1.59, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1900, 4qxjb, 0.8578, 1.60, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1901, 3mkaL, 0.8578, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1902, 3mg0N, 0.8578, 1.59, 0.262, 196, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1903, 3mg02, 0.8578, 1.59, 0.262, 196, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1904, 3krdC, 0.8578, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1905, 5ts0N, 0.8577, 1.59, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1906, 5tryH, 0.8577, 2.53, 0.228, 251, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1907, 5thoN, 0.8577, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1908, 4zzgH, 0.8577, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1909, 4qz1N, 0.8577, 2.42, 0.235, 222, 204, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1910, 4qz1b, 0.8577, 2.44, 0.234, 223, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1911, 4hrcb, 0.8577, 2.42, 0.235, 222, 204, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1912, 4gk7V, 0.8577, 2.40, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1913, 4gk7H, 0.8577, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1914, 4y8hN, 0.8576, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1915, 4qbyN, 0.8576, 1.60, 0.262, 196, 195, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1916, 4qbyb, 0.8576, 1.60, 0.262, 196, 195, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1917, 5t0gO, 0.8575, 1.43, 0.276, 222, 192, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1918, 4y8pN, 0.8575, 1.43, 0.276, 222, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1919, 4y8iN, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1920, 4y8hb, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1921, 4y8gN, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1922, 4y75N, 0.8575, 1.43, 0.250, 220, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1923, 4qz4N, 0.8575, 1.60, 0.262, 196, 195, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1924, 4qz4b, 0.8575, 1.60, 0.262, 196, 195, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1925, 4jsqN, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1926, 4jsqb, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1927, 4intN, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1928, 3krdG, 0.8575, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1929, 5nifH, 0.8574, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1930, 4y8qN, 0.8574, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1931, 4y8pb, 0.8574, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1932, 4qz5N, 0.8574, 1.60, 0.262, 196, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1933, 4qz5b, 0.8574, 2.42, 0.235, 222, 204, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1934, 4gk7N, 0.8574, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1935, 3wxrH, 0.8574, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1936, 1rypH, 0.8574, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1937, 1jd2O, 0.8574, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1938, 1jd2H, 0.8574, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1939, 5thoX, 0.8573, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1940, 4ya2N, 0.8573, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1941, 4ya2b, 0.8573, 1.60, 0.256, 205, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1942, 4y8gb, 0.8573, 1.44, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1943, 4gk7b, 0.8573, 1.44, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1944, 3wxrV, 0.8573, 2.42, 0.235, 222, 204, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1945, 2fakN, 0.8573, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1946, 2fak2, 0.8573, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1947, 5trsX, 0.8572, 1.60, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1948, 4y8qb, 0.8572, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1949, 4y81N, 0.8572, 1.61, 0.256, 199, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1950, 4y81b, 0.8572, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1951, 4nnwb, 0.8572, 1.60, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1952, 4intb, 0.8572, 2.42, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1953, 3krdZ, 0.8572, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1954, 3krdX, 0.8572, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1955, 5trsJ, 0.8571, 1.60, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1956, 5m32V, 0.8571, 1.60, 0.262, 196, 195, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1957, 5m32H, 0.8571, 1.60, 0.262, 196, 195, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1958, 4y8ob, 0.8571, 2.41, 0.235, 222, 204, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1959, 4nnwN, 0.8571, 2.43, 0.235, 222, 204, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1960, 5ts0Z, 0.8570, 2.43, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1961, 5tryM, 0.8570, 1.44, 0.250, 220, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1962, 4y8oN, 0.8570, 1.44, 0.250, 221, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1963, 4inub, 0.8570, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1964, 1rypV, 0.8570, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1965, 5tryX, 0.8569, 2.41, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1966, 4nnwV, 0.8569, 2.42, 0.235, 222, 204, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1967, 4nnwH, 0.8569, 1.61, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1968, 4inuN, 0.8569, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1969, 5vfpGA, 0.8568, 1.61, 0.256, 205, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1970, 5vfoo, 0.8568, 2.42, 0.235, 222, 204, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1971, 4zzgV, 0.8568, 1.44, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1972, 3dy3N, 0.8568, 1.44, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1973, 3dy32, 0.8568, 1.61, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1974, 2fhhH, 0.8568, 1.45, 0.255, 220, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1975, 2fhgX, 0.8568, 1.46, 0.255, 220, 192, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1976, 2fhgP, 0.8568, 1.61, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1977, 5ts0X, 0.8567, 1.62, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1978, 5ts0M, 0.8567, 1.62, 0.262, 196, 195, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1979, 5ts0J, 0.8567, 2.43, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1980, 5nifV, 0.8567, 2.44, 0.230, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1981, 3dy4N, 0.8567, 2.44, 0.235, 222, 204, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1982, 3dy42, 0.8567, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1983, 2fhhX, 0.8567, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1984, 2fhhG, 0.8567, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1985, 2fhgH, 0.8567, 1.61, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1986, 2fhgC, 0.8567, 1.62, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1987, 5bxlV, 0.8566, 1.62, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1988, 5bxlH, 0.8566, 2.43, 0.235, 222, 204, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1989, 3un4N, 0.8566, 2.43, 0.235, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1990, 3un4b, 0.8566, 2.44, 0.230, 222, 204, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1991, 3mkaP, 0.8566, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1992, 3mkaE, 0.8566, 1.61, 0.269, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1993, 2fhhZ, 0.8566, 1.61, 0.269, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1994, 2fhgV, 0.8566, 1.61, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1995, 2fhgN, 0.8566, 1.61, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1996, 2fhgG, 0.8566, 2.42, 0.230, 250, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1997, 3mkaR, 0.8565, 2.45, 0.229, 248, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1998, 3krdH, 0.8565, 2.43, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1999, 2fhhP, 0.8565, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2000, 2fhhC, 0.8565, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2001, 2fhgZ, 0.8565, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2002, 2fhgJ, 0.8565, 2.43, 0.230, 246, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2003, 2fhg2, 0.8565, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2004, 5vfqHA, 0.8564, 2.43, 0.235, 222, 204, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2005, 3mfeP, 0.8564, 2.43, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2006, 2fhhR, 0.8564, 2.45, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2007, 2fhhN, 0.8564, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2008, 2fhhE, 0.8564, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2009, 2fhgR, 0.8564, 1.46, 0.255, 220, 192, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2010, 2fhgL, 0.8564, 2.42, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2011, 2fhgE, 0.8564, 2.43, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2012, 5vfoO, 0.8563, 2.43, 0.235, 222, 204, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2013, 3krdP, 0.8563, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
2014, 2fhhT, 0.8563, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2015, 2fhgT, 0.8563, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2016, 1jd2N, 0.8563, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2017, 1g65N, 0.8563, 1.62, 0.259, 220, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2018, 2fhhL, 0.8562, 2.44, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2019, 2fhhJ, 0.8562, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2020, 2fhh2, 0.8562, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2021, 5vfqI, 0.8561, 1.62, 0.256, 196, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2022, 5vfpI, 0.8561, 1.61, 0.262, 196, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2023, 4g4sH, 0.8561, 2.44, 0.235, 222, 204, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2024, 1jd2U, 0.8561, 2.44, 0.235, 222, 204, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2025, 1g652, 0.8561, 2.44, 0.235, 222, 204, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2026, 3okjN, 0.8560, 1.47, 0.255, 220, 192, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2027, 2fhhV, 0.8560, 2.10, 0.206, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2028, 3mkaH, 0.8559, 1.47, 0.255, 220, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2029, 3mkaG, 0.8558, 2.03, 0.179, 199, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2030, 3gpj2, 0.8557, 1.63, 0.256, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2031, 3bdm1, 0.8557, 1.63, 0.256, 196, 195, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2032, 3gpjN, 0.8556, 1.61, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2033, 3bdmN, 0.8556, 1.62, 0.262, 196, 195, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2034, 5tryJ, 0.8554, 2.44, 0.230, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
2035, 3mkaT, 0.8554, 2.42, 0.230, 249, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2036, 3mkaN, 0.8554, 2.43, 0.230, 251, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2037, 3mka2, 0.8554, 1.62, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2038, 5mp9h, 0.8552, 1.63, 0.262, 196, 195, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2039, 5vfro, 0.8551, 1.63, 0.262, 196, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2040, 5a5b2, 0.8550, 1.63, 0.262, 196, 195, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2041, 4v7oV, 0.8550, 2.44, 0.235, 222, 204, 
2042, 4cr32, 0.8550, 2.44, 0.230, 250, 204, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2043, 3jcpRA, 0.8549, 2.50, 0.229, 252, 205, 
2044, 3jcpD, 0.8549, 2.44, 0.230, 246, 204, 
2045, 5mpcI, 0.8548, 1.63, 0.256, 196, 195, 
2046, 2zcyN, 0.8548, 1.48, 0.255, 220, 192, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2047, 2zcy1, 0.8548, 1.52, 0.276, 223, 192, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2048, 5mpa2, 0.8547, 1.64, 0.251, 196, 195, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2049, 4v7oPA, 0.8547, 1.52, 0.276, 223, 192, 
2050, 4v7oH, 0.8547, 1.46, 0.276, 222, 192, 
2051, 4v7oDB, 0.8547, 1.46, 0.276, 222, 192, 
2052, 3mfeC, 0.8547, 1.46, 0.276, 226, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2053, 5vfrO, 0.8546, 1.64, 0.262, 196, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2054, 5mp91, 0.8546, 1.64, 0.262, 196, 195, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2055, 3d292, 0.8545, 1.45, 0.276, 226, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
2056, 3mfeH, 0.8544, 1.64, 0.251, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2057, 3d29N, 0.8544, 0.33, 0.995, 212, 211, PROTEASOME INHIBITION BY FELLUTAMIDE B
2058, 3mkaJ, 0.8542, 1.64, 0.251, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2059, 3mkaC, 0.8541, 1.64, 0.251, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2060, 1fntV, 0.8538, 2.42, 0.232, 221, 203, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2061, 1fntH, 0.8536, 1.49, 0.255, 220, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2062, 5ln35, 0.8534, 1.64, 0.256, 196, 195, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2063, 3mfeG, 0.8532, 1.64, 0.262, 196, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2064, 3mfeV, 0.8528, 2.41, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2065, 3jcpC, 0.8528, 1.64, 0.262, 196, 195, 
2066, 3jcpQA, 0.8527, 2.45, 0.230, 252, 204, 
2067, 5mpbH, 0.8519, 2.45, 0.230, 250, 204, 
2068, 5mpah, 0.8515, 1.65, 0.256, 196, 195, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2069, 3okj2, 0.8514, 1.65, 0.256, 196, 195, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2070, 5mpa1, 0.8510, 1.69, 0.663, 195, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2071, 5mpbV, 0.8502, 2.46, 0.235, 222, 204, 
2072, 4cr42, 0.8497, 2.56, 0.233, 224, 206, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2073, 3jcoC, 0.8497, 1.64, 0.262, 205, 195, 
2074, 3mfeT, 0.8496, 1.65, 0.262, 205, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2075, 3jcoQA, 0.8495, 1.66, 0.262, 196, 195, 
2076, 5mpcV, 0.8492, 1.69, 0.262, 196, 195, 
2077, 5t0jO, 0.8490, 1.62, 0.263, 195, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2078, 3jcoRA, 0.8484, 1.69, 0.256, 196, 195, 
2079, 3jcoD, 0.8484, 1.67, 0.262, 196, 195, 
2080, 2h6jI, 0.8479, 1.55, 0.276, 223, 192, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2081, 2h6jK, 0.8478, 1.68, 0.262, 205, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2082, 2h6jH, 0.8478, 2.45, 0.232, 221, 203, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2083, 3mfe2, 0.8477, 1.68, 0.262, 205, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2084, 2h6jM, 0.8477, 1.71, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2085, 2h6jL, 0.8477, 1.74, 0.254, 220, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2086, 4cr22, 0.8476, 1.56, 0.276, 222, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2087, 2h6jJ, 0.8475, 1.56, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2088, 2h6jN, 0.8474, 2.25, 0.265, 242, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2089, 3mkaZ, 0.8471, 2.24, 0.265, 242, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2090, 3mfeZ, 0.8471, 2.24, 0.265, 242, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2091, 3mfeR, 0.8469, 2.48, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2092, 3mfeN, 0.8468, 2.25, 0.265, 242, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2093, 3mfeJ, 0.8468, 2.25, 0.265, 242, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2094, 6avoW, 0.8466, 1.63, 0.276, 223, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2095, 6avoa, 0.8466, 2.25, 0.265, 242, 200, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2096, 3mkaX, 0.8465, 2.25, 0.265, 242, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2097, 3mfeX, 0.8464, 2.51, 0.230, 245, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2098, 3mfeE, 0.8463, 2.49, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2099, 3mfeL, 0.8457, 2.48, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2100, 5mpcH, 0.8451, 2.48, 0.232, 221, 203, 
2101, 1q5rM, 0.8451, 2.49, 0.232, 221, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2102, 1q5rL, 0.8451, 2.10, 0.230, 216, 200, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2103, 1q5rI, 0.8451, 2.10, 0.230, 216, 200, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2104, 1q5rH, 0.8451, 2.51, 0.230, 249, 204, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2105, 1q5rN, 0.8450, 2.49, 0.232, 221, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2106, 1q5rK, 0.8450, 2.49, 0.232, 221, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2107, 1q5rJ, 0.8450, 2.49, 0.232, 221, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2108, 5m32M, 0.8447, 1.77, 0.262, 196, 195, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2109, 5m32a, 0.8442, 2.37, 0.264, 251, 201, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2110, 5mpcW, 0.8441, 2.38, 0.264, 251, 201, 
2111, 5vfon, 0.8439, 2.37, 0.264, 251, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2112, 5a0qW, 0.8437, 2.38, 0.264, 251, 201, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2113, 5a0qI, 0.8437, 2.38, 0.264, 251, 201, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2114, 5vfsN, 0.8435, 2.38, 0.264, 251, 201, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2115, 5fmgZ, 0.8435, 2.38, 0.264, 251, 201, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2116, 5fmgL, 0.8435, 2.13, 0.230, 216, 200, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2117, 5vfuEA, 0.8431, 2.13, 0.230, 216, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2118, 5vftT, 0.8431, 1.62, 0.276, 226, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2119, 5l4gY, 0.8431, 1.46, 0.274, 191, 190, 
2120, 5gjqu, 0.8431, 1.58, 0.257, 198, 191, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2121, 5vfuSA, 0.8430, 1.58, 0.257, 198, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2122, 5vftt, 0.8430, 2.17, 0.230, 215, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2123, 5vfpFA, 0.8430, 1.35, 0.473, 189, 188, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2124, 5vfoT, 0.8430, 1.35, 0.473, 189, 188, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2125, 5gjqg, 0.8429, 2.03, 0.231, 215, 199, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2126, 5mp9n, 0.8428, 2.03, 0.231, 215, 199, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2127, 5l4gK, 0.8428, 2.03, 0.231, 217, 199, 
2128, 5vfpN, 0.8426, 2.16, 0.230, 217, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2129, 5vfoN, 0.8426, 2.17, 0.230, 215, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2130, 5vfqGA, 0.8424, 2.17, 0.230, 215, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2131, 5vfpLA, 0.8422, 1.48, 0.274, 191, 190, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2132, 5t0hO, 0.8421, 2.18, 0.230, 215, 200, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2133, 5gjrTA, 0.8418, 2.16, 0.230, 216, 200, 
2134, 5vfsMA, 0.8417, 2.32, 0.178, 232, 202, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2135, 5vfqH, 0.8417, 2.02, 0.231, 217, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2136, 5wvkH, 0.8416, 2.18, 0.230, 215, 200, 
2137, 5gjrFA, 0.8416, 1.49, 0.274, 191, 190, 
2138, 5vfot, 0.8413, 1.49, 0.274, 191, 190, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2139, 5wvkA, 0.8412, 2.19, 0.230, 215, 200, 
2140, 5vfpH, 0.8412, 1.83, 0.254, 220, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2141, 5le5a, 0.8411, 2.17, 0.230, 217, 200, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2142, 3unfM, 0.8410, 2.05, 0.231, 215, 199, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2143, 3unfa, 0.8410, 1.46, 0.255, 220, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2144, 5lf7a, 0.8408, 1.50, 0.274, 191, 190, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2145, 3unhM, 0.8408, 1.82, 0.256, 196, 195, MOUSE 20S IMMUNOPROTEASOME
2146, 3unha, 0.8408, 2.17, 0.230, 216, 200, MOUSE 20S IMMUNOPROTEASOME
2147, 5vfuY, 0.8407, 2.04, 0.231, 215, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2148, 5vftN, 0.8407, 1.81, 0.256, 196, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2149, 4g4sN, 0.8407, 1.51, 0.274, 191, 190, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2150, 3unea, 0.8407, 2.10, 0.206, 204, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
2151, 3h6fR, 0.8407, 2.18, 0.230, 216, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2152, 5mpa7, 0.8406, 2.20, 0.230, 216, 200, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2153, 5wvkI, 0.8405, 2.20, 0.230, 216, 200, 
2154, 5wviFA, 0.8405, 2.18, 0.230, 216, 200, 
2155, 5vfsH, 0.8404, 2.20, 0.230, 216, 200, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2156, 5vfrn, 0.8404, 2.20, 0.230, 216, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2157, 5lf3a, 0.8404, 1.51, 0.274, 191, 190, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2158, 5le5M, 0.8404, 1.51, 0.274, 191, 190, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2159, 5a5b1, 0.8404, 2.32, 0.178, 233, 202, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2160, 4cr31, 0.8404, 2.21, 0.230, 216, 200, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2161, 5lf4a, 0.8403, 2.86, 0.223, 222, 206, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2162, 3h6iR, 0.8403, 2.33, 0.178, 229, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2163, 5leya, 0.8402, 1.64, 0.276, 223, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2164, 4r3oN, 0.8402, 1.63, 0.276, 222, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
2165, 4r3o2, 0.8402, 1.40, 0.250, 220, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
2166, 5vfqMA, 0.8400, 1.51, 0.274, 191, 190, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2167, 5leyM, 0.8400, 1.52, 0.274, 191, 190, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2168, 3sdkM, 0.8400, 2.18, 0.230, 216, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2169, 5lf7M, 0.8399, 2.19, 0.230, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2170, 5lf4M, 0.8398, 1.81, 0.262, 205, 195, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2171, 5vfrN, 0.8397, 1.81, 0.262, 205, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2172, 5ln32, 0.8397, 2.18, 0.230, 216, 200, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2173, 5lf6a, 0.8397, 2.86, 0.223, 222, 206, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2174, 5lf1a, 0.8397, 2.19, 0.230, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2175, 5vfrT, 0.8396, 2.20, 0.230, 217, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2176, 3une3, 0.8396, 2.19, 0.230, 217, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
2177, 3sdk1, 0.8396, 2.06, 0.231, 215, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2178, 5lf6M, 0.8395, 2.19, 0.230, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2179, 5lf3M, 0.8394, 2.35, 0.178, 233, 202, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2180, 4r67p, 0.8394, 2.19, 0.230, 216, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2181, 4r67N, 0.8394, 2.19, 0.230, 216, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2182, 4r67b, 0.8394, 1.53, 0.274, 191, 190, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2183, 4r672, 0.8394, 1.67, 0.255, 222, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2184, 4eu22, 0.8394, 2.21, 0.230, 216, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2185, 3mg41, 0.8394, 2.19, 0.230, 216, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2186, 5mpbI, 0.8393, 2.07, 0.231, 215, 199, 
2187, 5lf0a, 0.8393, 2.21, 0.230, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2188, 5fggM, 0.8393, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2189, 5fgga, 0.8393, 2.20, 0.230, 216, 200, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2190, 1rypN, 0.8393, 2.20, 0.230, 216, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2191, 1ryp2, 0.8393, 2.20, 0.230, 217, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2192, 5vfqN, 0.8392, 2.20, 0.230, 217, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2193, 5lf1M, 0.8392, 2.20, 0.230, 217, 200, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2194, 5l5rM, 0.8392, 2.20, 0.230, 217, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2195, 5l5ra, 0.8392, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2196, 5bxnM, 0.8392, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2197, 3mg61, 0.8392, 1.86, 0.275, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2198, 5l5uM, 0.8391, 2.19, 0.230, 216, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2199, 5l5ua, 0.8391, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2200, 5bxna, 0.8391, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2201, 3unb3, 0.8391, 2.34, 0.178, 233, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2202, 2fakM, 0.8391, 2.33, 0.178, 233, 202, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2203, 2fak1, 0.8391, 2.07, 0.231, 215, 199, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2204, 5wviC, 0.8390, 2.20, 0.230, 216, 200, 
2205, 5mpbW, 0.8390, 2.35, 0.178, 233, 202, 
2206, 5l5bM, 0.8390, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2207, 5l5ba, 0.8390, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2208, 4qvnM, 0.8390, 2.36, 0.178, 233, 202, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2209, 4qvna, 0.8390, 2.35, 0.178, 233, 202, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2210, 3gpjM, 0.8390, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2211, 3gpj1, 0.8390, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2212, 3dy31, 0.8390, 2.20, 0.230, 216, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2213, 4qwuM, 0.8389, 2.34, 0.178, 233, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2214, 4qwua, 0.8389, 2.34, 0.178, 233, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2215, 4q1sa, 0.8389, 1.65, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2216, 3mg71, 0.8389, 1.66, 0.276, 226, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2217, 3dy3M, 0.8389, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2218, 2zcyM, 0.8389, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2219, 2zcy0, 0.8389, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2220, 5vfuMA, 0.8388, 2.34, 0.178, 233, 202, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2221, 5vftn, 0.8388, 2.34, 0.178, 233, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2222, 5lexM, 0.8388, 2.34, 0.178, 233, 202, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2223, 4ya4a, 0.8388, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2224, 5lf0M, 0.8387, 2.33, 0.178, 233, 202, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2225, 5lezM, 0.8387, 2.33, 0.178, 233, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2226, 5lexa, 0.8387, 2.36, 0.178, 233, 202, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2227, 5l5ya, 0.8387, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2228, 4ya4M, 0.8387, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2229, 4r18M, 0.8387, 2.34, 0.178, 233, 202, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2230, 4r18a, 0.8387, 2.34, 0.178, 233, 202, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2231, 1g0u1, 0.8387, 1.53, 0.274, 191, 190, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2232, 5m2bM, 0.8386, 1.53, 0.274, 191, 190, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2233, 5m2ba, 0.8386, 2.20, 0.230, 216, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2234, 5l66M, 0.8386, 2.35, 0.178, 232, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2235, 5l66a, 0.8386, 2.21, 0.230, 216, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2236, 5l63M, 0.8386, 2.20, 0.230, 216, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2237, 5l63a, 0.8386, 2.20, 0.230, 216, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2238, 5l61M, 0.8386, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2239, 5l61a, 0.8386, 2.35, 0.178, 229, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2240, 5l5yM, 0.8386, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2241, 5cggM, 0.8386, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2242, 5cgga, 0.8386, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2243, 5bxlM, 0.8386, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2244, 5bxla, 0.8386, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2245, 5ahjM, 0.8386, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2246, 5ahja, 0.8386, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2247, 4qltM, 0.8386, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2248, 4qlta, 0.8386, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2249, 3mg81, 0.8386, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2250, 3bdmM, 0.8386, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2251, 3bdm0, 0.8386, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2252, 5vfrt, 0.8385, 2.35, 0.178, 233, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2253, 5l6aM, 0.8385, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2254, 5l6aa, 0.8385, 2.36, 0.178, 229, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2255, 5l5sM, 0.8385, 2.36, 0.178, 232, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2256, 5l5sa, 0.8385, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2257, 5l5da, 0.8385, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2258, 5d0wa, 0.8385, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2259, 4y8gM, 0.8385, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2260, 4y8ga, 0.8385, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2261, 5laja, 0.8384, 2.35, 0.178, 233, 202, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2262, 5l65M, 0.8384, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2263, 5l65a, 0.8384, 2.08, 0.231, 215, 199, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2264, 5l62M, 0.8384, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2265, 5l62a, 0.8384, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2266, 5l5zM, 0.8384, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2267, 5l5za, 0.8384, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2268, 5l5tM, 0.8384, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2269, 5l5ta, 0.8384, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2270, 5l5dM, 0.8384, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2271, 5d0wM, 0.8384, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2272, 5czaa, 0.8384, 2.36, 0.178, 231, 202, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2273, 4y8ha, 0.8384, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2274, 4r17M, 0.8384, 2.35, 0.178, 233, 202, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2275, 4r17a, 0.8384, 2.36, 0.178, 233, 202, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2276, 4qz7M, 0.8384, 2.36, 0.178, 233, 202, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2277, 4qz7a, 0.8384, 2.35, 0.178, 233, 202, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2278, 4qz0M, 0.8384, 2.35, 0.178, 233, 202, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2279, 4qz0a, 0.8384, 2.36, 0.178, 233, 202, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2280, 4qw6M, 0.8384, 2.36, 0.178, 233, 202, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2281, 4qw6a, 0.8384, 2.36, 0.178, 233, 202, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2282, 4fzgM, 0.8384, 2.36, 0.178, 233, 202, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2283, 4fzga, 0.8384, 2.36, 0.178, 232, 202, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2284, 3uneM, 0.8384, 2.35, 0.178, 233, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
2285, 3mg7M, 0.8384, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2286, 3gpwM, 0.8384, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2287, 3gpw1, 0.8384, 2.35, 0.178, 232, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2288, 1g0uM, 0.8384, 2.35, 0.178, 233, 202, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2289, 5mpan, 0.8383, 2.35, 0.178, 233, 202, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2290, 5lajM, 0.8383, 2.35, 0.178, 233, 202, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2291, 5l6bM, 0.8383, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2292, 5l6ba, 0.8383, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2293, 5l5wM, 0.8383, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2294, 5l5wa, 0.8383, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2295, 5l5pM, 0.8383, 2.22, 0.230, 216, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2296, 5l5pa, 0.8383, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2297, 5l54M, 0.8383, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2298, 5l54a, 0.8383, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2299, 5d0sM, 0.8383, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2300, 5d0sa, 0.8383, 2.25, 0.179, 232, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2301, 5czaM, 0.8383, 2.36, 0.178, 228, 202, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2302, 4y8hM, 0.8383, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2303, 4qwfM, 0.8383, 2.36, 0.178, 233, 202, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2304, 4qwfa, 0.8383, 2.36, 0.178, 233, 202, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2305, 4qvlM, 0.8383, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH BORTEZOMIB
2306, 4qvla, 0.8383, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH BORTEZOMIB
2307, 4qv5M, 0.8383, 2.36, 0.178, 233, 202, YCP BETA5-M45I MUTANT
2308, 4qv5a, 0.8383, 2.35, 0.178, 233, 202, YCP BETA5-M45I MUTANT
2309, 4quyM, 0.8383, 2.35, 0.178, 233, 202, YCP BETA5-A49S-MUTANT
2310, 4quya, 0.8383, 2.35, 0.178, 233, 202, YCP BETA5-A49S-MUTANT
2311, 4no8M, 0.8383, 2.35, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2312, 3unba, 0.8383, 2.36, 0.178, 229, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2313, 5leza, 0.8382, 2.35, 0.178, 233, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2314, 5l6cM, 0.8382, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2315, 5l6ca, 0.8382, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2316, 5l64M, 0.8382, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2317, 5l64a, 0.8382, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2318, 5l5oM, 0.8382, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2319, 5l5oa, 0.8382, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2320, 5l5jM, 0.8382, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2321, 5l5ja, 0.8382, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2322, 5l5hM, 0.8382, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2323, 5l5ha, 0.8382, 2.21, 0.230, 216, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2324, 5jhsM, 0.8382, 2.21, 0.230, 216, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2325, 5jhsa, 0.8382, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2326, 4qwlM, 0.8382, 2.36, 0.178, 233, 202, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2327, 4qwla, 0.8382, 2.36, 0.178, 233, 202, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2328, 4qv9M, 0.8382, 2.36, 0.178, 233, 202, YCP BETA5-C63F MUTANT
2329, 4qv9a, 0.8382, 2.37, 0.178, 233, 202, YCP BETA5-C63F MUTANT
2330, 4qv0a, 0.8382, 2.37, 0.178, 233, 202, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2331, 4no8a, 0.8382, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2332, 3oev1, 0.8382, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2333, 1jd2T, 0.8382, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2334, 5l60M, 0.8381, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2335, 5l60a, 0.8381, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2336, 5l55M, 0.8381, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2337, 5l52M, 0.8381, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2338, 5l52a, 0.8381, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2339, 5fgiM, 0.8381, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2340, 5fgia, 0.8381, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2341, 5fgfa, 0.8381, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2342, 5fgaM, 0.8381, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2343, 5fgaa, 0.8381, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2344, 5dkjM, 0.8381, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2345, 5dkja, 0.8381, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2346, 5d0tM, 0.8381, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2347, 5d0ta, 0.8381, 2.35, 0.178, 228, 202, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2348, 5cz9a, 0.8381, 2.35, 0.178, 225, 202, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2349, 5cghM, 0.8381, 2.35, 0.178, 225, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2350, 5cgha, 0.8381, 2.35, 0.178, 232, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2351, 4ya9M, 0.8381, 2.35, 0.178, 232, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2352, 4ya9a, 0.8381, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2353, 4y8rM, 0.8381, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2354, 4y8ra, 0.8381, 2.36, 0.178, 232, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2355, 4qvpa, 0.8381, 2.36, 0.178, 233, 202, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2356, 4qv6M, 0.8381, 2.36, 0.178, 233, 202, YCP BETA5-A49V MUTANT
2357, 4qv6a, 0.8381, 2.36, 0.178, 231, 202, YCP BETA5-A49V MUTANT
2358, 4qv3a, 0.8381, 2.35, 0.178, 233, 202, YCP BETA5-M45V MUTANT
2359, 4qv0M, 0.8381, 2.35, 0.178, 233, 202, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2360, 3shjM, 0.8381, 2.36, 0.178, 233, 202, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2361, 3shj1, 0.8381, 2.36, 0.178, 233, 202, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2362, 3sdi1, 0.8381, 2.35, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2363, 3mg4M, 0.8381, 2.35, 0.178, 233, 202, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2364, 3hyeM, 0.8381, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2365, 3hye1, 0.8381, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2366, 3e471, 0.8381, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2367, 1jd2M, 0.8381, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2368, 6gopa, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2369, 5vfsGA, 0.8380, 2.36, 0.178, 233, 202, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2370, 5l67M, 0.8380, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2371, 5l67a, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2372, 5l5qM, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2373, 5l5qa, 0.8380, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2374, 5l5fa, 0.8380, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2375, 5l55a, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2376, 5fgfM, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2377, 5fgeM, 0.8380, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2378, 5fgea, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2379, 5fg7M, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2380, 5fg7a, 0.8380, 1.54, 0.274, 191, 190, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2381, 5cz9M, 0.8380, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2382, 4qw5M, 0.8380, 2.36, 0.178, 233, 202, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2383, 4qw5a, 0.8380, 2.37, 0.178, 233, 202, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2384, 4qw1M, 0.8380, 2.37, 0.178, 233, 202, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2385, 4qw1a, 0.8380, 2.36, 0.178, 233, 202, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2386, 4qvqM, 0.8380, 2.35, 0.178, 229, 202, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2387, 4qvqa, 0.8380, 2.35, 0.178, 233, 202, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2388, 4qvpM, 0.8380, 2.35, 0.178, 233, 202, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2389, 4qv7M, 0.8380, 2.35, 0.178, 233, 202, YCP BETA5-A50V MUTANT
2390, 4qv7a, 0.8380, 2.36, 0.178, 233, 202, YCP BETA5-A50V MUTANT
2391, 4qv4a, 0.8380, 2.36, 0.178, 233, 202, YCP BETA5-M45T MUTANT
2392, 4qv3M, 0.8380, 2.35, 0.178, 233, 202, YCP BETA5-M45V MUTANT
2393, 4qv1M, 0.8380, 2.35, 0.178, 233, 202, YCP BETA5-M45A MUTANT
2394, 4qv1a, 0.8380, 2.35, 0.178, 233, 202, YCP BETA5-M45A MUTANT
2395, 4q1sM, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2396, 4inta, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2397, 4inra, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2398, 3unbM, 0.8380, 2.35, 0.178, 233, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2399, 3e47M, 0.8380, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2400, 6gopM, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2401, 5laiM, 0.8379, 2.36, 0.178, 233, 202, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2402, 5laia, 0.8379, 2.36, 0.178, 233, 202, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2403, 5l69M, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2404, 5l69a, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2405, 5l68M, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2406, 5l68a, 0.8379, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2407, 5l5vM, 0.8379, 2.36, 0.178, 233, 202,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2408, 5l5va, 0.8379, 2.36, 0.178, 233, 202,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2409, 5l5fM, 0.8379, 2.23, 0.230, 216, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2410, 5jhrM, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2411, 5jhra, 0.8379, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2412, 5fhsM, 0.8379, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2413, 5fhsa, 0.8379, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2414, 5fgda, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2415, 5d0vM, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2416, 5d0va, 0.8379, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2417, 5cgfM, 0.8379, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2418, 5cgfa, 0.8379, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2419, 4ya2M, 0.8379, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2420, 4ya2a, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2421, 4qz1M, 0.8379, 2.36, 0.178, 233, 202, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2422, 4qz1a, 0.8379, 2.36, 0.178, 233, 202, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2423, 4qw7M, 0.8379, 2.35, 0.178, 233, 202, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2424, 4qw7a, 0.8379, 2.35, 0.178, 233, 202, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2425, 4qv4M, 0.8379, 2.35, 0.178, 233, 202, YCP BETA5-M45T MUTANT
2426, 4eu2N, 0.8379, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2427, 3oeu1, 0.8379, 2.35, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2428, 3nzjM, 0.8379, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2429, 3nzj1, 0.8379, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2430, 3mg8M, 0.8379, 2.35, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2431, 3d29M, 0.8379, 2.35, 0.178, 233, 202, PROTEASOME INHIBITION BY FELLUTAMIDE B
2432, 3d291, 0.8379, 2.35, 0.178, 231, 202, PROTEASOME INHIBITION BY FELLUTAMIDE B
2433, 1iruN, 0.8379, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2434, 1iru2, 0.8379, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2435, 5l5xM, 0.8378, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2436, 5l5xa, 0.8378, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2437, 5l5iM, 0.8378, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2438, 5l5ia, 0.8378, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2439, 5fgdM, 0.8378, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2440, 5d0zM, 0.8378, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2441, 5d0za, 0.8378, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2442, 4ya1M, 0.8378, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2443, 4ya1a, 0.8378, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2444, 4y84M, 0.8378, 2.23, 0.230, 217, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2445, 4y84a, 0.8378, 2.23, 0.230, 217, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2446, 4y75M, 0.8378, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2447, 4y75a, 0.8378, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2448, 4r02M, 0.8378, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2449, 4qzzM, 0.8378, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH OMURALIDE
2450, 4qzza, 0.8378, 2.35, 0.178, 233, 202, YCP IN COMPLEX WITH OMURALIDE
2451, 4qvwM, 0.8378, 2.35, 0.178, 233, 202, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2452, 4qvwa, 0.8378, 2.35, 0.178, 233, 202, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2453, 4qlvM, 0.8378, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2454, 4qlva, 0.8378, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2455, 3wxrN, 0.8378, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2456, 3wxr2, 0.8378, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2457, 3tddM, 0.8378, 2.35, 0.178, 224, 202, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2458, 3tdd1, 0.8378, 2.35, 0.178, 224, 202, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2459, 3okjM, 0.8378, 2.37, 0.178, 233, 202, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2460, 5lttM, 0.8377, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2461, 5cz7M, 0.8377, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2462, 5cz7a, 0.8377, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2463, 5boua, 0.8377, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2464, 4y9yM, 0.8377, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2465, 4y9ya, 0.8377, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2466, 4r02a, 0.8377, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2467, 4qz4M, 0.8377, 2.36, 0.178, 233, 202, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2468, 4qz4a, 0.8377, 2.37, 0.178, 233, 202, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2469, 4qvma, 0.8377, 2.37, 0.178, 233, 202, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2470, 4qv8M, 0.8377, 2.35, 0.178, 233, 202, YCP BETA5-C52F MUTANT
2471, 4qv8a, 0.8377, 2.37, 0.178, 233, 202, YCP BETA5-C52F MUTANT
2472, 4qlsM, 0.8377, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2473, 4qlsa, 0.8377, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2474, 4no6M, 0.8377, 2.37, 0.178, 232, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2475, 4no6a, 0.8377, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2476, 4ltcM, 0.8377, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2477, 4ltca, 0.8377, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2478, 4intM, 0.8377, 2.35, 0.178, 225, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2479, 4inrM, 0.8377, 2.35, 0.178, 225, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2480, 3uneo, 0.8377, 2.36, 0.178, 233, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
2481, 3nzwM, 0.8377, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2482, 3nzw1, 0.8377, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2483, 3mg01, 0.8377, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2484, 2f16M, 0.8377, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2485, 2f161, 0.8377, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2486, 5ltta, 0.8376, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2487, 5l5aa, 0.8376, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2488, 5fghM, 0.8376, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2489, 5bouM, 0.8376, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2490, 4y8tM, 0.8376, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2491, 4y8ta, 0.8376, 2.23, 0.230, 216, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2492, 4y8kM, 0.8376, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2493, 4y8ka, 0.8376, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2494, 4x6zN, 0.8376, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2495, 4x6z2, 0.8376, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2496, 4qw4M, 0.8376, 2.35, 0.178, 233, 202, YCP IN COMPLEX WITH CARFILZOMIB
2497, 4qw4a, 0.8376, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH CARFILZOMIB
2498, 4qvmM, 0.8376, 2.37, 0.178, 233, 202, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2499, 4qluM, 0.8376, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2500, 4qlua, 0.8376, 2.37, 0.178, 229, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2501, 4lqiM, 0.8376, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2502, 4lqia, 0.8376, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2503, 4j70a, 0.8376, 2.36, 0.178, 230, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2504, 4cr41, 0.8376, 2.36, 0.178, 233, 202, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2505, 3oevM, 0.8376, 2.37, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2506, 3mg6M, 0.8376, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2507, 3gptM, 0.8376, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2508, 3gpt1, 0.8376, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2509, 5l5aM, 0.8375, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2510, 5fgha, 0.8375, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2511, 5cz6M, 0.8375, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2512, 5cz6a, 0.8375, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2513, 5cgiM, 0.8375, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2514, 5cgia, 0.8375, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2515, 4ya7M, 0.8375, 1.83, 0.256, 205, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2516, 4ya7a, 0.8375, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2517, 4y77M, 0.8375, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2518, 4qz6M, 0.8375, 2.36, 0.178, 233, 202, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2519, 4qvyM, 0.8375, 2.36, 0.178, 233, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2520, 4qvya, 0.8375, 2.37, 0.178, 233, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2521, 4nnnM, 0.8375, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH MG132
2522, 4nnna, 0.8375, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH MG132
2523, 3unbo, 0.8375, 2.37, 0.178, 233, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2524, 3un4a, 0.8375, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2525, 3nzx1, 0.8375, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2526, 3dy41, 0.8375, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2527, 5l5eM, 0.8374, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2528, 5l5ea, 0.8374, 2.36, 0.178, 224, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2529, 5cz8M, 0.8374, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2530, 5cz8a, 0.8374, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2531, 4zzg2, 0.8374, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2532, 4qz6a, 0.8374, 2.35, 0.178, 233, 202, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2533, 4qz2a, 0.8374, 2.35, 0.178, 233, 202, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2534, 4qwrM, 0.8374, 2.22, 0.230, 216, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2535, 4qwra, 0.8374, 2.36, 0.178, 233, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2536, 4quxM, 0.8374, 2.36, 0.178, 233, 202, YCP BETA5-A49T-MUTANT
2537, 4quxa, 0.8374, 2.36, 0.178, 233, 202, YCP BETA5-A49T-MUTANT
2538, 4nnwM, 0.8374, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2539, 4nnwa, 0.8374, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2540, 4j70M, 0.8374, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2541, 3un8M, 0.8374, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2542, 3un8a, 0.8374, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2543, 3un4M, 0.8374, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2544, 3sdiM, 0.8374, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2545, 3oeuM, 0.8374, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2546, 3nzxM, 0.8374, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2547, 3mg0M, 0.8374, 2.37, 0.178, 233, 202, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2548, 3dy4M, 0.8374, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2549, 5nif2, 0.8373, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2550, 5fg9M, 0.8373, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2551, 5fg9a, 0.8373, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2552, 4y9zM, 0.8373, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2553, 4y9za, 0.8373, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2554, 4r00M, 0.8373, 2.36, 0.178, 233, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2555, 4r00a, 0.8373, 2.38, 0.178, 233, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2556, 4qz2M, 0.8373, 2.38, 0.178, 233, 202, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2557, 4qlqM, 0.8373, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2558, 4qlqa, 0.8373, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2559, 4qbya, 0.8373, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2560, 4jsqM, 0.8373, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2561, 4jsqa, 0.8373, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2562, 4inua, 0.8373, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2563, 4fzcM, 0.8373, 2.35, 0.178, 233, 202, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2564, 4fzca, 0.8373, 2.35, 0.178, 233, 202, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2565, 1g65M, 0.8373, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2566, 4z1lM, 0.8372, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2567, 4z1la, 0.8372, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2568, 4y6aa, 0.8372, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2569, 4qbyM, 0.8372, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2570, 4y8lM, 0.8371, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2571, 4y8la, 0.8371, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2572, 4y6va, 0.8371, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2573, 4y6aM, 0.8371, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2574, 4y69a, 0.8371, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2575, 4rura, 0.8371, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2576, 4qz3M, 0.8371, 2.37, 0.178, 233, 202, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2577, 4qz3a, 0.8371, 2.37, 0.178, 229, 202, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2578, 4qwxM, 0.8371, 2.37, 0.178, 232, 202, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2579, 4qwxa, 0.8371, 2.38, 0.178, 233, 202, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2580, 4inuM, 0.8371, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2581, 4hnpa, 0.8371, 2.36, 0.178, 230, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2582, 1g651, 0.8371, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2583, 5dkiM, 0.8370, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2584, 5dkia, 0.8370, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2585, 5cz5M, 0.8370, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2586, 5cz5a, 0.8370, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2587, 4y8ua, 0.8370, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2588, 4y82M, 0.8370, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2589, 4y82a, 0.8370, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2590, 4y81a, 0.8370, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2591, 4y6vM, 0.8370, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2592, 4y69M, 0.8370, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2593, 4rurM, 0.8370, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2594, 4qz5M, 0.8370, 2.36, 0.178, 233, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2595, 4qz5a, 0.8370, 2.36, 0.178, 233, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2596, 4qw3a, 0.8370, 2.36, 0.178, 233, 202, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2597, 4no9M, 0.8370, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2598, 4no9a, 0.8370, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2599, 4no1M, 0.8370, 2.37, 0.178, 230, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2600, 4no1a, 0.8370, 2.37, 0.178, 232, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2601, 4y8uM, 0.8369, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2602, 4y8iM, 0.8369, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2603, 4y81M, 0.8369, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2604, 4y77a, 0.8369, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2605, 4y74M, 0.8369, 2.35, 0.178, 225, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2606, 4qzwM, 0.8369, 2.35, 0.178, 225, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2607, 4qzwa, 0.8369, 2.37, 0.178, 233, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2608, 4qwkM, 0.8369, 2.37, 0.178, 233, 202, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2609, 4qwka, 0.8369, 2.37, 0.178, 233, 202, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2610, 4qwiM, 0.8369, 2.37, 0.178, 233, 202, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2611, 4qwia, 0.8369, 2.37, 0.178, 233, 202, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2612, 4qw3M, 0.8369, 2.37, 0.178, 233, 202, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2613, 4hrda, 0.8369, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2614, 5nifN, 0.8368, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2615, 4y8ia, 0.8368, 2.28, 0.174, 223, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2616, 4y74a, 0.8368, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2617, 4qw0a, 0.8368, 2.37, 0.178, 233, 202, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2618, 4hrca, 0.8368, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2619, 4gk7M, 0.8368, 2.36, 0.178, 230, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2620, 4gk7a, 0.8368, 2.36, 0.178, 230, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2621, 5d0xM, 0.8367, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2622, 5d0xa, 0.8367, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2623, 4y7xM, 0.8367, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2624, 4y7xa, 0.8367, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2625, 4y6zM, 0.8367, 2.36, 0.178, 232, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2626, 4y6za, 0.8367, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2627, 4qw0M, 0.8367, 2.37, 0.178, 233, 202, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2628, 4jsuM, 0.8367, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2629, 4jsua, 0.8367, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2630, 4hrdM, 0.8367, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2631, 4cr21, 0.8367, 2.36, 0.178, 233, 202, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2632, 4zzgN, 0.8366, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2633, 4y8sM, 0.8366, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2634, 4y8nM, 0.8366, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2635, 4qwsa, 0.8366, 2.37, 0.178, 233, 202, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2636, 4jt0M, 0.8366, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2637, 4jt0a, 0.8366, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2638, 2gpl1, 0.8366, 2.38, 0.178, 233, 202, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2639, 4ya5M, 0.8365, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2640, 4ya5a, 0.8365, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2641, 4y8sa, 0.8365, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2642, 4y8jM, 0.8365, 1.89, 0.262, 205, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2643, 4y8ja, 0.8365, 2.37, 0.178, 232, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2644, 4y80a, 0.8365, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2645, 4qwsM, 0.8365, 2.39, 0.178, 224, 202, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2646, 2gplM, 0.8365, 2.37, 0.178, 233, 202, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2647, 4y80M, 0.8364, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2648, 4hnpM, 0.8364, 2.38, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2649, 4y7wM, 0.8363, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2650, 4y7wa, 0.8363, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2651, 4y70M, 0.8363, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2652, 4y70a, 0.8363, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2653, 4qzxM, 0.8362, 2.36, 0.178, 230, 202, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2654, 4qzxa, 0.8362, 2.36, 0.178, 233, 202, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2655, 4qxjM, 0.8362, 2.37, 0.178, 233, 202, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2656, 4qxja, 0.8362, 2.37, 0.178, 233, 202, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2657, 4qwgM, 0.8362, 2.39, 0.178, 233, 202, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2658, 4qwga, 0.8362, 2.37, 0.178, 232, 202, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2659, 3h6fV, 0.8362, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2660, 5mp97, 0.8361, 2.37, 0.178, 233, 202, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2661, 3h6iV, 0.8361, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2662, 4y7yM, 0.8360, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2663, 4y7ya, 0.8360, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2664, 4qwjM, 0.8360, 2.37, 0.178, 231, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2665, 4qwja, 0.8360, 2.37, 0.178, 232, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2666, 5cz4M, 0.8359, 2.37, 0.178, 228, 202, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2667, 5cz4a, 0.8359, 2.37, 0.178, 226, 202, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2668, 4y78M, 0.8359, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2669, 4y78a, 0.8359, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2670, 5wvkB, 0.8358, 2.86, 0.224, 221, 205, 
2671, 4y8ma, 0.8358, 2.40, 0.178, 229, 202, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2672, 4qvvM, 0.8358, 2.87, 0.224, 220, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2673, 4qvva, 0.8358, 2.37, 0.178, 233, 202, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2674, 4y8na, 0.8357, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2675, 4ya3M, 0.8355, 2.37, 0.178, 230, 202, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2676, 4ya3a, 0.8355, 2.37, 0.178, 228, 202, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2677, 4ya0M, 0.8354, 2.39, 0.178, 229, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2678, 4ya0a, 0.8354, 2.39, 0.178, 232, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2679, 4y8pM, 0.8354, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2680, 4y8pa, 0.8354, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2681, 4y8mM, 0.8354, 1.83, 0.275, 223, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2682, 4y8oM, 0.8351, 2.20, 0.175, 222, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2683, 4hrcM, 0.8351, 2.38, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2684, 3hf9e, 0.8351, 2.38, 0.178, 233, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2685, 4y8qM, 0.8350, 2.33, 0.174, 223, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2686, 4y8qa, 0.8350, 2.39, 0.178, 233, 202, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2687, 3hf9r, 0.8350, 2.39, 0.178, 233, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2688, 3hf9P, 0.8349, 2.39, 0.178, 233, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2689, 1z7qN, 0.8349, 2.39, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2690, 1z7qb, 0.8349, 2.16, 0.176, 224, 199, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2691, 3hf9X, 0.8348, 2.16, 0.176, 224, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2692, 4y8oa, 0.8347, 2.22, 0.175, 222, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2693, 3hf94, 0.8347, 2.12, 0.176, 222, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2694, 3hf9z, 0.8346, 2.38, 0.178, 233, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2695, 3hf9l, 0.8346, 2.55, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2696, 3hf9G, 0.8346, 2.21, 0.175, 222, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2697, 3hf9v, 0.8345, 2.21, 0.175, 222, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2698, 3hf9n, 0.8345, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2699, 3hf9H, 0.8345, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2700, 3hf9Z, 0.8344, 2.42, 0.178, 233, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2701, 3hf9x, 0.8344, 2.42, 0.178, 233, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2702, 5t0cLB, 0.8343, 2.56, 0.229, 216, 201, 
2703, 5t0cFA, 0.8343, 2.21, 0.175, 222, 200, 
2704, 5l5wZ, 0.8343, 2.57, 0.229, 216, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2705, 5l5wL, 0.8343, 2.55, 0.229, 216, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2706, 3hf9t, 0.8343, 2.55, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2707, 5cgfL, 0.8342, 2.55, 0.229, 216, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2708, 4ya3Z, 0.8342, 2.68, 0.227, 218, 203, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2709, 4ya3L, 0.8342, 2.55, 0.229, 216, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2710, 4y8uZ, 0.8342, 2.55, 0.229, 216, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2711, 4y8uL, 0.8342, 2.56, 0.229, 216, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2712, 3hf9J, 0.8342, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2713, 1fntN, 0.8342, 2.26, 0.230, 215, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2714, 1fntb, 0.8342, 2.26, 0.230, 215, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2715, 4y8tZ, 0.8341, 1.88, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2716, 4y8tL, 0.8341, 1.88, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2717, 3hf9R, 0.8341, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2718, 3hf9p, 0.8341, 2.05, 0.196, 222, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2719, 3hf92, 0.8341, 2.05, 0.196, 222, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2720, 4zzg1, 0.8339, 2.05, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2721, 3hf9L, 0.8339, 1.89, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2722, 3hf9j, 0.8339, 1.89, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2723, 5lajZ, 0.8338, 2.56, 0.229, 216, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2724, 3hf9T, 0.8338, 2.42, 0.178, 233, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2725, 3hf9g, 0.8338, 2.42, 0.178, 233, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2726, 3hf9C, 0.8338, 1.89, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2727, 5lajL, 0.8337, 1.89, 0.197, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2728, 5l5bZ, 0.8337, 2.56, 0.229, 216, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2729, 5l5bL, 0.8337, 2.57, 0.229, 216, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2730, 5fgfZ, 0.8337, 2.56, 0.229, 216, 201, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2731, 5fgfL, 0.8337, 2.05, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2732, 4ya0Z, 0.8337, 2.56, 0.229, 216, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2733, 4ya0L, 0.8337, 2.56, 0.229, 216, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2734, 4y6aL, 0.8337, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2735, 4y69Z, 0.8337, 2.56, 0.229, 216, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2736, 4y69L, 0.8337, 2.56, 0.229, 216, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2737, 3hf9N, 0.8337, 2.57, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2738, 1z7qM, 0.8337, 1.89, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2739, 5laiL, 0.8336, 1.89, 0.192, 222, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2740, 5l65Z, 0.8336, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2741, 4z1lZ, 0.8336, 1.88, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2742, 4z1lL, 0.8336, 1.88, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2743, 4y6aZ, 0.8336, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2744, 4j70Z, 0.8336, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2745, 1z7qa, 0.8336, 1.89, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2746, 5l65L, 0.8335, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2747, 5l5rZ, 0.8335, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2748, 5l5rL, 0.8335, 2.56, 0.229, 216, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2749, 5l5aZ, 0.8335, 2.04, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2750, 5l5aL, 0.8335, 2.06, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2751, 5fgdZ, 0.8335, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2752, 5fgdL, 0.8335, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2753, 5cgfZ, 0.8335, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2754, 5bouZ, 0.8335, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2755, 5bouL, 0.8335, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2756, 5m2bZ, 0.8334, 2.05, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2757, 5m2bL, 0.8334, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2758, 5fgaZ, 0.8334, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2759, 4y8nZ, 0.8334, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2760, 4y8nL, 0.8334, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2761, 5l5eZ, 0.8333, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2762, 5l5eL, 0.8333, 1.88, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2763, 5fgaL, 0.8333, 1.88, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2764, 4ya5Z, 0.8333, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2765, 4ya5L, 0.8333, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2766, 4y8rZ, 0.8333, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2767, 4y8rL, 0.8333, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2768, 4j70L, 0.8333, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2769, 5t0cZ, 0.8332, 2.06, 0.191, 222, 194, 
2770, 5t0cFB, 0.8332, 2.06, 0.191, 222, 194, 
2771, 5laiZ, 0.8332, 2.06, 0.191, 222, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2772, 5cz7Z, 0.8332, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2773, 5cz7L, 0.8332, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2774, 5l6bZ, 0.8331, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2775, 5l6bL, 0.8331, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2776, 5l66Z, 0.8331, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2777, 5l66L, 0.8331, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2778, 4ya1Z, 0.8331, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2779, 4ya1L, 0.8331, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2780, 4r17Z, 0.8331, 1.62, 0.274, 191, 190, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2781, 4r17L, 0.8331, 1.62, 0.274, 191, 190, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2782, 5l6cZ, 0.8330, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2783, 5l6cL, 0.8330, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2784, 5fg9Z, 0.8330, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2785, 5fg9L, 0.8330, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2786, 4r18Z, 0.8330, 1.90, 0.192, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2787, 4r18L, 0.8330, 1.90, 0.192, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2788, 4qv9Z, 0.8330, 1.90, 0.192, 222, 193, YCP BETA5-C63F MUTANT
2789, 4qv9L, 0.8330, 1.90, 0.197, 222, 193, YCP BETA5-C63F MUTANT
2790, 3wxr1, 0.8330, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2791, 5nif1, 0.8329, 2.06, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2792, 5fg7Z, 0.8329, 2.06, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2793, 5fg7L, 0.8329, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2794, 4y8mZ, 0.8329, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2795, 4y6vZ, 0.8329, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2796, 4y6vL, 0.8329, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2797, 4qv7Z, 0.8329, 1.90, 0.197, 222, 193, YCP BETA5-A50V MUTANT
2798, 4qv7L, 0.8329, 1.90, 0.197, 222, 193, YCP BETA5-A50V MUTANT
2799, 4q1sZ, 0.8329, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2800, 1rypM, 0.8329, 1.90, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2801, 5l67Z, 0.8328, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2802, 5l67L, 0.8328, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2803, 5czaZ, 0.8328, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2804, 5cz4Z, 0.8328, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2805, 5cz4L, 0.8328, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2806, 4y8mL, 0.8328, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2807, 5czaL, 0.8327, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2808, 4ya4Z, 0.8327, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2809, 4ya4L, 0.8327, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2810, 4y9yZ, 0.8327, 2.07, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2811, 4quyZ, 0.8327, 1.90, 0.197, 222, 193, YCP BETA5-A49S-MUTANT
2812, 4quyL, 0.8327, 1.90, 0.192, 222, 193, YCP BETA5-A49S-MUTANT
2813, 4quxZ, 0.8327, 1.90, 0.192, 222, 193, YCP BETA5-A49T-MUTANT
2814, 4quxL, 0.8327, 1.90, 0.197, 222, 193, YCP BETA5-A49T-MUTANT
2815, 3hf9E, 0.8327, 1.90, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2816, 1ryp1, 0.8327, 1.91, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2817, 5l5fZ, 0.8326, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2818, 5l5fL, 0.8326, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2819, 4zzgM, 0.8326, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2820, 4y9yL, 0.8326, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2821, 3wxrM, 0.8326, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2822, 1fntM, 0.8326, 1.90, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2823, 5l5zZ, 0.8325, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2824, 5l5zL, 0.8325, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2825, 5bxlZ, 0.8325, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2826, 5bxlL, 0.8325, 2.59, 0.229, 216, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2827, 4r00Z, 0.8325, 1.90, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2828, 4qv3Z, 0.8325, 1.91, 0.192, 222, 193, YCP BETA5-M45V MUTANT
2829, 4qv3L, 0.8325, 1.91, 0.192, 222, 193, YCP BETA5-M45V MUTANT
2830, 3hf9V, 0.8325, 1.90, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2831, 1fnta, 0.8325, 1.90, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2832, 5fgeZ, 0.8324, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2833, 5fgeL, 0.8324, 2.03, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2834, 5d0wZ, 0.8324, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2835, 5d0wL, 0.8324, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2836, 4r00L, 0.8324, 2.06, 0.191, 222, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2837, 4qv4Z, 0.8324, 2.06, 0.191, 222, 194, YCP BETA5-M45T MUTANT
2838, 4qv4L, 0.8324, 1.91, 0.197, 222, 193, YCP BETA5-M45T MUTANT
2839, 5l6aZ, 0.8323, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2840, 5l6aL, 0.8322, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2841, 5l68Z, 0.8322, 2.63, 0.233, 217, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2842, 5l68L, 0.8322, 2.03, 0.196, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2843, 5l5pZ, 0.8322, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2844, 5l5pL, 0.8322, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2845, 4rurZ, 0.8322, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2846, 4rurL, 0.8322, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2847, 4qzzZ, 0.8322, 1.91, 0.197, 222, 193, YCP IN COMPLEX WITH OMURALIDE
2848, 4qzzL, 0.8322, 1.91, 0.197, 222, 193, YCP IN COMPLEX WITH OMURALIDE
2849, 4qwuZ, 0.8322, 1.91, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2850, 4qvvL, 0.8322, 1.91, 0.192, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2851, 4qv8Z, 0.8322, 1.91, 0.192, 222, 193, YCP BETA5-C52F MUTANT
2852, 4qv5Z, 0.8322, 1.91, 0.192, 222, 193, YCP BETA5-M45I MUTANT
2853, 4qv5L, 0.8322, 1.91, 0.192, 222, 193, YCP BETA5-M45I MUTANT
2854, 4qv1Z, 0.8322, 1.91, 0.192, 222, 193, YCP BETA5-M45A MUTANT
2855, 4qv1L, 0.8322, 1.91, 0.192, 222, 193, YCP BETA5-M45A MUTANT
2856, 5nifM, 0.8321, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2857, 5l5dZ, 0.8321, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2858, 5l5dL, 0.8321, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2859, 4x6z1, 0.8321, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2860, 4qwuL, 0.8321, 1.91, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2861, 4qv8L, 0.8321, 2.07, 0.196, 222, 194, YCP BETA5-C52F MUTANT
2862, 5wviEA, 0.8320, 1.91, 0.197, 222, 193, 
2863, 5mp96, 0.8320, 1.91, 0.197, 222, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2864, 5l5uZ, 0.8320, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2865, 5l5uL, 0.8320, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2866, 4x6zM, 0.8320, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2867, 4qw0Z, 0.8320, 1.90, 0.197, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2868, 4qw0L, 0.8320, 1.91, 0.192, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2869, 4qvyZ, 0.8320, 1.91, 0.192, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2870, 4qvyL, 0.8320, 1.91, 0.197, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2871, 5l64Z, 0.8319, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2872, 5l64L, 0.8319, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2873, 5l5oZ, 0.8319, 1.94, 0.251, 205, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2874, 5l5oL, 0.8319, 2.04, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2875, 5l5jZ, 0.8319, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2876, 5l5jL, 0.8319, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2877, 5cz6Z, 0.8319, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2878, 5cz6L, 0.8319, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2879, 4lqiZ, 0.8319, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2880, 4lqiL, 0.8319, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2881, 5l5tZ, 0.8318, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2882, 5l5tL, 0.8318, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2883, 4qv0Z, 0.8318, 1.91, 0.192, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2884, 4qv0L, 0.8318, 1.91, 0.192, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2885, 4q1sL, 0.8317, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2886, 6gopZ, 0.8316, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2887, 6gopL, 0.8316, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2888, 3dy4Z, 0.8316, 1.91, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2889, 5wviQA, 0.8315, 1.91, 0.197, 222, 193, 
2890, 5l62Z, 0.8315, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2891, 5l62L, 0.8315, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2892, 5fghZ, 0.8315, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2893, 5fghL, 0.8315, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2894, 4qvwL, 0.8315, 1.91, 0.197, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2895, 3dy4L, 0.8315, 1.91, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2896, 5l69Z, 0.8314, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2897, 5l63Z, 0.8314, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2898, 5l63L, 0.8314, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2899, 5l61Z, 0.8314, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2900, 5l61L, 0.8314, 1.93, 0.256, 205, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2901, 5l60Z, 0.8314, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2902, 5l60L, 0.8314, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2903, 5fhsZ, 0.8314, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2904, 5d0xZ, 0.8314, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2905, 5d0xL, 0.8314, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2906, 4qvwZ, 0.8314, 1.92, 0.197, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2907, 4qvvZ, 0.8314, 1.92, 0.192, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2908, 3un8Z, 0.8314, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2909, 3hyeL, 0.8314, 1.92, 0.192, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2910, 3gpwZ, 0.8314, 1.92, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2911, 3gpwL, 0.8314, 1.92, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2912, 3gptL, 0.8314, 1.92, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2913, 5l69L, 0.8313, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2914, 5l5xZ, 0.8313, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2915, 5l5iZ, 0.8313, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2916, 5l5iL, 0.8313, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2917, 5fhsL, 0.8313, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2918, 4qvlZ, 0.8313, 1.92, 0.197, 222, 193, YCP IN COMPLEX WITH BORTEZOMIB
2919, 4qvlL, 0.8313, 2.08, 0.196, 222, 194, YCP IN COMPLEX WITH BORTEZOMIB
2920, 3hyeZ, 0.8313, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2921, 3gptZ, 0.8313, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2922, 6epc5, 0.8312, 1.92, 0.197, 222, 193, GROUND STATE 26S PROTEASOME (GS2)
2923, 5l5xL, 0.8312, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2924, 5l5vZ, 0.8312, 1.92, 0.192, 222, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2925, 5l5vL, 0.8312, 1.92, 0.192, 222, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2926, 3e47Z, 0.8312, 1.92, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2927, 3e47L, 0.8312, 1.92, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2928, 2gplZ, 0.8312, 1.91, 0.197, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2929, 2gplL, 0.8312, 1.92, 0.197, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2930, 3tddZ, 0.8311, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2931, 3tddL, 0.8311, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2932, 1g0uZ, 0.8311, 1.92, 0.197, 222, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2933, 5mp9m, 0.8310, 2.05, 0.081, 201, 198, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2934, 4eu21, 0.8310, 1.92, 0.192, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2935, 5lttZ, 0.8309, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2936, 5lttL, 0.8309, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2937, 4qw3Z, 0.8309, 1.93, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2938, 4qw3L, 0.8309, 1.93, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2939, 3h6iJ, 0.8308, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2940, 5t0iO, 0.8307, 1.93, 0.197, 222, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2941, 5lf6I, 0.8307, 1.93, 0.197, 222, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2942, 5l5yZ, 0.8307, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2943, 5l5yL, 0.8307, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2944, 5l5sZ, 0.8307, 2.05, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2945, 5l5sL, 0.8307, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2946, 5bxnZ, 0.8307, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2947, 4qvmZ, 0.8307, 1.92, 0.197, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2948, 4qvmL, 0.8307, 1.93, 0.197, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2949, 4eu2M, 0.8307, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2950, 5d0tZ, 0.8306, 2.54, 0.230, 215, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2951, 5d0tL, 0.8306, 1.79, 0.250, 220, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2952, 5bxnL, 0.8306, 2.07, 0.206, 204, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2953, 5t0gT, 0.8305, 1.92, 0.192, 222, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2954, 5lf6W, 0.8305, 1.92, 0.192, 222, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2955, 5fggZ, 0.8305, 1.93, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2956, 5fggL, 0.8305, 1.93, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2957, 4qwrZ, 0.8305, 1.92, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2958, 4qw1Z, 0.8305, 1.93, 0.197, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2959, 4qw1L, 0.8305, 1.93, 0.197, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2960, 4qluL, 0.8305, 1.92, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2961, 3oevZ, 0.8305, 1.93, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2962, 2fakL, 0.8305, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2963, 1g0uL, 0.8305, 1.93, 0.197, 222, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2964, 4qwrL, 0.8304, 2.16, 0.231, 215, 199, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2965, 4qv6Z, 0.8304, 2.07, 0.206, 204, 194, YCP BETA5-A49V MUTANT
2966, 4qv6L, 0.8304, 1.92, 0.197, 222, 193, YCP BETA5-A49V MUTANT
2967, 4qluZ, 0.8304, 1.92, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2968, 3h6iE, 0.8304, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2969, 3dy3Z, 0.8304, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2970, 3dy3L, 0.8304, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2971, 2fakZ, 0.8304, 2.08, 0.196, 222, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2972, 5t0iT, 0.8303, 2.09, 0.196, 222, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2973, 5l5qZ, 0.8303, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2974, 5l5qL, 0.8303, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2975, 5cz9Z, 0.8303, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2976, 4y8sZ, 0.8303, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2977, 4y8sL, 0.8303, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2978, 4y8kZ, 0.8303, 2.08, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2979, 4r02L, 0.8303, 2.54, 0.230, 215, 200, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2980, 3h6fJ, 0.8303, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2981, 1z7qX, 0.8303, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2982, 5l5hZ, 0.8302, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2983, 5l5hL, 0.8302, 2.30, 0.230, 215, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2984, 5cz9L, 0.8302, 1.93, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2985, 4y8kL, 0.8302, 1.93, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2986, 4r02Z, 0.8302, 1.92, 0.197, 222, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2987, 1z7qJ, 0.8302, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2988, 5dkiZ, 0.8301, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2989, 5dkiL, 0.8301, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2990, 4qwjZ, 0.8301, 1.92, 0.197, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2991, 4qwjL, 0.8301, 2.56, 0.230, 215, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2992, 3un8L, 0.8301, 1.99, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2993, 3h6iT, 0.8301, 1.93, 0.192, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2994, 3h6fE, 0.8301, 1.93, 0.192, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2995, 5l64W, 0.8300, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2996, 5l64I, 0.8300, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2997, 4y7xZ, 0.8300, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2998, 4y7xL, 0.8300, 1.99, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2999, 4qvqZ, 0.8300, 1.93, 0.197, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3000, 4qvqL, 0.8300, 1.93, 0.197, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3001, 4qvpZ, 0.8300, 2.09, 0.196, 222, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3002, 4qvpL, 0.8300, 2.08, 0.196, 222, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3003, 4jt0Z, 0.8300, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3004, 4jt0L, 0.8300, 2.55, 0.225, 215, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3005, 3h6iL, 0.8300, 2.55, 0.230, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3006, 5ln37, 0.8299, 1.99, 0.192, 204, 193, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3007, 5dkjZ, 0.8299, 1.99, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3008, 5dkjL, 0.8299, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3009, 5cghZ, 0.8299, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3010, 5cghL, 0.8299, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3011, 3h6fT, 0.8299, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3012, 3h6fL, 0.8299, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3013, 4qzwZ, 0.8298, 1.93, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3014, 4qzwL, 0.8298, 1.94, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3015, 3oevL, 0.8298, 1.94, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3016, 5l63W, 0.8297, 2.55, 0.225, 215, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3017, 5l63I, 0.8297, 2.44, 0.219, 218, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3018, 4qvnZ, 0.8297, 1.93, 0.197, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3019, 4qvnL, 0.8297, 1.93, 0.197, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3020, 4qlvL, 0.8297, 1.92, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3021, 4qlsZ, 0.8297, 1.93, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3022, 4qlsL, 0.8297, 2.55, 0.225, 215, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3023, 3sdkZ, 0.8297, 2.55, 0.225, 215, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3024, 3mg0Z, 0.8297, 1.93, 0.197, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3025, 3h6iP, 0.8297, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3026, 3h6iG, 0.8297, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3027, 3h6fG, 0.8297, 1.99, 0.192, 204, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3028, 2zcyZ, 0.8297, 1.99, 0.192, 204, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3029, 5l61W, 0.8296, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3030, 5l61I, 0.8296, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3031, 5l5vW, 0.8296, 1.93, 0.197, 222, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3032, 5l5vI, 0.8296, 1.93, 0.197, 222, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3033, 5fmgV, 0.8296, 1.93, 0.197, 222, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3034, 5fmgH, 0.8296, 2.09, 0.196, 222, 194, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3035, 5cz5Z, 0.8296, 2.10, 0.196, 222, 194, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3036, 5cz5L, 0.8296, 2.55, 0.225, 215, 200, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3037, 4qlvZ, 0.8296, 2.56, 0.225, 215, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3038, 3nzjZ, 0.8296, 2.57, 0.230, 215, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3039, 3h6iX, 0.8296, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3040, 2zcyL, 0.8296, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3041, 5l62W, 0.8295, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3042, 5l62I, 0.8295, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3043, 5d0vZ, 0.8295, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3044, 5d0vL, 0.8295, 1.56, 0.202, 191, 188, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3045, 5d0sZ, 0.8295, 1.56, 0.202, 191, 188, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3046, 3nzjL, 0.8295, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3047, 3mg7Z, 0.8295, 1.93, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3048, 5m2bW, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3049, 5m2bI, 0.8294, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3050, 5l67W, 0.8294, 2.56, 0.230, 215, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3051, 5l67I, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3052, 5l5yW, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3053, 5l5yI, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3054, 5jhsZ, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3055, 5jhsL, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3056, 5fgiZ, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3057, 5fgiL, 0.8294, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3058, 5d0zZ, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3059, 5d0zL, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3060, 5d0sL, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3061, 5cz8Z, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3062, 3shjZ, 0.8294, 2.00, 0.192, 204, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3063, 3shjL, 0.8294, 2.00, 0.192, 204, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3064, 5lf3W, 0.8293, 2.00, 0.192, 204, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3065, 5leyW, 0.8293, 1.93, 0.197, 222, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3066, 5l5wW, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3067, 5l5wI, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3068, 5l5qI, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3069, 5cz8L, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3070, 5cggZ, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3071, 5cggL, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3072, 4ya2Z, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3073, 4qwsZ, 0.8293, 1.95, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3074, 4qwsL, 0.8293, 1.95, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3075, 3mg4Z, 0.8293, 2.08, 0.206, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3076, 5lf7W, 0.8292, 2.07, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3077, 5l5oW, 0.8292, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3078, 4ya2L, 0.8292, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3079, 4y8qZ, 0.8292, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3080, 4y8qL, 0.8292, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3081, 4qw5Z, 0.8292, 1.93, 0.197, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3082, 3oeuZ, 0.8292, 1.93, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3083, 5leyI, 0.8291, 1.93, 0.197, 222, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3084, 5le5I, 0.8291, 1.93, 0.197, 222, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3085, 5l6cW, 0.8291, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3086, 5l6cI, 0.8291, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3087, 5l6aW, 0.8291, 2.08, 0.206, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3088, 5l6aI, 0.8291, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3089, 5l60W, 0.8291, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3090, 5l60I, 0.8291, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3091, 5l5tW, 0.8291, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3092, 5l5tI, 0.8291, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3093, 4qz6Z, 0.8291, 1.93, 0.197, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3094, 4qz6L, 0.8291, 2.08, 0.206, 204, 194, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3095, 4qwiZ, 0.8291, 2.08, 0.206, 204, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3096, 4qwiL, 0.8291, 2.00, 0.192, 204, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3097, 4qw7Z, 0.8291, 2.00, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3098, 4qw6Z, 0.8291, 2.00, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3099, 4qw6L, 0.8291, 2.00, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3100, 4qw5L, 0.8291, 2.00, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3101, 5lf3I, 0.8290, 2.00, 0.192, 204, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3102, 5lezI, 0.8290, 2.00, 0.192, 204, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3103, 5l5rW, 0.8290, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3104, 5l5qW, 0.8290, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3105, 5l54Z, 0.8290, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3106, 5l54L, 0.8290, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3107, 5fmgW, 0.8290, 1.93, 0.197, 222, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3108, 5fmgI, 0.8290, 1.93, 0.197, 222, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3109, 4qwkZ, 0.8290, 1.93, 0.197, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3110, 4qwkL, 0.8290, 1.93, 0.197, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3111, 4qw7L, 0.8290, 1.93, 0.197, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3112, 4qltZ, 0.8290, 2.08, 0.206, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3113, 4qltL, 0.8290, 2.08, 0.206, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3114, 4no1Z, 0.8290, 2.00, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3115, 4no1L, 0.8290, 2.00, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3116, 4inrZ, 0.8290, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3117, 4inrL, 0.8290, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3118, 3sdkL, 0.8290, 1.35, 0.249, 186, 185, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3119, 3oeuL, 0.8290, 1.35, 0.249, 186, 185, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3120, 3h6fX, 0.8290, 1.94, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3121, 5lf1W, 0.8289, 1.94, 0.197, 222, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3122, 5l5pW, 0.8289, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3123, 5lf1I, 0.8288, 2.09, 0.196, 222, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3124, 5lexI, 0.8288, 2.09, 0.196, 222, 194, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3125, 5l5sW, 0.8288, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3126, 5l5sI, 0.8288, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3127, 5l5rI, 0.8288, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3128, 5l5pI, 0.8288, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3129, 5l5oI, 0.8288, 2.09, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3130, 5l5hW, 0.8288, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3131, 5l5hI, 0.8288, 2.58, 0.230, 215, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3132, 5l5bW, 0.8288, 2.08, 0.206, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3133, 5l5bI, 0.8288, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3134, 5jhrZ, 0.8288, 2.08, 0.206, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3135, 5jhrL, 0.8288, 2.08, 0.206, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3136, 4y78Z, 0.8288, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3137, 4y78L, 0.8288, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3138, 4qwgZ, 0.8288, 2.01, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3139, 4qwgL, 0.8288, 2.00, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3140, 4qwfZ, 0.8288, 2.00, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3141, 4qwfL, 0.8288, 2.00, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3142, 3gpjZ, 0.8288, 2.00, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3143, 3gpjL, 0.8288, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3144, 5lttW, 0.8287, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3145, 5lttI, 0.8287, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3146, 5lexW, 0.8287, 1.94, 0.197, 222, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3147, 5le5W, 0.8287, 1.94, 0.197, 222, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3148, 5l5zW, 0.8287, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3149, 5l5xW, 0.8287, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3150, 5l5xI, 0.8287, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3151, 5l5uW, 0.8287, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3152, 5l5uI, 0.8287, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3153, 5l5jI, 0.8287, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3154, 4no8W, 0.8287, 1.94, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3155, 4no8I, 0.8287, 2.00, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3156, 4fzcZ, 0.8287, 2.00, 0.192, 204, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3157, 3mg0L, 0.8287, 2.08, 0.206, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3158, 5vfsM, 0.8286, 2.08, 0.206, 204, 194, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3159, 5l69W, 0.8286, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3160, 5l69I, 0.8286, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3161, 5l66W, 0.8286, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3162, 5l66I, 0.8286, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3163, 5l5zI, 0.8286, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3164, 5l5jW, 0.8286, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3165, 4y82Z, 0.8286, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3166, 4y82L, 0.8286, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3167, 4fzcL, 0.8286, 1.95, 0.197, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3168, 3h6fP, 0.8286, 1.95, 0.197, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3169, 5l65W, 0.8285, 2.05, 0.231, 215, 199, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3170, 5l65I, 0.8285, 2.06, 0.201, 213, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3171, 5cgiZ, 0.8285, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3172, 4r02I, 0.8285, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3173, 4qwlZ, 0.8285, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3174, 4qwlL, 0.8285, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3175, 4g4sM, 0.8285, 2.01, 0.192, 204, 193, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3176, 4fzgZ, 0.8285, 2.01, 0.192, 204, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3177, 3okjL, 0.8285, 1.94, 0.197, 222, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3178, 6avoX, 0.8284, 1.94, 0.197, 222, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3179, 6avoS, 0.8284, 1.95, 0.197, 222, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3180, 5lf7I, 0.8284, 2.57, 0.225, 215, 200, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3181, 5lf4W, 0.8284, 2.01, 0.192, 204, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3182, 5lezW, 0.8284, 2.01, 0.192, 204, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3183, 5cgiL, 0.8284, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3184, 4y8pZ, 0.8284, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3185, 4r18W, 0.8284, 1.94, 0.197, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3186, 4r18I, 0.8284, 1.94, 0.197, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3187, 4r02W, 0.8284, 1.93, 0.197, 222, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3188, 4qz7Z, 0.8284, 1.95, 0.197, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3189, 4qw4Z, 0.8284, 1.95, 0.197, 222, 193, YCP IN COMPLEX WITH CARFILZOMIB
3190, 4qw4L, 0.8284, 1.94, 0.207, 213, 193, YCP IN COMPLEX WITH CARFILZOMIB
3191, 4fzgL, 0.8284, 1.94, 0.207, 213, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3192, 5l6bW, 0.8283, 2.09, 0.206, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3193, 5l6bI, 0.8283, 2.08, 0.206, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3194, 5l68W, 0.8283, 2.09, 0.206, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3195, 5l68I, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3196, 5l5fW, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3197, 5l5fI, 0.8283, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3198, 5l54W, 0.8283, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3199, 4y8pL, 0.8283, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3200, 4y8lZ, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3201, 4y8lL, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3202, 4y81Z, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3203, 4y81L, 0.8283, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3204, 4y7yL, 0.8283, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3205, 4qz7L, 0.8283, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3206, 4q1sW, 0.8283, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3207, 3nzwL, 0.8283, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3208, 3bdmZ, 0.8283, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3209, 5vfuDA, 0.8282, 2.01, 0.192, 204, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3210, 5vftS, 0.8282, 2.00, 0.192, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3211, 5lf4I, 0.8282, 1.94, 0.197, 222, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3212, 5l55W, 0.8282, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3213, 5l55I, 0.8282, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3214, 5fggW, 0.8282, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3215, 5fggI, 0.8282, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3216, 4y7yZ, 0.8282, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3217, 4qlsW, 0.8282, 1.94, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3218, 4qlsI, 0.8282, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3219, 3nzwZ, 0.8282, 1.95, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3220, 3mg7L, 0.8282, 1.95, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3221, 3bdmL, 0.8282, 2.10, 0.206, 213, 194, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3222, 5lf0W, 0.8281, 2.10, 0.206, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3223, 5lajW, 0.8281, 2.09, 0.206, 204, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3224, 5lajI, 0.8281, 2.00, 0.192, 204, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3225, 5l5iW, 0.8281, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3226, 5l5eW, 0.8281, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3227, 5l5eI, 0.8281, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3228, 5l5dW, 0.8281, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3229, 5l5dI, 0.8281, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3230, 5l52Z, 0.8281, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3231, 5l52L, 0.8281, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3232, 4ya9Z, 0.8281, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3233, 4ya9L, 0.8281, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3234, 4y80Z, 0.8281, 2.09, 0.206, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3235, 4y80L, 0.8281, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3236, 4qv7W, 0.8281, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT
3237, 4qv7I, 0.8281, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT
3238, 4qv3W, 0.8281, 2.01, 0.192, 204, 193, YCP BETA5-M45V MUTANT
3239, 4qv3I, 0.8281, 2.01, 0.192, 204, 193, YCP BETA5-M45V MUTANT
3240, 4nnwW, 0.8281, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3241, 4nnwI, 0.8281, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3242, 4jsuZ, 0.8281, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3243, 4jsuL, 0.8281, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3244, 3unbI, 0.8281, 1.94, 0.197, 222, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3245, 6avoU, 0.8280, 1.94, 0.197, 222, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3246, 5l5iI, 0.8280, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3247, 5l54I, 0.8280, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3248, 5jhrW, 0.8280, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3249, 5jhrI, 0.8280, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3250, 4y9zZ, 0.8280, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3251, 4y9zL, 0.8280, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3252, 4y77Z, 0.8280, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3253, 4y77L, 0.8280, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3254, 4x6zX, 0.8280, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3255, 4qzxZ, 0.8280, 1.96, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3256, 4qzxL, 0.8280, 2.09, 0.211, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3257, 4qz0Z, 0.8280, 2.09, 0.206, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3258, 4qz0L, 0.8280, 2.01, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3259, 4qv4W, 0.8280, 2.01, 0.192, 204, 193, YCP BETA5-M45T MUTANT
3260, 4qv4I, 0.8280, 2.01, 0.192, 204, 193, YCP BETA5-M45T MUTANT
3261, 4qv1W, 0.8280, 2.01, 0.192, 204, 193, YCP BETA5-M45A MUTANT
3262, 4qv1I, 0.8280, 1.95, 0.197, 222, 193, YCP BETA5-M45A MUTANT
3263, 4intL, 0.8280, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3264, 5lf0I, 0.8279, 1.95, 0.197, 222, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3265, 5l52I, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3266, 5fgeI, 0.8279, 1.99, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3267, 5fgdW, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3268, 5fgdI, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3269, 5fg7I, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3270, 5ahjZ, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3271, 5ahjL, 0.8279, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3272, 4ya7Z, 0.8279, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3273, 4ya7L, 0.8279, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3274, 4y8jZ, 0.8279, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3275, 4y8jL, 0.8279, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3276, 4y8iZ, 0.8279, 2.09, 0.206, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3277, 4y8iL, 0.8279, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3278, 4qz7W, 0.8279, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3279, 4qz7I, 0.8279, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3280, 4qz5Z, 0.8279, 2.01, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3281, 4qv5W, 0.8279, 2.02, 0.192, 204, 193, YCP BETA5-M45I MUTANT
3282, 4qv5I, 0.8279, 1.95, 0.197, 222, 193, YCP BETA5-M45I MUTANT
3283, 4jsqZ, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3284, 4jsqL, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3285, 4intZ, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3286, 3nzjW, 0.8279, 1.95, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3287, 3nzjI, 0.8279, 1.95, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3288, 5l52W, 0.8278, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3289, 5gjqr, 0.8278, 1.95, 0.197, 222, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3290, 5fgiW, 0.8278, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3291, 5fgiI, 0.8278, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3292, 5fg7W, 0.8278, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3293, 5d0tW, 0.8278, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3294, 5d0tI, 0.8278, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3295, 4y7wZ, 0.8278, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3296, 4y7wL, 0.8278, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3297, 4qzzW, 0.8278, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH OMURALIDE
3298, 4qzzI, 0.8278, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH OMURALIDE
3299, 4qz5L, 0.8278, 2.01, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3300, 4qz3Z, 0.8278, 2.00, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3301, 4qz3L, 0.8278, 2.05, 0.179, 199, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3302, 4hnpZ, 0.8278, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3303, 3unek, 0.8278, 2.01, 0.192, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3304, 1iruJ, 0.8278, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3305, 5fgfW, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3306, 5fgfI, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3307, 5cghI, 0.8277, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3308, 5bxnW, 0.8277, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3309, 5bxnI, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3310, 5bxlW, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3311, 5bouW, 0.8277, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3312, 5bouI, 0.8277, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3313, 4y8oL, 0.8277, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3314, 4y8mW, 0.8277, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3315, 4y75W, 0.8277, 1.95, 0.212, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3316, 4y75I, 0.8277, 2.11, 0.206, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3317, 4y6zZ, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3318, 4y6zL, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3319, 4qz2Z, 0.8277, 2.01, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3320, 4qz2L, 0.8277, 2.01, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3321, 4qxjZ, 0.8277, 2.01, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3322, 4qvnW, 0.8277, 2.02, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3323, 4qvnI, 0.8277, 2.02, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3324, 4qv9W, 0.8277, 2.02, 0.192, 204, 193, YCP BETA5-C63F MUTANT
3325, 4qv9I, 0.8277, 1.95, 0.197, 222, 193, YCP BETA5-C63F MUTANT
3326, 4qv8W, 0.8277, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT
3327, 4qv8I, 0.8277, 2.01, 0.192, 204, 193, YCP BETA5-C52F MUTANT
3328, 4qv6W, 0.8277, 2.01, 0.192, 204, 193, YCP BETA5-A49V MUTANT
3329, 4qv6I, 0.8277, 1.95, 0.197, 222, 193, YCP BETA5-A49V MUTANT
3330, 4quyW, 0.8277, 1.95, 0.197, 222, 193, YCP BETA5-A49S-MUTANT
3331, 4quyI, 0.8277, 1.95, 0.197, 222, 193, YCP BETA5-A49S-MUTANT
3332, 4q1sI, 0.8277, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3333, 4no8Z, 0.8277, 1.95, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3334, 4no8L, 0.8277, 2.00, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3335, 3mg4L, 0.8277, 2.00, 0.192, 204, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3336, 3dy4W, 0.8277, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3337, 3dy4I, 0.8277, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3338, 1iruX, 0.8277, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3339, 6avoY, 0.8276, 2.02, 0.192, 204, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3340, 5l55Z, 0.8276, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3341, 5l55L, 0.8276, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3342, 5fhsW, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3343, 5fhsI, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3344, 5fgaI, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3345, 5czaW, 0.8276, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3346, 5czaI, 0.8276, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3347, 5cggW, 0.8276, 1.97, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3348, 5cggI, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3349, 5cgfW, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3350, 5cgfI, 0.8276, 2.11, 0.206, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3351, 5bxlI, 0.8276, 2.09, 0.206, 204, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3352, 4ya1I, 0.8276, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3353, 4y8tW, 0.8276, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3354, 4y8tI, 0.8276, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3355, 4y8oZ, 0.8276, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3356, 4y8mI, 0.8276, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3357, 4y8hZ, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3358, 4y8hL, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3359, 4qxjL, 0.8276, 2.00, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3360, 4qv0W, 0.8276, 2.00, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3361, 4qv0I, 0.8276, 2.02, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3362, 4qlvW, 0.8276, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3363, 4cr26, 0.8276, 2.02, 0.192, 204, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3364, 3mg7I, 0.8276, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3365, 5mpam, 0.8275, 2.02, 0.192, 204, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3366, 5l5aW, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3367, 5l5aI, 0.8275, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3368, 5jhsI, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3369, 5gjqd, 0.8275, 1.95, 0.197, 222, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3370, 5fgaW, 0.8275, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3371, 5d0sW, 0.8275, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3372, 5d0sI, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3373, 4ya4W, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3374, 4ya1W, 0.8275, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3375, 4y8hI, 0.8275, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3376, 4y75Z, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3377, 4y75L, 0.8275, 2.06, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3378, 4y70Z, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3379, 4y70L, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3380, 4qluI, 0.8275, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3381, 4nnnW, 0.8275, 2.04, 0.179, 199, 195, YCP IN COMPLEX WITH MG132
3382, 4inrI, 0.8275, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3383, 3uneW, 0.8275, 2.01, 0.192, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3384, 3un4Z, 0.8275, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3385, 3e47I, 0.8275, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3386, 2fakW, 0.8275, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3387, 5mpa6, 0.8274, 2.01, 0.192, 204, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3388, 5laiW, 0.8274, 1.95, 0.197, 222, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3389, 5laiI, 0.8274, 1.95, 0.197, 222, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3390, 5jhsW, 0.8274, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3391, 5fgeW, 0.8274, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3392, 5cghW, 0.8274, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3393, 5ahjW, 0.8274, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3394, 5ahjI, 0.8274, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3395, 4ya4I, 0.8274, 2.11, 0.211, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3396, 4y8kI, 0.8274, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3397, 4y8hW, 0.8274, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3398, 4qlvI, 0.8274, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3399, 4qluW, 0.8274, 2.07, 0.196, 222, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3400, 4qlqW, 0.8274, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3401, 4no1W, 0.8274, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3402, 4no1I, 0.8274, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3403, 4nnnI, 0.8274, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH MG132
3404, 3un4L, 0.8274, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3405, 3oevI, 0.8274, 2.00, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3406, 3e47W, 0.8274, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3407, 2fakI, 0.8274, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3408, 1g65Z, 0.8274, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3409, 1g65L, 0.8274, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3410, 5vfqM, 0.8273, 2.01, 0.192, 204, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3411, 5fg9W, 0.8273, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3412, 5fg9I, 0.8273, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3413, 5cz9W, 0.8273, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3414, 5cgiI, 0.8273, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3415, 4y8uI, 0.8273, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3416, 4y6aW, 0.8273, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3417, 4y6aI, 0.8273, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3418, 4quxW, 0.8273, 2.02, 0.192, 204, 193, YCP BETA5-A49T-MUTANT
3419, 4quxI, 0.8273, 2.02, 0.192, 204, 193, YCP BETA5-A49T-MUTANT
3420, 4qlqI, 0.8273, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3421, 4qbyZ, 0.8273, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3422, 4qbyL, 0.8273, 2.06, 0.231, 215, 199, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3423, 4ltcZ, 0.8273, 2.10, 0.206, 213, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3424, 4ltcL, 0.8273, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3425, 4inrW, 0.8273, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3426, 4g4sJ, 0.8273, 2.01, 0.192, 204, 193, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3427, 3tddW, 0.8273, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3428, 3tddI, 0.8273, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3429, 3hf9c, 0.8273, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
3430, 3dy3I, 0.8273, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3431, 5cgiW, 0.8272, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3432, 4y8uW, 0.8272, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3433, 4y8gZ, 0.8272, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3434, 4y8gW, 0.8272, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3435, 4y8gL, 0.8272, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3436, 4y8gI, 0.8272, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3437, 4r00W, 0.8272, 1.96, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3438, 4r00I, 0.8272, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3439, 4qz1Z, 0.8272, 2.02, 0.192, 203, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3440, 4qz1L, 0.8272, 2.02, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3441, 4qz0W, 0.8272, 2.02, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3442, 4qz0I, 0.8272, 2.55, 0.226, 214, 199, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3443, 4qvpW, 0.8272, 2.03, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3444, 4qvpI, 0.8272, 2.01, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3445, 4qltW, 0.8272, 2.03, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3446, 4qltI, 0.8272, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3447, 4qlqZ, 0.8272, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3448, 4qlqL, 0.8272, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3449, 4no6W, 0.8272, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3450, 4no6I, 0.8272, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3451, 4inuZ, 0.8272, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3452, 3un8I, 0.8272, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3453, 3mg6Z, 0.8272, 1.96, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3454, 6gopI, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3455, 5vfsLA, 0.8271, 2.01, 0.192, 204, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3456, 5d0zW, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3457, 5d0zI, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3458, 5d0wW, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3459, 5d0wI, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3460, 4z1lW, 0.8271, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3461, 4z1lI, 0.8271, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3462, 4ya2W, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3463, 4ya2I, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3464, 4y8qW, 0.8271, 1.97, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3465, 4y8nI, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3466, 4y84Z, 0.8271, 2.12, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3467, 4y84L, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3468, 4y7xW, 0.8271, 2.08, 0.201, 213, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3469, 4y7xI, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3470, 4y77I, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3471, 4y74L, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3472, 4y6zW, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3473, 4rurI, 0.8271, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3474, 4qz5W, 0.8271, 2.03, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3475, 4qz5I, 0.8271, 2.02, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3476, 4qz4Z, 0.8271, 2.02, 0.192, 204, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3477, 4qz4L, 0.8271, 2.02, 0.192, 204, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3478, 4qwxZ, 0.8271, 2.03, 0.192, 204, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3479, 4qwxW, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3480, 4qwxL, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3481, 4qwxI, 0.8271, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3482, 4qwlW, 0.8271, 2.02, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3483, 4qw7I, 0.8271, 2.01, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3484, 4no9Z, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3485, 4no9L, 0.8271, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3486, 4nnwZ, 0.8271, 2.03, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3487, 4nnwL, 0.8271, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3488, 4nnnZ, 0.8271, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH MG132
3489, 4nnnL, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH MG132
3490, 4hrcZ, 0.8271, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3491, 3sdkI, 0.8271, 1.96, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3492, 3oeuI, 0.8271, 2.01, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3493, 1fntX, 0.8271, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3494, 1fntJ, 0.8271, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3495, 5vfpM, 0.8270, 2.01, 0.192, 204, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3496, 5gjrQA, 0.8270, 2.01, 0.192, 204, 193, 
3497, 5fghW, 0.8270, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3498, 5dkjW, 0.8270, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3499, 5dkjI, 0.8270, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3500, 5cz9I, 0.8270, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3501, 5cz7W, 0.8270, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3502, 5cz7I, 0.8270, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3503, 4ya7W, 0.8270, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3504, 4ya7I, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3505, 4y8rW, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3506, 4y8pW, 0.8270, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3507, 4y8pI, 0.8270, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3508, 4y8kW, 0.8270, 2.11, 0.206, 213, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3509, 4y77W, 0.8270, 1.91, 0.180, 199, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3510, 4y74Z, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3511, 4y6zI, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3512, 4rurW, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3513, 4qz6W, 0.8270, 2.01, 0.192, 204, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3514, 4qz6I, 0.8270, 2.02, 0.192, 204, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3515, 4qwlI, 0.8270, 2.02, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3516, 4qw7W, 0.8270, 2.02, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3517, 4inuL, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3518, 4hnpL, 0.8270, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3519, 3uneI, 0.8270, 2.01, 0.192, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3520, 3sdiL, 0.8270, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3521, 3nzxZ, 0.8270, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3522, 3nzxL, 0.8270, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3523, 3nzwW, 0.8270, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3524, 3nzwI, 0.8270, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3525, 2f16I, 0.8270, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3526, 5vfrs, 0.8269, 2.02, 0.192, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3527, 5vfoS, 0.8269, 2.02, 0.192, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3528, 5vfoP, 0.8269, 2.01, 0.192, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3529, 5gjrCA, 0.8269, 2.01, 0.192, 204, 193, 
3530, 5fmgY, 0.8269, 1.97, 0.197, 222, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3531, 5fmgK, 0.8269, 1.96, 0.197, 222, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3532, 5fghI, 0.8269, 1.95, 0.212, 204, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3533, 5cz6W, 0.8269, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3534, 4y9yW, 0.8269, 1.97, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3535, 4y8rI, 0.8269, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3536, 4y8qI, 0.8269, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3537, 4y8nW, 0.8269, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3538, 4y82I, 0.8269, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3539, 4y74I, 0.8269, 1.94, 0.207, 213, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3540, 4r17W, 0.8269, 2.11, 0.206, 213, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3541, 4r17I, 0.8269, 2.09, 0.206, 204, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3542, 4qz3W, 0.8269, 1.91, 0.180, 199, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3543, 4qz3I, 0.8269, 1.75, 0.157, 194, 191, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3544, 4qw6W, 0.8269, 1.75, 0.157, 194, 191, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3545, 4qw6I, 0.8269, 2.02, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3546, 4qvqW, 0.8269, 2.02, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3547, 4qvlW, 0.8269, 2.03, 0.192, 204, 193, YCP IN COMPLEX WITH BORTEZOMIB
3548, 4qvlI, 0.8269, 2.03, 0.192, 204, 193, YCP IN COMPLEX WITH BORTEZOMIB
3549, 4jt0W, 0.8269, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3550, 4jt0I, 0.8269, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3551, 3un8W, 0.8269, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3552, 3oevW, 0.8269, 2.02, 0.197, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3553, 3mg8Z, 0.8269, 2.03, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3554, 3mg8I, 0.8269, 2.03, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3555, 3mg6I, 0.8269, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3556, 2f16Z, 0.8269, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3557, 2f16W, 0.8269, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3558, 2f16L, 0.8269, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3559, 6gopW, 0.8268, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3560, 5vfsIA, 0.8268, 2.02, 0.192, 204, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3561, 5d0vW, 0.8268, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3562, 5d0vI, 0.8268, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3563, 4y9yI, 0.8268, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3564, 4y8sW, 0.8268, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3565, 4y82W, 0.8268, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3566, 4y74W, 0.8268, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3567, 4qz4W, 0.8268, 2.02, 0.192, 204, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3568, 4qz4I, 0.8268, 2.02, 0.192, 204, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3569, 4qw5W, 0.8268, 1.97, 0.197, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3570, 4qw5I, 0.8268, 2.03, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3571, 4qvqI, 0.8268, 1.97, 0.197, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3572, 4no6Z, 0.8268, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3573, 4no6L, 0.8268, 2.11, 0.206, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3574, 4gk7Z, 0.8268, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3575, 4gk7L, 0.8268, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3576, 3unbk, 0.8268, 2.03, 0.192, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3577, 3oeuW, 0.8268, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3578, 3mg6L, 0.8268, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3579, 3d29Z, 0.8268, 2.02, 0.197, 204, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3580, 3d29W, 0.8268, 2.02, 0.192, 204, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3581, 3d29L, 0.8268, 2.02, 0.192, 204, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3582, 3d29I, 0.8268, 2.02, 0.192, 204, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3583, 5t0gP, 0.8267, 2.02, 0.192, 204, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3584, 5l4gW, 0.8267, 2.02, 0.192, 204, 193, 
3585, 5cz5I, 0.8267, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3586, 4ya9I, 0.8267, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3587, 4y8lW, 0.8267, 1.97, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3588, 4no9I, 0.8267, 1.97, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3589, 4hrdZ, 0.8267, 1.96, 0.212, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3590, 3unbW, 0.8267, 2.02, 0.192, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3591, 3okjW, 0.8267, 1.96, 0.197, 222, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3592, 3okjI, 0.8267, 1.97, 0.197, 222, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3593, 3nzxW, 0.8267, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3594, 3nzxI, 0.8267, 1.97, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3595, 3gptW, 0.8267, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3596, 5nifJ, 0.8266, 2.14, 0.206, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3597, 5cz5W, 0.8266, 2.06, 0.179, 199, 195, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3598, 4y8lI, 0.8266, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3599, 4y84W, 0.8266, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3600, 4y70W, 0.8266, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3601, 4y6vI, 0.8266, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3602, 4y69W, 0.8266, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3603, 4y69I, 0.8266, 2.12, 0.211, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3604, 4qzxW, 0.8266, 2.02, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3605, 4qzxI, 0.8266, 2.02, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3606, 4qwfW, 0.8266, 2.03, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3607, 4qwfI, 0.8266, 2.03, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3608, 4qvmW, 0.8266, 2.03, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3609, 4qvmI, 0.8266, 2.03, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3610, 4no9W, 0.8266, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3611, 3hyeW, 0.8266, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3612, 3hyeI, 0.8266, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3613, 3gpwW, 0.8266, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3614, 3gptI, 0.8266, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3615, 3gpjW, 0.8266, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3616, 5vfrp, 0.8265, 2.03, 0.192, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3617, 5vfqIA, 0.8265, 2.02, 0.192, 204, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3618, 4ya9W, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3619, 4y8sI, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3620, 4y84I, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3621, 4y7wI, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3622, 4y70I, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3623, 4y6vW, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3624, 4x6zJ, 0.8265, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3625, 4r67z, 0.8265, 2.03, 0.192, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3626, 4qz1W, 0.8265, 2.03, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3627, 4qz1I, 0.8265, 2.03, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3628, 4qwrW, 0.8265, 2.03, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3629, 4qbyW, 0.8265, 2.10, 0.206, 204, 194, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3630, 4qbyI, 0.8265, 2.10, 0.206, 204, 194, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3631, 4ltcW, 0.8265, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3632, 4lqiW, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3633, 4lqiI, 0.8265, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3634, 4inuW, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3635, 3sdkW, 0.8265, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3636, 3sdiZ, 0.8265, 2.03, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3637, 3sdiI, 0.8265, 1.87, 0.193, 204, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3638, 3gpwI, 0.8265, 1.96, 0.207, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3639, 3gpjI, 0.8265, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3640, 2zcyW, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3641, 2zcyI, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3642, 5cz6I, 0.8264, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3643, 4y9zI, 0.8264, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3644, 4y7wW, 0.8264, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3645, 4r67X, 0.8264, 2.03, 0.192, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3646, 4r67l, 0.8264, 2.03, 0.192, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3647, 4r67J, 0.8264, 2.03, 0.192, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3648, 4qwrI, 0.8264, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3649, 4qw3W, 0.8264, 1.97, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3650, 4qw1W, 0.8264, 2.02, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3651, 4qw1I, 0.8264, 2.03, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3652, 4qw0W, 0.8264, 2.03, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3653, 4qw0I, 0.8264, 2.03, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3654, 4qvyW, 0.8264, 2.03, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3655, 4qvyI, 0.8264, 2.02, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3656, 4ltcI, 0.8264, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3657, 4j70I, 0.8264, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3658, 3mg8L, 0.8264, 1.96, 0.207, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3659, 3mg4W, 0.8264, 1.96, 0.207, 204, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3660, 3mg0W, 0.8264, 1.96, 0.207, 204, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3661, 3h6i2, 0.8264, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3662, 3dy3W, 0.8264, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3663, 5vfsJ, 0.8263, 2.02, 0.192, 204, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3664, 5vfrP, 0.8263, 2.02, 0.192, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3665, 5vfqJ, 0.8263, 2.03, 0.192, 204, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3666, 4ya5I, 0.8263, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3667, 4y9zW, 0.8263, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3668, 4y80W, 0.8263, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3669, 4y80I, 0.8263, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3670, 4r3oY, 0.8263, 1.87, 0.193, 204, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
3671, 4r3oK, 0.8263, 1.97, 0.197, 222, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
3672, 4qz2W, 0.8263, 2.02, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3673, 4qz2I, 0.8263, 2.03, 0.197, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3674, 4j70W, 0.8263, 2.54, 0.226, 214, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3675, 4eu2J, 0.8263, 1.87, 0.193, 204, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3676, 3unhW, 0.8263, 2.11, 0.206, 204, 194, MOUSE 20S IMMUNOPROTEASOME
3677, 3unhI, 0.8263, 2.14, 0.179, 199, 195, MOUSE 20S IMMUNOPROTEASOME
3678, 3mg4I, 0.8263, 2.11, 0.206, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3679, 3h6f2, 0.8263, 2.11, 0.206, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3680, 4zzgJ, 0.8262, 2.03, 0.179, 199, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3681, 4ya5W, 0.8262, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3682, 4y8oW, 0.8262, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3683, 4y8oI, 0.8262, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3684, 4y8jW, 0.8262, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3685, 4y8jI, 0.8262, 1.92, 0.180, 199, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3686, 4y81W, 0.8262, 1.91, 0.180, 199, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3687, 4y81I, 0.8262, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3688, 4qzwW, 0.8262, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3689, 4qzwI, 0.8262, 1.87, 0.193, 204, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3690, 4qwuW, 0.8262, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3691, 4qwuI, 0.8262, 2.11, 0.211, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3692, 4qwkW, 0.8262, 2.11, 0.211, 204, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3693, 4qwiW, 0.8262, 2.03, 0.192, 204, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3694, 4jsqW, 0.8262, 2.55, 0.231, 214, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3695, 4jsqI, 0.8262, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3696, 4hnpW, 0.8262, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3697, 3unfW, 0.8262, 2.03, 0.192, 204, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3698, 3unfI, 0.8262, 2.03, 0.192, 204, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3699, 3uney, 0.8262, 2.02, 0.192, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3700, 3mg7W, 0.8262, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3701, 3bdmW, 0.8262, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3702, 5t0cHB, 0.8261, 2.03, 0.192, 204, 193, 
3703, 5t0cBA, 0.8261, 2.02, 0.192, 204, 193, 
3704, 5gjqc, 0.8261, 2.02, 0.192, 204, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3705, 5dkiW, 0.8261, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3706, 5dkiI, 0.8261, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3707, 4ya3I, 0.8261, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3708, 4qxjW, 0.8261, 2.03, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3709, 4qxjI, 0.8261, 2.03, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3710, 4qwkI, 0.8261, 2.03, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3711, 4qwiI, 0.8261, 2.03, 0.192, 204, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3712, 4qw4W, 0.8261, 2.10, 0.211, 204, 194, YCP IN COMPLEX WITH CARFILZOMIB
3713, 4qw4I, 0.8261, 2.10, 0.211, 204, 194, YCP IN COMPLEX WITH CARFILZOMIB
3714, 4qvwW, 0.8261, 1.96, 0.212, 204, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3715, 4qvwI, 0.8261, 2.02, 0.192, 204, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3716, 4inuI, 0.8261, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3717, 3shjW, 0.8261, 2.10, 0.206, 204, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3718, 3shjI, 0.8261, 2.10, 0.206, 204, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3719, 3mg8W, 0.8261, 1.96, 0.207, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3720, 3mg0I, 0.8261, 2.03, 0.192, 204, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3721, 3bdmI, 0.8261, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3722, 5vfop, 0.8260, 2.04, 0.192, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3723, 5d0xW, 0.8260, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3724, 5d0xI, 0.8260, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3725, 5cz4W, 0.8260, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3726, 5cz4I, 0.8260, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3727, 4ya3W, 0.8260, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3728, 4y78I, 0.8260, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3729, 4qwsW, 0.8260, 2.03, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3730, 4qwsI, 0.8260, 2.03, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3731, 4qwgW, 0.8260, 2.04, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3732, 5vfrS, 0.8259, 1.87, 0.193, 204, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3733, 5vfpHA, 0.8259, 1.87, 0.193, 204, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3734, 5vfos, 0.8259, 2.02, 0.192, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3735, 5cz8W, 0.8259, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3736, 5cz8I, 0.8259, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3737, 4y7yW, 0.8259, 2.10, 0.206, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3738, 4y78W, 0.8259, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3739, 4qwjW, 0.8259, 2.03, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3740, 4qwgI, 0.8259, 2.04, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3741, 4qw3I, 0.8259, 2.04, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3742, 4intW, 0.8259, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3743, 4intI, 0.8259, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3744, 4y8iW, 0.8258, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3745, 4y8iI, 0.8258, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3746, 4y7yI, 0.8258, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3747, 4qwjI, 0.8258, 2.11, 0.206, 213, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3748, 3un4W, 0.8258, 2.10, 0.206, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3749, 3un4I, 0.8258, 1.96, 0.207, 213, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3750, 3sdiW, 0.8258, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3751, 1g0uW, 0.8258, 2.02, 0.192, 204, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3752, 4jsuW, 0.8257, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3753, 4jsuI, 0.8257, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3754, 4hrdL, 0.8257, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3755, 3mg6W, 0.8257, 2.03, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3756, 3h6iC, 0.8257, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3757, 5ln31, 0.8256, 2.03, 0.192, 204, 193, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3758, 5gjrPA, 0.8256, 2.03, 0.192, 204, 193, 
3759, 5gjrBA, 0.8256, 2.03, 0.192, 204, 193, 
3760, 4r3oX, 0.8256, 2.03, 0.192, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
3761, 4r3oJ, 0.8256, 2.03, 0.192, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
3762, 1jd2I, 0.8256, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3763, 3okjZ, 0.8255, 2.04, 0.192, 204, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3764, 5t0gN, 0.8254, 2.04, 0.192, 204, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3765, 4hnpI, 0.8254, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3766, 4fzcI, 0.8254, 2.04, 0.192, 204, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3767, 3wxrX, 0.8254, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3768, 1g0uI, 0.8254, 2.04, 0.192, 204, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3769, 5vfuOA, 0.8253, 1.97, 0.197, 222, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3770, 5vftp, 0.8253, 2.03, 0.192, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3771, 5vfqLA, 0.8253, 2.56, 0.226, 214, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3772, 5vfpJ, 0.8253, 2.33, 0.268, 214, 198, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3773, 4ya0I, 0.8253, 1.98, 0.207, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3774, 4fzcW, 0.8253, 1.98, 0.207, 204, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3775, 4cr27, 0.8253, 1.98, 0.207, 204, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3776, 1jd2S, 0.8253, 1.98, 0.207, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3777, 1iruM, 0.8253, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3778, 1iru1, 0.8253, 2.01, 0.197, 221, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3779, 4ya0W, 0.8252, 1.73, 0.274, 191, 190, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3780, 4eu2X, 0.8252, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3781, 4hrcL, 0.8251, 1.88, 0.193, 204, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3782, 4fzgW, 0.8251, 1.88, 0.193, 204, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3783, 3h6iZ, 0.8251, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3784, 1rypX, 0.8251, 2.12, 0.206, 204, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3785, 5t0jT, 0.8250, 2.12, 0.206, 204, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3786, 5gjrSA, 0.8250, 1.97, 0.207, 213, 193, 
3787, 5gjrEA, 0.8250, 0.83, 0.665, 201, 200, 
3788, 4qvvW, 0.8250, 2.12, 0.206, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3789, 4qvvI, 0.8250, 2.05, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3790, 4gk7I, 0.8250, 1.88, 0.193, 204, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3791, 4fzgI, 0.8250, 2.42, 0.178, 233, 202, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3792, 5gjqn, 0.8249, 1.98, 0.197, 222, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3793, 4gk7W, 0.8249, 1.99, 0.207, 213, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3794, 1rypJ, 0.8249, 1.99, 0.207, 213, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3795, 1jd2L, 0.8249, 2.05, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3796, 4hrcI, 0.8248, 1.89, 0.193, 204, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3797, 3okj1, 0.8248, 1.98, 0.197, 222, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3798, 2gplW, 0.8248, 1.89, 0.193, 204, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3799, 2gplI, 0.8248, 2.56, 0.231, 214, 199, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3800, 1g65W, 0.8248, 2.05, 0.192, 204, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3801, 5l4gI, 0.8247, 2.33, 0.230, 215, 200, 
3802, 3wxrJ, 0.8247, 1.99, 0.207, 213, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3803, 3hf9h, 0.8247, 1.99, 0.207, 213, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
3804, 3h6fZ, 0.8247, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3805, 1jd2P, 0.8247, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3806, 5l4gV, 0.8246, 2.05, 0.192, 204, 193, 
3807, 3h6fC, 0.8246, 1.89, 0.193, 204, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3808, 5nifX, 0.8245, 2.58, 0.136, 243, 199, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3809, 5gjqX, 0.8245, 2.05, 0.192, 204, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3810, 4r3oM, 0.8244, 2.04, 0.192, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
3811, 4zzgX, 0.8243, 1.99, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3812, 4hrdI, 0.8243, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3813, 4r3o1, 0.8242, 2.41, 0.175, 228, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
3814, 5vfuRA, 0.8241, 1.89, 0.193, 204, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3815, 5vfuAA, 0.8241, 1.89, 0.193, 204, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3816, 5vfts, 0.8241, 2.03, 0.192, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3817, 5vftP, 0.8241, 2.06, 0.179, 199, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3818, 5gjrMA, 0.8241, 1.89, 0.193, 204, 192, 
3819, 1g65I, 0.8241, 2.53, 0.227, 213, 198, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3820, 4hrcW, 0.8240, 2.57, 0.231, 214, 199, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3821, 5vfpKA, 0.8239, 1.89, 0.193, 204, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3822, 4r3oU, 0.8239, 2.13, 0.206, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME
3823, 3unby, 0.8239, 2.58, 0.231, 214, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3824, 5l4gH, 0.8238, 1.89, 0.193, 204, 192, 
3825, 4r3oG, 0.8237, 2.63, 0.136, 243, 199, HUMAN CONSTITUTIVE 20S PROTEASOME
3826, 5gjrY, 0.8236, 2.01, 0.207, 213, 193, 
3827, 5gjqt, 0.8236, 1.89, 0.193, 204, 192, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3828, 5gjqf, 0.8235, 2.05, 0.192, 204, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3829, 3uneL, 0.8235, 2.01, 0.207, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3830, 6avoV, 0.8234, 2.10, 0.206, 213, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3831, 6avoT, 0.8234, 2.15, 0.206, 204, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3832, 5gjqq, 0.8233, 2.10, 0.206, 213, 194, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3833, 4hrdW, 0.8233, 2.15, 0.206, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3834, 3unen, 0.8233, 2.61, 0.131, 243, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
3835, 5a5bG, 0.8231, 2.04, 0.192, 204, 193, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3836, 4cr3G, 0.8231, 2.06, 0.192, 204, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3837, 5mp93, 0.8226, 1.98, 0.207, 213, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3838, 3une2, 0.8226, 2.64, 0.131, 245, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
3839, 4r67Y, 0.8225, 2.00, 0.212, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3840, 4r67m, 0.8225, 2.15, 0.206, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3841, 4r67K, 0.8225, 2.64, 0.131, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3842, 4r670, 0.8225, 2.62, 0.131, 243, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3843, 5t0hT, 0.8223, 2.00, 0.207, 213, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3844, 4r67i, 0.8223, 2.01, 0.207, 213, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3845, 5vfoQ, 0.8222, 2.01, 0.202, 213, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3846, 4r67w, 0.8220, 1.82, 0.182, 196, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3847, 4r67U, 0.8220, 1.82, 0.182, 196, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3848, 5vfoq, 0.8219, 2.00, 0.207, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3849, 5vfrQ, 0.8218, 2.06, 0.197, 204, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3850, 5mp9j, 0.8218, 2.03, 0.202, 213, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3851, 4r67G, 0.8218, 2.69, 0.146, 245, 198, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3852, 3uneZ, 0.8218, 2.69, 0.146, 245, 198, MOUSE CONSTITUTIVE 20S PROTEASOME
3853, 6epf1, 0.8217, 2.06, 0.192, 204, 193, GROUND STATE 26S PROTEASOME (GS1)
3854, 5l4gJ, 0.8216, 2.02, 0.202, 213, 193, 
3855, 1iruY, 0.8216, 1.96, 0.180, 199, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3856, 1iruK, 0.8216, 1.96, 0.180, 199, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3857, 5t0cKB, 0.8215, 1.96, 0.180, 199, 194, 
3858, 5t0cEA, 0.8215, 1.96, 0.180, 199, 194, 
3859, 4r67M, 0.8210, 2.38, 0.230, 215, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3860, 4r67a, 0.8210, 2.65, 0.136, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3861, 4r671, 0.8210, 2.00, 0.179, 199, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3862, 4r67o, 0.8209, 2.65, 0.136, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3863, 5vfuBA, 0.8208, 2.65, 0.136, 245, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3864, 5vftQ, 0.8208, 2.01, 0.179, 199, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3865, 5t0iN, 0.8208, 2.00, 0.179, 199, 195, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3866, 5l4gG, 0.8208, 2.04, 0.197, 204, 193, 
3867, 5le5Z, 0.8205, 2.65, 0.136, 245, 199, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3868, 5l4gX, 0.8205, 2.03, 0.202, 213, 193, 
3869, 5lf6Z, 0.8204, 2.35, 0.080, 202, 199, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3870, 5vfqJA, 0.8202, 2.14, 0.206, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3871, 5vfpIA, 0.8202, 1.97, 0.180, 199, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3872, 5lf6L, 0.8202, 1.97, 0.180, 199, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3873, 3unbZ, 0.8202, 2.03, 0.207, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3874, 5vfpK, 0.8201, 2.03, 0.207, 213, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3875, 5l4gU, 0.8201, 2.04, 0.207, 213, 193, 
3876, 5lexZ, 0.8200, 2.04, 0.207, 213, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3877, 5lexL, 0.8199, 2.04, 0.207, 213, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3878, 5le5L, 0.8199, 2.04, 0.207, 213, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3879, 3unb2, 0.8199, 2.08, 0.179, 199, 195, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3880, 3unhZ, 0.8197, 2.08, 0.179, 199, 195, MOUSE 20S IMMUNOPROTEASOME
3881, 3unhL, 0.8197, 1.77, 0.274, 191, 190, MOUSE 20S IMMUNOPROTEASOME
3882, 3unbL, 0.8196, 2.71, 0.131, 242, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3883, 5lf1Z, 0.8195, 2.05, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3884, 3unez, 0.8195, 2.18, 0.206, 204, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3885, 3h6iN, 0.8195, 2.04, 0.207, 213, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3886, 5vfuPA, 0.8194, 2.03, 0.179, 199, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3887, 5vftq, 0.8194, 2.03, 0.179, 199, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3888, 5lf3F, 0.8194, 2.04, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3889, 5lf1L, 0.8194, 2.05, 0.202, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3890, 3h6fN, 0.8194, 1.98, 0.207, 213, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3891, 5leyF, 0.8193, 2.03, 0.179, 199, 195, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3892, 3unbn, 0.8193, 2.67, 0.131, 241, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3893, 5lf7F, 0.8192, 2.05, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3894, 5lf6F, 0.8192, 2.05, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3895, 5le5F, 0.8191, 2.05, 0.207, 213, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3896, 5vfuLA, 0.8190, 2.06, 0.202, 213, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3897, 5vftm, 0.8190, 2.06, 0.202, 213, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3898, 5vfqK, 0.8190, 2.06, 0.202, 213, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3899, 5t0gS, 0.8190, 2.06, 0.202, 213, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3900, 5lf1F, 0.8190, 2.05, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3901, 5lf0F, 0.8190, 1.88, 0.187, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3902, 5lexT, 0.8190, 2.54, 0.228, 212, 197, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3903, 5m32Z, 0.8189, 2.10, 0.179, 199, 195, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3904, 5m32L, 0.8189, 2.10, 0.179, 199, 195, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3905, 5lf7Z, 0.8189, 2.62, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3906, 5lf4F, 0.8189, 2.05, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3907, 5leyZ, 0.8188, 2.55, 0.228, 212, 197, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3908, 5lexF, 0.8188, 2.62, 0.131, 239, 198, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3909, 5lf4Z, 0.8187, 2.06, 0.202, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3910, 4cr2G, 0.8186, 2.63, 0.131, 239, 198, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3911, 3unhT, 0.8186, 2.63, 0.131, 239, 198, MOUSE 20S IMMUNOPROTEASOME
3912, 3unhF, 0.8186, 2.62, 0.131, 239, 198, MOUSE 20S IMMUNOPROTEASOME
3913, 5vfrq, 0.8185, 2.60, 0.141, 240, 198, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3914, 5leyL, 0.8185, 2.60, 0.141, 240, 198, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3915, 3unbh, 0.8185, 0.83, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3916, 5lf4L, 0.8184, 2.04, 0.179, 199, 195, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3917, 5lf3Z, 0.8184, 2.06, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3918, 5lf0Z, 0.8184, 2.62, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3919, 3unfZ, 0.8184, 2.63, 0.131, 239, 198, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3920, 3unfT, 0.8184, 2.62, 0.131, 240, 198, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3921, 3unfL, 0.8184, 2.02, 0.202, 213, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3922, 3unfF, 0.8184, 2.02, 0.202, 213, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3923, 1iruU, 0.8183, 2.06, 0.207, 213, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3924, 1iruG, 0.8183, 2.62, 0.131, 239, 198, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3925, 5lezL, 0.8182, 2.06, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3926, 5lf0L, 0.8181, 2.63, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3927, 5lezZ, 0.8181, 2.06, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3928, 3h6iH, 0.8181, 2.69, 0.146, 245, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3929, 5vfsK, 0.8180, 2.65, 0.136, 244, 198, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3930, 5lf7L, 0.8180, 2.65, 0.136, 244, 198, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3931, 5lf3L, 0.8180, 2.05, 0.179, 199, 195, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3932, 5lezF, 0.8180, 2.06, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3933, 3unhX, 0.8180, 2.65, 0.131, 244, 198, MOUSE 20S IMMUNOPROTEASOME
3934, 3unhJ, 0.8180, 2.07, 0.207, 213, 193, MOUSE 20S IMMUNOPROTEASOME
3935, 3h6fH, 0.8180, 2.07, 0.207, 213, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3936, 5lf6T, 0.8179, 2.06, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3937, 5lf3T, 0.8179, 2.07, 0.202, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3938, 5lf1T, 0.8179, 2.64, 0.136, 244, 198, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3939, 5lezT, 0.8179, 2.07, 0.202, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3940, 5m32T, 0.8178, 2.64, 0.136, 244, 198, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3941, 5lf7T, 0.8178, 2.67, 0.136, 245, 199, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3942, 5lf0T, 0.8178, 2.67, 0.136, 245, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3943, 5lf4T, 0.8177, 2.07, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3944, 5leyT, 0.8177, 2.07, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3945, 3uneX, 0.8177, 2.07, 0.207, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3946, 3uneT, 0.8177, 2.56, 0.228, 212, 197, MOUSE CONSTITUTIVE 20S PROTEASOME
3947, 3unbF, 0.8177, 0.85, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3948, 5vfsJA, 0.8176, 2.12, 0.179, 199, 195, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3949, 5mpa3, 0.8176, 2.07, 0.207, 213, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3950, 3uneJ, 0.8176, 2.07, 0.207, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3951, 3unfX, 0.8173, 2.63, 0.131, 239, 198, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3952, 3unfJ, 0.8173, 1.89, 0.187, 196, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3953, 5vfoM, 0.8172, 1.89, 0.187, 196, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3954, 5le5T, 0.8172, 2.56, 0.228, 212, 197, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3955, 5le5J, 0.8171, 2.64, 0.131, 240, 198, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3956, 4cr46, 0.8171, 2.65, 0.131, 240, 198, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3957, 5t0jN, 0.8169, 2.64, 0.131, 240, 198, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3958, 5vfpG, 0.8168, 2.64, 0.131, 240, 198, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3959, 5m32W, 0.8168, 2.76, 0.131, 240, 199, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3960, 5m32I, 0.8168, 2.65, 0.131, 240, 198, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3961, 3unel, 0.8168, 2.65, 0.131, 240, 198, MOUSE CONSTITUTIVE 20S PROTEASOME
3962, 3unbv, 0.8168, 2.64, 0.131, 240, 198, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3963, 5le5X, 0.8167, 2.64, 0.131, 240, 198, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3964, 5vfrM, 0.8166, 1.90, 0.187, 196, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3965, 4cr4E, 0.8166, 2.66, 0.131, 244, 198, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3966, 3uneh, 0.8166, 2.66, 0.131, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME
3967, 3unbl, 0.8165, 2.14, 0.179, 199, 195, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3968, 5lexJ, 0.8164, 2.11, 0.192, 204, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3969, 3uneF, 0.8164, 1.90, 0.187, 196, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
3970, 5lf7J, 0.8163, 1.90, 0.187, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3971, 5lf1J, 0.8163, 1.90, 0.187, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3972, 5lf0J, 0.8163, 2.65, 0.146, 240, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3973, 3unev, 0.8163, 2.64, 0.131, 240, 198, MOUSE CONSTITUTIVE 20S PROTEASOME
3974, 3unbT, 0.8163, 1.92, 0.182, 195, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3975, 3unbJ, 0.8163, 2.13, 0.196, 222, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3976, 5lf0X, 0.8162, 1.86, 0.274, 191, 190, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3977, 5lexX, 0.8162, 1.45, 0.255, 220, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3978, 6avoQ, 0.8161, 2.64, 0.146, 240, 199, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3979, 6avoJ, 0.8161, 2.20, 0.206, 204, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3980, 5leyX, 0.8161, 2.20, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3981, 3unbX, 0.8161, 1.91, 0.187, 196, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3982, 5lf7X, 0.8160, 2.67, 0.131, 244, 198, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3983, 5lf1X, 0.8160, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3984, 4cr4G, 0.8160, 2.63, 0.146, 240, 199, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3985, 5vfqG, 0.8159, 2.93, 0.208, 243, 202, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3986, 5t0hN, 0.8159, 2.67, 0.131, 244, 198, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3987, 5lf4J, 0.8159, 1.91, 0.187, 196, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3988, 5leyJ, 0.8159, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3989, 5vfqFA, 0.8158, 2.56, 0.137, 244, 197, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3990, 5lf4X, 0.8158, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3991, 5lf3X, 0.8158, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3992, 5lf3J, 0.8158, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3993, 3unbz, 0.8158, 2.67, 0.131, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3994, 5vfom, 0.8156, 2.66, 0.141, 244, 198, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3995, 5t0iP, 0.8156, 1.92, 0.187, 196, 192, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3996, 5lezJ, 0.8156, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3997, 5vfuX, 0.8155, 1.93, 0.182, 195, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3998, 5vftM, 0.8155, 2.65, 0.131, 239, 198, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3999, 5vfsG, 0.8155, 2.65, 0.131, 239, 198, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4000, 4cr47, 0.8155, 1.93, 0.182, 195, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4001, 5m32J, 0.8154, 1.92, 0.187, 196, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4002, 5lf6J, 0.8153, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4003, 5fmgM, 0.8153, 1.94, 0.182, 195, 192, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4004, 5fmga, 0.8153, 2.64, 0.152, 245, 197, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4005, 5m32X, 0.8152, 1.49, 0.274, 191, 190, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4006, 5lezX, 0.8152, 2.65, 0.146, 240, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4007, 5dsvF, 0.8152, 1.84, 0.274, 191, 190, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4008, 5dsvB, 0.8152, 1.93, 0.182, 195, 192, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4009, 5lf6X, 0.8150, 1.94, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4010, 5dsvL, 0.8150, 2.65, 0.146, 240, 199, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4011, 5vfsFA, 0.8147, 1.94, 0.182, 195, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4012, 5dsvA, 0.8144, 1.94, 0.182, 195, 192, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4013, 3oevR, 0.8144, 1.94, 0.182, 195, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4014, 5t0cIB, 0.8142, 1.93, 0.187, 196, 192, 
4015, 5t0cCA, 0.8142, 2.66, 0.146, 240, 199, 
4016, 5dsvN, 0.8142, 2.12, 0.207, 204, 193, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4017, 5vfpEA, 0.8141, 1.94, 0.182, 195, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4018, 5mpaj, 0.8141, 2.55, 0.142, 240, 197, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4019, 5dsvE, 0.8140, 2.55, 0.142, 240, 197, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4020, 5dsvD, 0.8140, 1.54, 0.274, 191, 190, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4021, 5nygB, 0.8139, 2.71, 0.141, 240, 199, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4022, 1g0uR, 0.8139, 2.48, 0.179, 233, 201, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4023, 5vfrm, 0.8138, 1.93, 0.187, 196, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4024, 5dsvG, 0.8137, 1.94, 0.182, 195, 192, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4025, 5nygA, 0.8136, 1.77, 0.191, 199, 188, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4026, 3mg8R, 0.8136, 1.77, 0.191, 199, 188, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4027, 3mg7R, 0.8135, 1.93, 0.187, 196, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4028, 3sdkX, 0.8134, 1.94, 0.182, 195, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4029, 3mg6R, 0.8134, 2.80, 0.136, 244, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4030, 5nygC, 0.8133, 2.57, 0.137, 245, 197, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4031, 5mp9G, 0.8133, 1.95, 0.182, 195, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4032, 3sdkJ, 0.8133, 2.80, 0.136, 245, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4033, 3mg8X, 0.8133, 2.71, 0.141, 240, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4034, 5t0hS, 0.8132, 2.81, 0.136, 244, 199, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4035, 5t0hP, 0.8131, 2.96, 0.204, 242, 201, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4036, 3mg7X, 0.8131, 2.15, 0.179, 199, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4037, 3mg7J, 0.8131, 2.15, 0.179, 199, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4038, 1g0uD, 0.8130, 2.80, 0.136, 244, 199, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4039, 5ln36, 0.8129, 2.66, 0.146, 240, 199, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4040, 3oevJ, 0.8129, 2.10, 0.197, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4041, 3mg6X, 0.8129, 2.81, 0.136, 245, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4042, 5t0cY, 0.8128, 2.81, 0.136, 244, 199, 
4043, 5t0cEB, 0.8128, 2.78, 0.172, 231, 203, 
4044, 6epd5, 0.8127, 2.96, 0.204, 230, 201, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4045, 5nywM, 0.8127, 2.67, 0.146, 240, 199, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4046, 3sdiR, 0.8127, 2.81, 0.136, 242, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4047, 5mpcU, 0.8126, 2.88, 0.167, 235, 204, 
4048, 4jsqX, 0.8126, 2.76, 0.206, 242, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4049, 4jsqJ, 0.8126, 2.76, 0.206, 242, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4050, 3sdkR, 0.8126, 2.01, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4051, 3oeuR, 0.8126, 2.76, 0.206, 242, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4052, 5mpaG, 0.8125, 2.79, 0.172, 231, 203, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4053, 4ltcJ, 0.8125, 2.67, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4054, 3oeuX, 0.8125, 2.04, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4055, 3mg8J, 0.8125, 2.01, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4056, 3mg7D, 0.8125, 2.12, 0.207, 213, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4057, 5nygH, 0.8124, 2.14, 0.207, 204, 193, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4058, 4intX, 0.8124, 2.02, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4059, 4intJ, 0.8124, 2.04, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4060, 5nygE, 0.8123, 2.97, 0.204, 230, 201, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4061, 3mg6J, 0.8123, 2.28, 0.206, 213, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4062, 3gpjX, 0.8123, 2.03, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4063, 4gk7X, 0.8122, 2.02, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4064, 4gk7J, 0.8122, 2.69, 0.141, 240, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4065, 3gpjJ, 0.8122, 2.69, 0.141, 240, 199, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4066, 5nywX, 0.8121, 2.22, 0.081, 201, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4067, 5nygD, 0.8121, 3.07, 0.180, 233, 206, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4068, 4fzgJ, 0.8121, 3.03, 0.203, 229, 202, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4069, 3okjJ, 0.8121, 2.71, 0.147, 243, 197, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4070, 5nyw1, 0.8120, 2.07, 0.228, 198, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4071, 4ltcX, 0.8120, 2.06, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4072, 4jsuX, 0.8120, 2.91, 0.205, 232, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4073, 4jsuJ, 0.8120, 2.90, 0.205, 236, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4074, 4fzgX, 0.8120, 2.68, 0.147, 243, 197, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4075, 3tddX, 0.8120, 2.06, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4076, 3tddJ, 0.8120, 2.02, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4077, 3okjX, 0.8120, 2.05, 0.228, 198, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4078, 5mpag, 0.8119, 3.03, 0.203, 242, 202, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4079, 4inuJ, 0.8119, 2.78, 0.172, 231, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4080, 4inrJ, 0.8119, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4081, 4eu2G, 0.8119, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4082, 4cr23, 0.8119, 2.93, 0.172, 227, 204, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4083, 3oevD, 0.8119, 2.06, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4084, 3bdmJ, 0.8119, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4085, 5fmgX, 0.8118, 2.07, 0.228, 198, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4086, 5fmgJ, 0.8118, 2.07, 0.228, 198, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4087, 3un4J, 0.8118, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4088, 3oevX, 0.8118, 3.05, 0.180, 236, 206, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4089, 3bdmX, 0.8118, 2.80, 0.172, 231, 203, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4090, 1rypY, 0.8118, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4091, 5t0jS, 0.8117, 2.07, 0.228, 198, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4092, 5mp9g, 0.8117, 3.06, 0.180, 234, 206, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4093, 4q1sX, 0.8117, 2.06, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4094, 4lqiX, 0.8117, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4095, 4lqiJ, 0.8117, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4096, 4jt0X, 0.8117, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4097, 4jt0J, 0.8117, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4098, 3un4X, 0.8117, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4099, 3oeuJ, 0.8117, 2.08, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4100, 3nzxJ, 0.8117, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4101, 2f16R, 0.8117, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4102, 3un8X, 0.8116, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4103, 3un8J, 0.8116, 2.69, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4104, 3nzxX, 0.8116, 2.06, 0.193, 204, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4105, 3nzwX, 0.8116, 3.04, 0.203, 242, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4106, 3nzwJ, 0.8116, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4107, 3mg0X, 0.8116, 1.79, 0.197, 191, 188, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4108, 2f16D, 0.8116, 1.79, 0.197, 191, 188, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4109, 1z7qE, 0.8116, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4110, 5nywB, 0.8115, 2.04, 0.228, 197, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4111, 5dsvK, 0.8115, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4112, 4r02F, 0.8115, 2.07, 0.228, 198, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4113, 4inrX, 0.8115, 2.13, 0.207, 213, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4114, 3wxrY, 0.8115, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4115, 3oeuD, 0.8115, 2.07, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4116, 3mg4J, 0.8115, 2.08, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4117, 5nywP, 0.8114, 2.08, 0.228, 198, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4118, 3mg4R, 0.8114, 2.08, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4119, 3gptX, 0.8114, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4120, 3gptJ, 0.8114, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4121, 1rypE, 0.8114, 2.05, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4122, 5dsvI, 0.8113, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4123, 4hrcX, 0.8113, 2.99, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4124, 3tddR, 0.8113, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4125, 3d29J, 0.8113, 2.08, 0.228, 198, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
4126, 2gplX, 0.8113, 2.07, 0.228, 198, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4127, 2gplR, 0.8113, 2.07, 0.228, 198, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4128, 2gplJ, 0.8113, 2.07, 0.228, 198, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4129, 2gplD, 0.8113, 2.07, 0.228, 198, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4130, 2fakX, 0.8113, 2.99, 0.204, 242, 201, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4131, 2fakJ, 0.8113, 2.98, 0.205, 245, 200, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4132, 1rypK, 0.8113, 3.08, 0.180, 233, 206, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4133, 4qwgT, 0.8112, 2.79, 0.136, 244, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4134, 4inuX, 0.8112, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4135, 4hrdX, 0.8112, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4136, 3tddD, 0.8112, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4137, 3nzjJ, 0.8112, 2.93, 0.205, 242, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4138, 3mg0J, 0.8112, 2.07, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4139, 3hyeX, 0.8112, 3.07, 0.180, 234, 206, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4140, 3hyeJ, 0.8112, 2.91, 0.205, 242, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4141, 3d29X, 0.8112, 2.08, 0.228, 198, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
4142, 2fakR, 0.8112, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4143, 1g0uT, 0.8112, 3.00, 0.204, 242, 201, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4144, 1g0uF, 0.8112, 2.80, 0.136, 244, 198, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4145, 5nywE, 0.8111, 2.06, 0.228, 198, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4146, 4v7oU, 0.8111, 2.99, 0.204, 242, 201, 
4147, 4v7oG, 0.8111, 2.08, 0.228, 198, 193, 
4148, 4qwgF, 0.8111, 2.09, 0.228, 198, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4149, 4hrdJ, 0.8111, 2.99, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4150, 4fzcJ, 0.8111, 2.09, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4151, 3nzjX, 0.8111, 2.99, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4152, 3mg8D, 0.8111, 2.08, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4153, 2fakD, 0.8111, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4154, 2f16X, 0.8111, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4155, 2f16J, 0.8111, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4156, 5a5b6, 0.8110, 2.08, 0.228, 198, 193, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4157, 4qz7T, 0.8110, 2.07, 0.228, 198, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4158, 4qz7F, 0.8110, 2.99, 0.204, 242, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4159, 4hnpJ, 0.8110, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4160, 4fzcX, 0.8110, 2.08, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4161, 4cr36, 0.8110, 2.08, 0.228, 198, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4162, 3sdiX, 0.8110, 2.08, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4163, 3gpwX, 0.8110, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4164, 5nywQ, 0.8109, 2.99, 0.204, 242, 201, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4165, 4v7oCB, 0.8109, 2.71, 0.147, 242, 197, 
4166, 4r18T, 0.8109, 2.71, 0.147, 242, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4167, 4r18F, 0.8109, 3.05, 0.180, 233, 206, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4168, 4q1sJ, 0.8109, 2.67, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4169, 4hrdF, 0.8109, 2.67, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4170, 3wxrK, 0.8109, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4171, 3gpwJ, 0.8109, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4172, 1jd2J, 0.8109, 2.09, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4173, 5l69T, 0.8108, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4174, 5l69F, 0.8108, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4175, 5a5b7, 0.8108, 3.00, 0.204, 242, 201, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4176, 4v7oOA, 0.8108, 2.08, 0.228, 198, 193, 
4177, 4qz1T, 0.8108, 2.08, 0.228, 198, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4178, 4qz1F, 0.8108, 2.11, 0.197, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4179, 4qlsR, 0.8108, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4180, 4no9T, 0.8108, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4181, 4no9F, 0.8108, 2.07, 0.228, 198, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4182, 4hnpF, 0.8108, 2.09, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4183, 4cr37, 0.8108, 2.11, 0.197, 222, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4184, 1z7qS, 0.8108, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4185, 1rypS, 0.8108, 2.09, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4186, 1jd2Q, 0.8108, 3.04, 0.180, 237, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4187, 5nywZ, 0.8107, 2.67, 0.147, 244, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4188, 4zzgU, 0.8107, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4189, 4qlvR, 0.8107, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4190, 4qlvD, 0.8107, 2.10, 0.228, 198, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4191, 4qlsD, 0.8107, 2.71, 0.147, 244, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4192, 4hnpX, 0.8107, 2.09, 0.228, 197, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4193, 4fzgF, 0.8107, 2.09, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4194, 3sdiT, 0.8107, 2.07, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4195, 5nifE, 0.8106, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4196, 5lajF, 0.8106, 2.70, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4197, 5l5tT, 0.8106, 2.53, 0.179, 233, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4198, 5l5tF, 0.8106, 2.67, 0.147, 244, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4199, 5l5jT, 0.8106, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4200, 5l5jF, 0.8106, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4201, 4y81T, 0.8106, 2.92, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4202, 4y81F, 0.8106, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4203, 4qw4T, 0.8106, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH CARFILZOMIB
4204, 4qw4F, 0.8106, 2.70, 0.147, 244, 197, YCP IN COMPLEX WITH CARFILZOMIB
4205, 4qlsF, 0.8106, 2.53, 0.179, 233, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4206, 4hrcJ, 0.8106, 2.90, 0.206, 245, 199, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4207, 4fzgT, 0.8106, 2.91, 0.205, 242, 200, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4208, 3shjX, 0.8106, 2.07, 0.228, 198, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4209, 3shjJ, 0.8106, 3.06, 0.180, 236, 206, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4210, 3okjD, 0.8106, 2.55, 0.148, 244, 196, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4211, 3hyeR, 0.8106, 2.92, 0.205, 235, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4212, 3hyeD, 0.8106, 2.92, 0.205, 235, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4213, 1g65J, 0.8106, 2.92, 0.205, 235, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4214, 5nywJ, 0.8105, 2.07, 0.228, 198, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4215, 5l5yT, 0.8105, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4216, 4ya9T, 0.8105, 2.70, 0.147, 242, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4217, 4ya9F, 0.8105, 2.94, 0.204, 236, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4218, 4qz4T, 0.8105, 2.70, 0.147, 243, 197, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4219, 4qz4F, 0.8105, 2.70, 0.147, 243, 197, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4220, 4qwkT, 0.8105, 2.70, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4221, 4qwkF, 0.8105, 2.70, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4222, 4qwfT, 0.8105, 2.70, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4223, 4qwfF, 0.8105, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4224, 4qlsT, 0.8105, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4225, 3sdiF, 0.8105, 2.71, 0.147, 243, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4226, 3mg4D, 0.8105, 2.71, 0.147, 243, 197, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4227, 5l68T, 0.8104, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4228, 5l68F, 0.8104, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4229, 5l63T, 0.8104, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4230, 5l63F, 0.8104, 2.09, 0.228, 198, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4231, 5l61T, 0.8104, 2.09, 0.228, 198, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4232, 5l61F, 0.8104, 3.00, 0.204, 242, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4233, 5l5yF, 0.8104, 3.00, 0.204, 242, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4234, 4y8iT, 0.8104, 3.00, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4235, 4y8iF, 0.8104, 2.10, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4236, 4qz7R, 0.8104, 3.06, 0.180, 235, 206, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4237, 4qz7D, 0.8104, 2.70, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4238, 4qwxF, 0.8104, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4239, 4qw6F, 0.8104, 2.70, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4240, 4nnwF, 0.8104, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4241, 4inuR, 0.8104, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4242, 3e47X, 0.8104, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4243, 3e47J, 0.8104, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4244, 1rypG, 0.8104, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4245, 5nifU, 0.8103, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4246, 5m2bT, 0.8103, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4247, 5m2bF, 0.8103, 2.60, 0.148, 242, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4248, 5l6cF, 0.8103, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4249, 5l64T, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4250, 5l64F, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4251, 5l62T, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4252, 5l62F, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4253, 5l60T, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4254, 5l60F, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4255, 5l5wT, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4256, 5l5wF, 0.8103, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4257, 5l5dT, 0.8103, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4258, 5l5dF, 0.8103, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4259, 5fgiT, 0.8103, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4260, 5fgiF, 0.8103, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4261, 5cghT, 0.8103, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4262, 5cghF, 0.8103, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4263, 4y8pT, 0.8103, 3.02, 0.204, 242, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4264, 4y8oT, 0.8103, 2.10, 0.228, 198, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4265, 4y8oF, 0.8103, 2.10, 0.228, 198, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4266, 4y7xT, 0.8103, 2.69, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4267, 4y7xF, 0.8103, 2.56, 0.148, 244, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4268, 4r02R, 0.8103, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4269, 4qwxT, 0.8103, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4270, 4qwrF, 0.8103, 2.70, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4271, 4qw6T, 0.8103, 2.70, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4272, 4no6F, 0.8103, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4273, 4nnwT, 0.8103, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4274, 3un4R, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4275, 3shjR, 0.8103, 2.71, 0.147, 243, 197, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4276, 3shjD, 0.8103, 2.71, 0.147, 243, 197, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4277, 3okjR, 0.8103, 2.70, 0.147, 243, 197, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4278, 3gpwR, 0.8103, 2.70, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4279, 3gpwD, 0.8103, 2.70, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4280, 3gptR, 0.8103, 2.70, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4281, 3e47R, 0.8103, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4282, 5nywU, 0.8102, 2.72, 0.147, 243, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4283, 5nywC, 0.8102, 2.70, 0.147, 243, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4284, 5l6cT, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4285, 5l66F, 0.8102, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4286, 5l65F, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4287, 5l5sT, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4288, 5l5sF, 0.8102, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4289, 5l5qT, 0.8102, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4290, 5l5qF, 0.8102, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4291, 5l5pT, 0.8102, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4292, 5l5pF, 0.8102, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4293, 5l5iT, 0.8102, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4294, 5l5iF, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4295, 5gjqm, 0.8102, 2.69, 0.147, 243, 197, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4296, 5fggT, 0.8102, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4297, 5fggF, 0.8102, 3.05, 0.203, 242, 202, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4298, 5fgdT, 0.8102, 3.05, 0.203, 242, 202, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4299, 5cz9T, 0.8102, 3.04, 0.203, 242, 202, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4300, 5cz9F, 0.8102, 3.04, 0.203, 242, 202, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4301, 5bouT, 0.8102, 3.05, 0.203, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4302, 5bouF, 0.8102, 2.95, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4303, 4ya2D, 0.8102, 3.00, 0.204, 242, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4304, 4y8pF, 0.8102, 3.07, 0.180, 235, 206, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4305, 4rurF, 0.8102, 3.07, 0.180, 236, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4306, 4qwrT, 0.8102, 2.70, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4307, 4qw5T, 0.8102, 2.70, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4308, 4qw5F, 0.8102, 2.70, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4309, 4qw3T, 0.8102, 2.70, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4310, 4qvmT, 0.8102, 2.70, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4311, 4qvmF, 0.8102, 2.70, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4312, 4qlvT, 0.8102, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4313, 4qlvF, 0.8102, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4314, 4no6T, 0.8102, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4315, 3un4D, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4316, 3mg7F, 0.8102, 2.70, 0.147, 243, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4317, 3mg6D, 0.8102, 2.84, 0.142, 238, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4318, 3e47D, 0.8102, 2.70, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4319, 1rypU, 0.8102, 2.70, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4320, 5nywH, 0.8101, 2.72, 0.147, 243, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4321, 5lajT, 0.8101, 2.71, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4322, 5laiT, 0.8101, 2.71, 0.147, 243, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4323, 5laiF, 0.8101, 2.71, 0.147, 243, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4324, 5l66T, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4325, 5l65T, 0.8101, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4326, 5jhsT, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4327, 5jhsF, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4328, 5fghT, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4329, 5fghF, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4330, 5fgeT, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4331, 5fgeF, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4332, 5fgdF, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4333, 4ya5T, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4334, 4ya5F, 0.8101, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4335, 4ya2R, 0.8101, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4336, 4y82F, 0.8101, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4337, 4y6vT, 0.8101, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4338, 4y6vF, 0.8101, 2.70, 0.147, 237, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4339, 4rurT, 0.8101, 2.98, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4340, 4qz6T, 0.8101, 3.00, 0.204, 242, 201, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4341, 4qz0T, 0.8101, 2.59, 0.148, 244, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4342, 4qz0F, 0.8101, 3.07, 0.180, 234, 206, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4343, 4qwsT, 0.8101, 2.69, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4344, 4qwsF, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4345, 4qwiT, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4346, 4qw7T, 0.8101, 2.70, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4347, 4qw7F, 0.8101, 2.70, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4348, 4qw3F, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4349, 4qvwT, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4350, 4quxF, 0.8101, 2.72, 0.147, 243, 197, YCP BETA5-A49T-MUTANT
4351, 4inuD, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4352, 3wxrS, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4353, 3sdiJ, 0.8101, 2.72, 0.147, 243, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4354, 3nzxD, 0.8101, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4355, 3bdmC, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4356, 2zcyX, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4357, 2zcyJ, 0.8101, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4358, 1g65X, 0.8101, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4359, 5nywL, 0.8100, 2.71, 0.147, 243, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4360, 5nywG, 0.8100, 2.71, 0.147, 243, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4361, 5nywD, 0.8100, 2.71, 0.147, 243, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4362, 5l6bT, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4363, 5l6bF, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4364, 5l6aT, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4365, 5l6aF, 0.8100, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4366, 5l5vT, 0.8100, 2.73, 0.147, 243, 197,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4367, 5l5vF, 0.8100, 2.72, 0.147, 243, 197,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4368, 5l5hT, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4369, 5l5hF, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4370, 5cz6F, 0.8100, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4371, 4ya7T, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4372, 4y8nT, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4373, 4y8nF, 0.8100, 3.02, 0.204, 242, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4374, 4y82T, 0.8100, 2.93, 0.205, 238, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4375, 4y80T, 0.8100, 2.09, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4376, 4y80F, 0.8100, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4377, 4x6zU, 0.8100, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4378, 4qxjT, 0.8100, 2.09, 0.228, 198, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4379, 4qxjF, 0.8100, 2.09, 0.228, 198, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4380, 4qwjF, 0.8100, 2.10, 0.228, 198, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4381, 4qwiF, 0.8100, 3.06, 0.180, 237, 206, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4382, 4qw0T, 0.8100, 3.08, 0.180, 234, 206, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4383, 4qw0F, 0.8100, 3.07, 0.180, 234, 206, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4384, 4qvyT, 0.8100, 2.70, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4385, 4qvyF, 0.8100, 2.70, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4386, 4qvwF, 0.8100, 2.69, 0.147, 243, 197, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4387, 4quxT, 0.8100, 2.69, 0.147, 243, 197, YCP BETA5-A49T-MUTANT
4388, 4qltR, 0.8100, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4389, 4qltD, 0.8100, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4390, 4qlqF, 0.8100, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4391, 4j70J, 0.8100, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4392, 3gptD, 0.8100, 2.70, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4393, 3bdmQ, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4394, 1g65R, 0.8100, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4395, 5l67T, 0.8099, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4396, 5l67F, 0.8099, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4397, 5l5xT, 0.8099, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4398, 5d0vT, 0.8099, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4399, 5d0vF, 0.8099, 2.61, 0.148, 244, 196, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4400, 5cz6T, 0.8099, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4401, 4y6zT, 0.8099, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4402, 4y6zF, 0.8099, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4403, 4y69T, 0.8099, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4404, 4y69F, 0.8099, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4405, 4r17R, 0.8099, 2.72, 0.147, 243, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4406, 4r17D, 0.8099, 2.71, 0.147, 243, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4407, 4qzwF, 0.8099, 2.71, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4408, 4qz5T, 0.8099, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4409, 4qz5F, 0.8099, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4410, 4qz2T, 0.8099, 2.93, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4411, 4qz2F, 0.8099, 2.93, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4412, 4qwjT, 0.8099, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4413, 4qvnF, 0.8099, 2.09, 0.228, 198, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4414, 4qlqT, 0.8099, 3.05, 0.203, 242, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4415, 4qbyR, 0.8099, 2.95, 0.180, 241, 200, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4416, 4qbyD, 0.8099, 3.01, 0.204, 242, 201, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4417, 4inrR, 0.8099, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4418, 3nzxR, 0.8099, 2.70, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4419, 3dy3X, 0.8099, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4420, 5nywY, 0.8098, 2.71, 0.147, 243, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4421, 5nywW, 0.8098, 2.71, 0.147, 243, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4422, 5l5xF, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4423, 5l5uT, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4424, 5l5uF, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4425, 5l5fT, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4426, 5l5fF, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4427, 5l5eT, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4428, 5l5eF, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4429, 5l55R, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4430, 5l54R, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4431, 5l54D, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4432, 5l52R, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4433, 5l52D, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4434, 5jhrT, 0.8098, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4435, 5jhrF, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4436, 5dkiT, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4437, 5dkiF, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4438, 5d0zT, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4439, 5d0zF, 0.8098, 3.02, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4440, 5cz5T, 0.8098, 3.05, 0.203, 242, 202, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4441, 5cz5F, 0.8098, 2.10, 0.228, 198, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4442, 5cgiT, 0.8098, 3.08, 0.180, 233, 206, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4443, 5cgiR, 0.8098, 3.07, 0.180, 233, 206, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4444, 5cgiF, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4445, 5cgiD, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4446, 5cggT, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4447, 5cggF, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4448, 4y8tT, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4449, 4y8tF, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4450, 4y8sF, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4451, 4y8qT, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4452, 4y8qF, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4453, 4y8kF, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4454, 4y8jT, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4455, 4y8jF, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4456, 4y74T, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4457, 4y74F, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4458, 4y6aT, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4459, 4y6aF, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4460, 4qzwT, 0.8098, 2.71, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4461, 4qz4R, 0.8098, 2.71, 0.147, 243, 197, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4462, 4qz4D, 0.8098, 2.73, 0.147, 243, 197, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4463, 4qz0R, 0.8098, 2.73, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4464, 4qz0D, 0.8098, 2.72, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4465, 4qw1T, 0.8098, 2.93, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4466, 4qw1F, 0.8098, 2.72, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4467, 4qvnT, 0.8098, 2.93, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4468, 4qvlT, 0.8098, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH BORTEZOMIB
4469, 4qvlF, 0.8098, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH BORTEZOMIB
4470, 4qluF, 0.8098, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4471, 4j70X, 0.8098, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4472, 4fzgR, 0.8098, 2.71, 0.147, 243, 197, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4473, 3nzwR, 0.8098, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4474, 3mg8T, 0.8098, 2.72, 0.147, 243, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4475, 3mg0R, 0.8098, 2.70, 0.147, 243, 197, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4476, 3dy4J, 0.8098, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4477, 3dy3J, 0.8098, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4478, 2zcyQ, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4479, 2zcyC, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4480, 5l5aT, 0.8097, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4481, 5l5aF, 0.8097, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4482, 5l55D, 0.8097, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4483, 5fggR, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4484, 5fggD, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4485, 5dkjT, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4486, 5dkjF, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4487, 5d0xT, 0.8097, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4488, 5d0xF, 0.8097, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4489, 5d0sT, 0.8097, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4490, 5d0sF, 0.8097, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4491, 5cz8R, 0.8097, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4492, 5cz8D, 0.8097, 2.68, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4493, 5bxnT, 0.8097, 2.09, 0.228, 198, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4494, 4ya2T, 0.8097, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4495, 4ya2F, 0.8097, 2.97, 0.204, 242, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4496, 4ya0F, 0.8097, 2.72, 0.147, 237, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4497, 4y9yT, 0.8097, 2.98, 0.204, 242, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4498, 4y8sT, 0.8097, 2.10, 0.228, 198, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4499, 4y8kT, 0.8097, 2.10, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4500, 4y78T, 0.8097, 3.00, 0.179, 241, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4501, 4y78F, 0.8097, 3.00, 0.179, 241, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4502, 4y77T, 0.8097, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4503, 4y77F, 0.8097, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4504, 4y75T, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4505, 4y75F, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4506, 4r02T, 0.8097, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4507, 4qz2R, 0.8097, 2.72, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4508, 4qw1R, 0.8097, 2.72, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4509, 4qvqT, 0.8097, 2.72, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4510, 4qvqF, 0.8097, 2.72, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4511, 4qv0T, 0.8097, 2.71, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4512, 4qv0F, 0.8097, 2.71, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4513, 4qluT, 0.8097, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4514, 4no1F, 0.8097, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4515, 4gk7R, 0.8097, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4516, 4gk7D, 0.8097, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4517, 4fzgD, 0.8097, 2.69, 0.147, 243, 197, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4518, 3nzwD, 0.8097, 2.73, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4519, 3dy4X, 0.8097, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4520, 5nywF, 0.8096, 2.71, 0.147, 243, 197, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4521, 5lttT, 0.8096, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4522, 5lttF, 0.8096, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4523, 5ln3G, 0.8096, 2.73, 0.147, 243, 197, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4524, 5lajR, 0.8096, 2.70, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4525, 5lajD, 0.8096, 2.70, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4526, 5l6bR, 0.8096, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4527, 5l6bD, 0.8096, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4528, 5l5zT, 0.8096, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4529, 5l5zF, 0.8096, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4530, 5l55F, 0.8096, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4531, 5fhsT, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4532, 5bxlF, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4533, 4ya3T, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4534, 4ya3F, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4535, 4ya0T, 0.8096, 2.68, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4536, 4y9zT, 0.8096, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4537, 4y9zF, 0.8096, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4538, 4y9yF, 0.8096, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4539, 4y8uT, 0.8096, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4540, 4y8uF, 0.8096, 2.98, 0.204, 242, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4541, 4y8sR, 0.8096, 2.10, 0.228, 198, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4542, 4y8sD, 0.8096, 3.09, 0.180, 234, 206, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4543, 4y8rR, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4544, 4y8gT, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4545, 4y8gF, 0.8096, 3.02, 0.134, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4546, 4y84T, 0.8096, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4547, 4y84F, 0.8096, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4548, 4r18R, 0.8096, 2.95, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4549, 4r18D, 0.8096, 2.95, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4550, 4qz2D, 0.8096, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4551, 4qwxR, 0.8096, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4552, 4qwxD, 0.8096, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4553, 4qwlT, 0.8096, 2.72, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4554, 4qwlR, 0.8096, 2.70, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4555, 4qwlF, 0.8096, 2.73, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4556, 4qwlD, 0.8096, 2.73, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4557, 4qw1D, 0.8096, 2.73, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4558, 4qvvT, 0.8096, 2.70, 0.147, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4559, 4qvvF, 0.8096, 2.70, 0.147, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4560, 4no8R, 0.8096, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4561, 4no8D, 0.8096, 2.72, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4562, 4no1T, 0.8096, 2.72, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4563, 4j70R, 0.8096, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4564, 4hrdR, 0.8096, 2.93, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4565, 4hnpT, 0.8096, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4566, 4eu2U, 0.8096, 2.60, 0.148, 243, 196, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4567, 3sdkT, 0.8096, 2.60, 0.148, 243, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4568, 3oeuT, 0.8096, 2.60, 0.148, 243, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4569, 1g65F, 0.8096, 2.60, 0.148, 243, 196, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4570, 1g65D, 0.8096, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4571, 1g0uJ, 0.8096, 2.94, 0.205, 235, 200, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4572, 5nywS, 0.8095, 2.94, 0.205, 235, 200, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4573, 5l65R, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4574, 5l65D, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4575, 5l5oT, 0.8095, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4576, 5l5oF, 0.8095, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4577, 5l55T, 0.8095, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4578, 5l54T, 0.8095, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4579, 5l54F, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4580, 5l52T, 0.8095, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4581, 5l52F, 0.8095, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4582, 5fhsF, 0.8095, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4583, 5fgfT, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4584, 5fgfF, 0.8095, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4585, 5cz4T, 0.8095, 2.93, 0.205, 242, 200, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4586, 5cz4F, 0.8095, 2.91, 0.205, 242, 200, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4587, 5cggR, 0.8095, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4588, 5cggD, 0.8095, 2.70, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4589, 5cgfR, 0.8095, 2.70, 0.147, 236, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4590, 5cgfD, 0.8095, 2.71, 0.147, 237, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4591, 5bxlT, 0.8095, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4592, 4zzgD, 0.8095, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4593, 4ya1R, 0.8095, 2.12, 0.228, 198, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4594, 4ya1D, 0.8095, 3.08, 0.180, 235, 206, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4595, 4y9zR, 0.8095, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4596, 4y9zD, 0.8095, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4597, 4y8rD, 0.8095, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4598, 4y7yF, 0.8095, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4599, 4qz6R, 0.8095, 2.71, 0.147, 243, 197, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4600, 4qz6F, 0.8095, 2.70, 0.147, 243, 197, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4601, 4qz6D, 0.8095, 2.70, 0.147, 243, 197, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4602, 4qz5R, 0.8095, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4603, 4qz5D, 0.8095, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4604, 4qz3T, 0.8095, 2.72, 0.147, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4605, 4qz3F, 0.8095, 2.72, 0.147, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4606, 4qw5R, 0.8095, 2.72, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4607, 4qv5T, 0.8095, 2.72, 0.147, 243, 197, YCP BETA5-M45I MUTANT
4608, 4qv5F, 0.8095, 2.72, 0.147, 243, 197, YCP BETA5-M45I MUTANT
4609, 4qv4T, 0.8095, 2.93, 0.205, 235, 200, YCP BETA5-M45T MUTANT
4610, 4qv4F, 0.8095, 2.93, 0.205, 235, 200, YCP BETA5-M45T MUTANT
4611, 4inuT, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4612, 4inuF, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4613, 4intT, 0.8095, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4614, 4hrdT, 0.8095, 2.87, 0.176, 241, 199, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4615, 3nzjF, 0.8095, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4616, 3gpjQ, 0.8095, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4617, 3gpjC, 0.8095, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4618, 3dy3C, 0.8095, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4619, 3d29C, 0.8095, 2.94, 0.205, 235, 200, PROTEASOME INHIBITION BY FELLUTAMIDE B
4620, 5nifG, 0.8094, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4621, 5laiR, 0.8094, 2.93, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4622, 5laiD, 0.8094, 2.70, 0.147, 243, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4623, 5l5rT, 0.8094, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4624, 5l5rF, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4625, 5l5eR, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4626, 5l5eD, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4627, 5l5dR, 0.8094, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4628, 5l5dD, 0.8094, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4629, 5l5bT, 0.8094, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4630, 5l5bF, 0.8094, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4631, 5fg7R, 0.8094, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4632, 5d0zD, 0.8094, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4633, 5d0wR, 0.8094, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4634, 5d0wF, 0.8094, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4635, 5d0wD, 0.8094, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4636, 5d0vR, 0.8094, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4637, 5d0vD, 0.8094, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4638, 5d0tT, 0.8094, 2.96, 0.180, 241, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4639, 5d0tF, 0.8094, 2.96, 0.180, 241, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4640, 5d0sR, 0.8094, 2.96, 0.180, 241, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4641, 5d0sD, 0.8094, 2.96, 0.180, 241, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4642, 5cz9D, 0.8094, 2.58, 0.148, 244, 196, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4643, 5ahjR, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4644, 5ahjD, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4645, 4zzgG, 0.8094, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4646, 4ya7R, 0.8094, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4647, 4ya7F, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4648, 4ya7D, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4649, 4ya4T, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4650, 4ya4R, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4651, 4ya4F, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4652, 4ya4D, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4653, 4y9yR, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4654, 4y9yD, 0.8094, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4655, 4y8mT, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4656, 4y8mF, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4657, 4y8lT, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4658, 4y8lF, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4659, 4y7yT, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4660, 4y70F, 0.8094, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4661, 4qzxR, 0.8094, 2.72, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4662, 4qz3R, 0.8094, 2.93, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4663, 4qz3D, 0.8094, 2.93, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4664, 4qwuT, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4665, 4qwuF, 0.8094, 2.93, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4666, 4qwfR, 0.8094, 2.93, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4667, 4qwfD, 0.8094, 2.57, 0.148, 244, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4668, 4qw6R, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4669, 4qw6D, 0.8094, 2.70, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4670, 4qw5D, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4671, 4qvwR, 0.8094, 2.70, 0.147, 243, 197, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4672, 4qvwD, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4673, 4qvpT, 0.8094, 2.70, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4674, 4qvpF, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4675, 4qvlR, 0.8094, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH BORTEZOMIB
4676, 4qvlD, 0.8094, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH BORTEZOMIB
4677, 4qv1T, 0.8094, 2.71, 0.147, 243, 197, YCP BETA5-M45A MUTANT
4678, 4qv1F, 0.8094, 2.71, 0.147, 243, 197, YCP BETA5-M45A MUTANT
4679, 4qlqR, 0.8094, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4680, 4qlqD, 0.8094, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4681, 4q1sR, 0.8094, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4682, 4nnnT, 0.8094, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH MG132
4683, 4nnnF, 0.8094, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH MG132
4684, 4jsuR, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4685, 4jsuD, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4686, 4gk7F, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4687, 3nzjT, 0.8094, 2.70, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4688, 3mg6F, 0.8094, 2.94, 0.205, 235, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4689, 3mg4F, 0.8094, 2.94, 0.205, 235, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4690, 3dy3Q, 0.8094, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4691, 3d29T, 0.8094, 2.94, 0.205, 235, 200, PROTEASOME INHIBITION BY FELLUTAMIDE B
4692, 3d29Q, 0.8094, 2.93, 0.205, 235, 200, PROTEASOME INHIBITION BY FELLUTAMIDE B
4693, 3d29F, 0.8094, 2.95, 0.205, 235, 200, PROTEASOME INHIBITION BY FELLUTAMIDE B
4694, 5l68R, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4695, 5l68D, 0.8093, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4696, 5l5oR, 0.8093, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4697, 5l5oD, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4698, 5l5jR, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4699, 5l5jD, 0.8093, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4700, 5l5bR, 0.8093, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4701, 5l5bD, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4702, 5jhsR, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4703, 5jhsD, 0.8093, 2.93, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4704, 5jhrR, 0.8093, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4705, 5jhrD, 0.8093, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4706, 5fgaR, 0.8093, 3.06, 0.203, 242, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4707, 5fgaD, 0.8093, 3.06, 0.203, 242, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4708, 5fg9F, 0.8093, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4709, 5fg7D, 0.8093, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4710, 5d0zR, 0.8093, 2.71, 0.147, 237, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4711, 5d0wT, 0.8093, 2.70, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4712, 5czaR, 0.8093, 2.96, 0.180, 241, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4713, 5czaD, 0.8093, 2.69, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4714, 5cz9R, 0.8093, 2.96, 0.180, 241, 200, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4715, 5cz8F, 0.8093, 2.69, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4716, 5bxnR, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4717, 5bxnD, 0.8093, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4718, 5bxlR, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4719, 5bxlD, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4720, 4z1lR, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4721, 4z1lD, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4722, 4ya1T, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4723, 4ya1F, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4724, 4y7wT, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4725, 4y7wF, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4726, 4y75R, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4727, 4y70T, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4728, 4r17T, 0.8093, 2.94, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4729, 4r17F, 0.8093, 2.94, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4730, 4qzzT, 0.8093, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH OMURALIDE
4731, 4qzzF, 0.8093, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH OMURALIDE
4732, 4qzxT, 0.8093, 2.93, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4733, 4qzxF, 0.8093, 2.70, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4734, 4qzxD, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4735, 4qz1R, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4736, 4qxjR, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4737, 4qxjD, 0.8093, 2.72, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4738, 4qvpR, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4739, 4qvpD, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4740, 4qv7R, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-A50V MUTANT
4741, 4qv7F, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-A50V MUTANT
4742, 4qv0R, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4743, 4qv0D, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4744, 4quyT, 0.8093, 2.71, 0.147, 243, 197, YCP BETA5-A49S-MUTANT
4745, 4quyR, 0.8093, 2.71, 0.147, 243, 197, YCP BETA5-A49S-MUTANT
4746, 4quyF, 0.8093, 2.71, 0.147, 243, 197, YCP BETA5-A49S-MUTANT
4747, 4no9R, 0.8093, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4748, 4no9D, 0.8093, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4749, 4jt0R, 0.8093, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4750, 4jt0D, 0.8093, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4751, 4intR, 0.8093, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4752, 4inrD, 0.8093, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4753, 3gpjT, 0.8093, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4754, 3d29R, 0.8093, 2.73, 0.147, 243, 197, PROTEASOME INHIBITION BY FELLUTAMIDE B
4755, 3d29D, 0.8093, 2.73, 0.147, 243, 197, PROTEASOME INHIBITION BY FELLUTAMIDE B
4756, 1g65C, 0.8093, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4757, 5nywV, 0.8092, 2.95, 0.205, 235, 200, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4758, 5nygF, 0.8092, 2.94, 0.205, 235, 200, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4759, 5l6aR, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4760, 5l6aD, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4761, 5l5uR, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4762, 5l5uD, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4763, 5l5tR, 0.8092, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4764, 5l5tD, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4765, 5l5rR, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4766, 5l5rD, 0.8092, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4767, 5l5iR, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4768, 5l5iD, 0.8092, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4769, 5l5aR, 0.8092, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4770, 5fgfR, 0.8092, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4771, 5fgfD, 0.8092, 3.06, 0.203, 242, 202, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4772, 5fgaT, 0.8092, 3.06, 0.203, 242, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4773, 5fgaF, 0.8092, 3.06, 0.203, 242, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4774, 5fg9T, 0.8092, 3.07, 0.203, 242, 202, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4775, 5fg9R, 0.8092, 2.70, 0.147, 244, 197, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4776, 5fg9D, 0.8092, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4777, 5d0tR, 0.8092, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4778, 5czaF, 0.8092, 3.09, 0.178, 241, 202, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4779, 5cz8T, 0.8092, 3.08, 0.180, 234, 206, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4780, 5cz6R, 0.8092, 2.84, 0.167, 229, 203, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4781, 5cz6D, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4782, 5ahjT, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4783, 5ahjF, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4784, 4y8tR, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4785, 4y8pR, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4786, 4y8pD, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4787, 4y8mR, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4788, 4y8mD, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4789, 4y8jR, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4790, 4y8jD, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4791, 4y8hR, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4792, 4y8hD, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4793, 4y84R, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4794, 4y84D, 0.8092, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4795, 4y7yR, 0.8092, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4796, 4y75D, 0.8092, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4797, 4y70R, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4798, 4y70D, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4799, 4x6zS, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4800, 4qzwR, 0.8092, 2.71, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4801, 4qzwD, 0.8092, 2.72, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4802, 4qz1D, 0.8092, 2.95, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4803, 4qwuR, 0.8092, 2.95, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4804, 4qwuD, 0.8092, 2.60, 0.148, 243, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4805, 4qwiR, 0.8092, 2.60, 0.148, 243, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4806, 4qwiD, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4807, 4qw7R, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4808, 4qw7D, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4809, 4qvyR, 0.8092, 2.95, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4810, 4qvyD, 0.8092, 2.95, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4811, 4qvnR, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4812, 4qvnD, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4813, 4qv9R, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-C63F MUTANT
4814, 4qv9D, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-C63F MUTANT
4815, 4qv8T, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-C52F MUTANT
4816, 4qv8F, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-C52F MUTANT
4817, 4qv7T, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-A50V MUTANT
4818, 4qv7D, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-A50V MUTANT
4819, 4qv3R, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT
4820, 4qv3D, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT
4821, 4quyD, 0.8092, 2.87, 0.205, 242, 200, YCP BETA5-A49S-MUTANT
4822, 4nnnR, 0.8092, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH MG132
4823, 4nnnD, 0.8092, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH MG132
4824, 4intD, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4825, 4cr43, 0.8092, 2.94, 0.205, 235, 200, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4826, 3un4T, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4827, 3un4F, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4828, 3jcpP, 0.8092, 2.94, 0.205, 235, 200, 
4829, 3jcoMA, 0.8092, 2.94, 0.205, 235, 200, 
4830, 3jcoM, 0.8092, 2.94, 0.205, 235, 200, 
4831, 2zcyR, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4832, 2fakT, 0.8092, 2.95, 0.205, 235, 200, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4833, 6gopD, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4834, 5nywT, 0.8091, 2.94, 0.205, 235, 200, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4835, 5nifD, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4836, 5lttR, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4837, 5lttD, 0.8091, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4838, 5l6cR, 0.8091, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4839, 5l6cD, 0.8091, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4840, 5l67R, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4841, 5l67D, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4842, 5l5pR, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4843, 5l5pD, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4844, 5l5fR, 0.8091, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4845, 5l5fD, 0.8091, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4846, 5l5aD, 0.8091, 3.07, 0.203, 242, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4847, 5fhsR, 0.8091, 2.09, 0.198, 204, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4848, 5fhsD, 0.8091, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4849, 5d0tD, 0.8091, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4850, 5czaT, 0.8091, 2.59, 0.148, 244, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4851, 5cz7R, 0.8091, 2.59, 0.148, 244, 196, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4852, 5cghR, 0.8091, 3.02, 0.179, 241, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4853, 5cghD, 0.8091, 3.02, 0.179, 241, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4854, 4ya9R, 0.8091, 3.02, 0.179, 241, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4855, 4ya9D, 0.8091, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4856, 4y8tD, 0.8091, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4857, 4y8rT, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4858, 4y8rF, 0.8091, 3.09, 0.180, 235, 206, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4859, 4y8gR, 0.8091, 2.88, 0.176, 241, 199, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4860, 4y8gD, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4861, 4y80R, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4862, 4y80D, 0.8091, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4863, 4y7yD, 0.8091, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4864, 4y7wR, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4865, 4y7wD, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4866, 4y77R, 0.8091, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4867, 4y77D, 0.8091, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4868, 4y6vR, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4869, 4y6vD, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4870, 4r00T, 0.8091, 2.95, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4871, 4r00F, 0.8091, 2.94, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4872, 4qw4R, 0.8091, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH CARFILZOMIB
4873, 4qw4D, 0.8091, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH CARFILZOMIB
4874, 4qv5R, 0.8091, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT
4875, 4qv5D, 0.8091, 2.95, 0.205, 235, 200, YCP BETA5-M45I MUTANT
4876, 4qv4R, 0.8091, 2.94, 0.205, 235, 200, YCP BETA5-M45T MUTANT
4877, 4qv4D, 0.8091, 2.94, 0.205, 235, 200, YCP BETA5-M45T MUTANT
4878, 4quxR, 0.8091, 2.94, 0.205, 235, 200, YCP BETA5-A49T-MUTANT
4879, 4quxD, 0.8091, 2.94, 0.205, 235, 200, YCP BETA5-A49T-MUTANT
4880, 4qluR, 0.8091, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4881, 4qluD, 0.8091, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4882, 4qltT, 0.8091, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4883, 4qltF, 0.8091, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4884, 4q1sF, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4885, 4no6R, 0.8091, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4886, 4no6D, 0.8091, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4887, 4ltcF, 0.8091, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4888, 4jsqR, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4889, 4jsqD, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4890, 4j70D, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4891, 4eu2E, 0.8091, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4892, 3un8F, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4893, 3oeuF, 0.8091, 2.95, 0.205, 235, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4894, 3nzjR, 0.8091, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4895, 3mg8F, 0.8091, 2.72, 0.147, 243, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4896, 3jcpPA, 0.8091, 2.94, 0.205, 235, 200, 
4897, 3dy4T, 0.8091, 2.95, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4898, 3dy4F, 0.8091, 2.94, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4899, 3bdmT, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4900, 2zcyD, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4901, 1g65Q, 0.8091, 2.95, 0.205, 235, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4902, 6gopR, 0.8090, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4903, 5m2bR, 0.8090, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4904, 5m2bD, 0.8090, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4905, 5l69R, 0.8090, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4906, 5l69D, 0.8090, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4907, 5l66R, 0.8090, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4908, 5l66D, 0.8090, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4909, 5l61R, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4910, 5l61D, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4911, 5l5sR, 0.8090, 2.73, 0.147, 244, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4912, 5l5qR, 0.8090, 3.10, 0.203, 242, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4913, 5l5hR, 0.8090, 3.10, 0.203, 242, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4914, 5l5hD, 0.8090, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4915, 5fg7T, 0.8090, 3.02, 0.204, 242, 201, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4916, 5fg7F, 0.8090, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4917, 5dkjR, 0.8090, 2.72, 0.147, 237, 197, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4918, 5dkjD, 0.8090, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4919, 5d0xR, 0.8090, 2.71, 0.147, 237, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4920, 5d0xD, 0.8090, 2.59, 0.148, 244, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4921, 5cz7D, 0.8090, 2.70, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4922, 5cz5R, 0.8090, 2.70, 0.147, 244, 197, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4923, 5cz5D, 0.8090, 2.60, 0.148, 244, 196, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4924, 5cgfF, 0.8090, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4925, 4z1lT, 0.8090, 3.09, 0.178, 241, 202, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4926, 4z1lF, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4927, 4y8lR, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4928, 4y8lD, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4929, 4y74R, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4930, 4y74D, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4931, 4x6zG, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4932, 4rurR, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4933, 4rurD, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4934, 4qzzR, 0.8090, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH OMURALIDE
4935, 4qzzD, 0.8090, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH OMURALIDE
4936, 4qwrR, 0.8090, 2.96, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4937, 4qwrD, 0.8090, 2.95, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4938, 4qwkR, 0.8090, 2.95, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4939, 4qwkD, 0.8090, 2.71, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4940, 4qvmR, 0.8090, 2.71, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4941, 4qvmD, 0.8090, 2.95, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4942, 4qv3T, 0.8090, 2.95, 0.205, 235, 200, YCP BETA5-M45V MUTANT
4943, 4qv3F, 0.8090, 2.95, 0.205, 235, 200, YCP BETA5-M45V MUTANT
4944, 4qv1R, 0.8090, 2.95, 0.205, 235, 200, YCP BETA5-M45A MUTANT
4945, 4qv1D, 0.8090, 2.95, 0.205, 235, 200, YCP BETA5-M45A MUTANT
4946, 4qbyF, 0.8090, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4947, 4no8T, 0.8090, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4948, 4no8F, 0.8090, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4949, 4lqiR, 0.8090, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4950, 4j70F, 0.8090, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4951, 4intF, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4952, 4inrF, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4953, 3wxrU, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4954, 3wxrG, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4955, 3nzjD, 0.8090, 2.62, 0.148, 244, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4956, 3mg6T, 0.8090, 2.96, 0.205, 235, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4957, 3mg4X, 0.8090, 2.96, 0.205, 235, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4958, 3dy3D, 0.8090, 2.95, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4959, 3bdmF, 0.8090, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4960, 5nywK, 0.8089, 2.94, 0.205, 235, 200, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4961, 5nywI, 0.8089, 2.94, 0.205, 235, 200, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4962, 5l63R, 0.8089, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4963, 5l63D, 0.8089, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4964, 5l62R, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4965, 5l62D, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4966, 5l5zR, 0.8089, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4967, 5l5zD, 0.8089, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4968, 5l5xR, 0.8089, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4969, 5l5xD, 0.8089, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4970, 5l5sD, 0.8089, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4971, 5l5qD, 0.8089, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4972, 5fgiR, 0.8089, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4973, 5fgiD, 0.8089, 2.98, 0.204, 242, 201, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4974, 5fghR, 0.8089, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4975, 5fghD, 0.8089, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4976, 5fgeR, 0.8089, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4977, 5fgeD, 0.8089, 2.71, 0.147, 237, 197, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4978, 5fgdR, 0.8089, 2.73, 0.147, 237, 197, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4979, 5fgdD, 0.8089, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4980, 5cgfT, 0.8089, 2.72, 0.147, 237, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4981, 5bouR, 0.8089, 2.09, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4982, 5bouD, 0.8089, 3.02, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4983, 4ya5R, 0.8089, 2.60, 0.148, 244, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4984, 4ya5D, 0.8089, 3.09, 0.180, 233, 206, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4985, 4y8qR, 0.8089, 3.09, 0.180, 233, 206, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4986, 4y8qD, 0.8089, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4987, 4y8oR, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4988, 4y8oD, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4989, 4y8nR, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4990, 4y8nD, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4991, 4y8iR, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4992, 4y8iD, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4993, 4y8hT, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4994, 4y8hF, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4995, 4y82R, 0.8089, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4996, 4y82D, 0.8089, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4997, 4qwjR, 0.8089, 2.95, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4998, 4qwjD, 0.8089, 2.96, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4999, 4qw0R, 0.8089, 2.96, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
5000, 4qw0D, 0.8089, 2.94, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
